<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE MedlineCitationSet PUBLIC "-//NLM//DTD Medline Citation, 1st January 2008//EN"
                                    "http://www.nlm.nih.gov/databases/dtd/nlmmedline_080101.dtd">
<MedlineCitationSet>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>267801</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-4970</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>26</Volume>
<Issue>1</Issue>
<PubDate>
<MedlineDate>1977 Jan-Mar</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Minerva stomatologica</Title>
</Journal>
<ArticleTitle>[Hyperostosis on the alveolar process margin]</ArticleTitle>
<Pagination>
<MedlinePgn>17-24</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Defects of the bone margin requiring ostectomy and osteoplasty include hyperostotic processes, formations which, while recalling palatine and mandibular tori, have their own nosological slot. Hyperostosis is characterized by thickening of the cervical margin and is linked by a narrow isthmus to the underlying bone plane; it occurs with greatest frequency in the vestibular region. The personal case, in a man of 52, presented two sausage-shaped protuberances located apically at the alveolar margin in the two left arches. Their removal presented no problem of surgical technique as the hyperostosis had no close links with the underlying bone planes. Histological examination of the fragments showed that the hyperostotic tissue consisted of fascicular bone with an intima vascular component. Two years after the operation, the patient presents no signs of relapse and would appear to be completely cured.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Calandriello</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Borsetti</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Le iperostosi del margine osseo alveolare.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>ITALY</Country>
<MedlineTA>Minerva Stomatol</MedlineTA>
<NlmUniqueID>0421071</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Alveolar Process</DescriptorName>
<QualifierName MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Exostoses</DescriptorName>
<QualifierName MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mandible</DescriptorName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Maxilla</DescriptorName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>267802</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-4970</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>26</Volume>
<Issue>1</Issue>
<PubDate>
<MedlineDate>1977 Jan-Mar</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Minerva stomatologica</Title>
</Journal>
<ArticleTitle>[The role of supplementary canaliculi in the etiology and therapy of periapical lesions]</ArticleTitle>
<Pagination>
<MedlinePgn>25-30</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Viti</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Messina</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Il ruolo dei canali supplementari nella genesi e terapia delle lesioni periapicali.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>ITALY</Country>
<MedlineTA>Minerva Stomatol</MedlineTA>
<NlmUniqueID>0421071</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dental Pulp Necrosis</DescriptorName>
<QualifierName MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Periapical Granuloma</DescriptorName>
<QualifierName MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Root Canal Therapy</DescriptorName>
<QualifierName MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329096</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-4970</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>26</Volume>
<Issue>1</Issue>
<PubDate>
<MedlineDate>1977 Jan-Mar</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Minerva stomatologica</Title>
</Journal>
<ArticleTitle>[Prosthetic rehabilitation by means of removable dentures with wires for the distribution of forces in Kennedy class 2a and 2a modification 1]</ArticleTitle>
<Pagination>
<MedlinePgn>31-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Prosthetic rehabilitation of unilateral distal edentulism (Kennedy class 2) and its combination with intercalated absence on the other side (class 2, modification 1) is discussed. Success obtained in a series of 29 cases followed for 9 yr using a removable prosthesis is described. This solved the difficult problems involved by employing metal wires to distribute the forces axially on the abutment teeth and over the unilateral edentulous ridge, thus creating a mixed dental and mucosal support.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pezzoli</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Borio</LastName>
<ForeName>P S</ForeName>
<Initials>PS</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>La riabilitazione protesicaper mezzo di protesi rimovibile con distribuzione di forze mediante fili nella 2a classe di Kennedy e 2a modificazione 1.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>ITALY</Country>
<MedlineTA>Minerva Stomatol</MedlineTA>
<NlmUniqueID>0421071</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Biophysics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dental Occlusion, Balanced</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dental Stress Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Denture Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Denture, Partial, Removable</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>267803</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-4970</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>26</Volume>
<Issue>1</Issue>
<PubDate>
<MedlineDate>1977 Jan-Mar</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Minerva stomatologica</Title>
</Journal>
<ArticleTitle>[The topical use of Boutycin (indomethacin) in odontostomatology. Clinical study]</ArticleTitle>
<Pagination>
<MedlinePgn>37-41</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The effect of indomethacin used topically for postoperative pain and oedema has been studied. The effect is positive and is particularly evident in the case of pain.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sapelli</LastName>
<ForeName>P L</ForeName>
<Initials>PL</Initials>
</Author>
</AuthorList>
<Language>ita</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>L'uso topico del Boutycin (indometacina) in odontostomatologia. Ricerche cliniche.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>ITALY</Country>
<MedlineTA>Minerva Stomatol</MedlineTA>
<NlmUniqueID>0421071</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>53-86-1</RegistryNumber>
<NameOfSubstance>Indomethacin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>D</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Administration, Topical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Edema</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Indomethacin</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pain</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Postoperative Complications</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Tooth Extraction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tooth, Impacted</DescriptorName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882087</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-6620</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>74</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Missouri medicine</Title>
</Journal>
<ArticleTitle>Physician manpower in Missouri: 1975.</ArticleTitle>
<Pagination>
<MedlinePgn>239-42</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Remmert</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mo Med</MedlineTA>
<NlmUniqueID>0400744</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Foreign Medical Graduates</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Missouri</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Physicians</DescriptorName>
<QualifierName MajorTopicYN="Y">supply &amp; distribution</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882088</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2005</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-6620</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>74</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Missouri medicine</Title>
</Journal>
<ArticleTitle>Treatment of tension and migraine headaches with biofeedback techniques.</ArticleTitle>
<Pagination>
<MedlinePgn>253-5</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fried</LastName>
<ForeName>F E</ForeName>
<Initials>FE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lamberti</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sneed</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mo Med</MedlineTA>
<NlmUniqueID>0400744</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Biofeedback (Psychology)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Headache</DescriptorName>
<QualifierName MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Migraine Disorders</DescriptorName>
<QualifierName MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vascular Headaches</DescriptorName>
<QualifierName MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882089</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-6620</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>74</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Missouri medicine</Title>
</Journal>
<ArticleTitle>Use of computers in radiation oncology.</ArticleTitle>
<Pagination>
<MedlinePgn>256-7, 260</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Richter</LastName>
<ForeName>C W</ForeName>
<Initials>CW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Canoy</LastName>
<ForeName>N R</ForeName>
<Initials>NR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mo Med</MedlineTA>
<NlmUniqueID>0400744</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Computers</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Information Systems</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radiotherapy Dosage</DescriptorName>
<QualifierName MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Registries</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882090</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-6620</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>74</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Missouri medicine</Title>
</Journal>
<ArticleTitle>Carcinoma of the vulva. Case report.</ArticleTitle>
<Pagination>
<MedlinePgn>258-60</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zeller</LastName>
<ForeName>D E</ForeName>
<Initials>DE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Newman</LastName>
<ForeName>R L</ForeName>
<Initials>RL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mo Med</MedlineTA>
<NlmUniqueID>0400744</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
<QualifierName MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hemangioma</DescriptorName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vulvar Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
<QualifierName MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882091</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-6620</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>74</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Missouri medicine</Title>
</Journal>
<ArticleTitle>Halothane hepatitis. Case report.</ArticleTitle>
<Pagination>
<MedlinePgn>261-3</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Huffman</LastName>
<ForeName>T L</ForeName>
<Initials>TL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wilkinson</LastName>
<ForeName>E A</ForeName>
<Initials>EA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mo Med</MedlineTA>
<NlmUniqueID>0400744</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>151-67-7</RegistryNumber>
<NameOfSubstance>Halothane</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Anesthesia, Inhalation</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Halothane</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hepatitis, Toxic</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Jaundice</DescriptorName>
<QualifierName MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882092</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-6620</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>74</Volume>
<Issue>7</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Missouri medicine</Title>
</Journal>
<ArticleTitle>Remarks of Max S. Franklin, M.D., President.</ArticleTitle>
<Pagination>
<MedlinePgn>285-6, 290</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Franklin</LastName>
<ForeName>M S</ForeName>
<Initials>MS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mo Med</MedlineTA>
<NlmUniqueID>0400744</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Missouri</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Societies, Medical</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>162630</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>Nursing homes don't see cost cuts despite new fire protection equipment.</ArticleTitle>
<Pagination>
<MedlinePgn>22-3</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Costs and Cost Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Equipment and Supplies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fires</DescriptorName>
<QualifierName MajorTopicYN="Y">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Insurance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nursing Homes</DescriptorName>
<QualifierName MajorTopicYN="Y">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142197</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>Three states are likely to continue abortion funding for Medicaid patient.</ArticleTitle>
<Pagination>
<MedlinePgn>26</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Abortion, Legal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">California</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Maryland</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Medicaid</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">New York</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142198</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>Johnson Foundation puts $43 million into healthcare improvement projects.</ArticleTitle>
<Pagination>
<MedlinePgn>30-2</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mayer</LastName>
<ForeName>E M</ForeName>
<Initials>EM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Financing, Organized</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Foundations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Health Services</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">New Jersey</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142199</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>Health systems agencies are seeking more power over capital expenditures.</ArticleTitle>
<Pagination>
<MedlinePgn>35</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Simler</LastName>
<ForeName>S L</ForeName>
<Initials>SL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Capital Expenditures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Economics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Health Planning</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Legislation as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142200</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>HSAs making hospitals more cautious in buying new imaging equipment.</ArticleTitle>
<Pagination>
<MedlinePgn>36</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Equipment and Supplies, Hospital</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Organizations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Purchasing, Hospital</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radionuclide Imaging</DescriptorName>
<QualifierName MajorTopicYN="N">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Regional Health Planning</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rural Health</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="N">instrumentation</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142201</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>Emission scanning units 'steal' the nuclear show.</ArticleTitle>
<Pagination>
<MedlinePgn>40-1</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Traska</LastName>
<ForeName>M R</ForeName>
<Initials>MR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Equipment and Supplies, Hospital</DescriptorName>
<QualifierName MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radionuclide Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y">instrumentation</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142202</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>New devices extend nuclear imaging.</ArticleTitle>
<Pagination>
<MedlinePgn>41-2</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radionuclide Imaging</DescriptorName>
<QualifierName MajorTopicYN="Y">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ultrasonography</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142203</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>Ultrasound device tells burn extent in seconds.</ArticleTitle>
<Pagination>
<MedlinePgn>46</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Traska</LastName>
<ForeName>M R</ForeName>
<Initials>MR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Burns</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ultrasonics</DescriptorName>
<QualifierName MajorTopicYN="N">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Ultrasonography</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142204</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>Hospitals, manufacturers fuzzy about who's liable in testing new technology.</ArticleTitle>
<Pagination>
<MedlinePgn>48</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Meyer</LastName>
<ForeName>E M</ForeName>
<Initials>EM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Equipment and Supplies, Hospital</DescriptorName>
<QualifierName MajorTopicYN="Y">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hospital Administration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Jurisprudence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Technology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142205</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>Hospitals seek to reduce labor cost.</ArticleTitle>
<Pagination>
<MedlinePgn>50</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Traska</LastName>
<ForeName>M R</ForeName>
<Initials>MR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Economics, Hospital</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Equipment and Supplies, Hospital</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Personnel Administration, Hospital</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142206</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>Proposed IRS rules reduce the appeal of refunding plans.</ArticleTitle>
<Pagination>
<MedlinePgn>56, 62</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fearheller</LastName>
<ForeName>D G</ForeName>
<Initials>DG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Economics, Hospital</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Government Agencies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Income Tax</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142207</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>Hospitals need new budgeting systems.</ArticleTitle>
<Pagination>
<MedlinePgn>61-2</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bowman</LastName>
<ForeName>R W</ForeName>
<Initials>RW</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Economics, Hospital</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142208</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0160-7480</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>7</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Modern healthcare</Title>
</Journal>
<ArticleTitle>Questions remains: can staff be sued?</ArticleTitle>
<Pagination>
<MedlinePgn>64, 67</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Horty</LastName>
<ForeName>J F</ForeName>
<Initials>JF</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Healthc</MedlineTA>
<NlmUniqueID>7801798</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Institutional Practice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Jurisprudence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Medical Staff, Hospital</DescriptorName>
<QualifierName MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">New Jersey</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882093</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Evaluating your CPA.</ArticleTitle>
<Pagination>
<MedlinePgn>496, 499</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vargo</LastName>
<ForeName>R J</ForeName>
<Initials>RJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Accounting</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Veterinary Medicine</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882094</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Cutting your malpractice risk.</ArticleTitle>
<Pagination>
<MedlinePgn>501-7</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Communication</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fees and Charges</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Insurance, Liability</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Malpractice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Records as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Veterinary Medicine</DescriptorName>
<QualifierName MajorTopicYN="N">manpower</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882095</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>A new prophylactic approach to reduction of piglet mortality.</ArticleTitle>
<Pagination>
<MedlinePgn>509-10, 513, 515</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ashmead</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Beck</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hopson</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hemoglobins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Iron Chelating Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7439-89-6</RegistryNumber>
<NameOfSubstance>Iron</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9004-66-4</RegistryNumber>
<NameOfSubstance>Iron-Dextran Complex</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Anemia, Hypochromic</DescriptorName>
<QualifierName MajorTopicYN="N">prevention &amp; control</QualifierName>
<QualifierName MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hemoglobins</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Iron</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Iron Chelating Agents</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Iron-Dextran Complex</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Maternal-Fetal Exchange</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Swine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Swine Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">prevention &amp; control</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882096</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Efficacy of levamisole resinate against Dirofilaria immitis in dogs.</ArticleTitle>
<Pagination>
<MedlinePgn>518-20</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bradley</LastName>
<ForeName>R E</ForeName>
<Initials>RE</Initials>
<Suffix>Sr</Suffix>
</Author>
<Author ValidYN="Y">
<LastName>Alford</LastName>
<ForeName>B T</ForeName>
<Initials>BT</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>14769-73-4</RegistryNumber>
<NameOfSubstance>Levamisole</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood</DescriptorName>
<QualifierName MajorTopicYN="N">parasitology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dirofilariasis</DescriptorName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N">parasitology</QualifierName>
<QualifierName MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dog Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N">parasitology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Levamisole</DescriptorName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microfilaria</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882097</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Preputial defect in a puppy.</ArticleTitle>
<Pagination>
<MedlinePgn>522-3</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jacobs</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Baughman</LastName>
<ForeName>G L</ForeName>
<Initials>GL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dog Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">congenital</QualifierName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Penis</DescriptorName>
<QualifierName MajorTopicYN="Y">abnormalities</QualifierName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882098</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Rectal neoplasia in the dog.</ArticleTitle>
<Pagination>
<MedlinePgn>525-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nelson</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Theilen</LastName>
<ForeName>G H</ForeName>
<Initials>GH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenocarcinoma</DescriptorName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
<QualifierName MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Dog Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rectal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
<QualifierName MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882099</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Colic colloquy.</ArticleTitle>
<Pagination>
<MedlinePgn>543-7</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Colic</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Horse Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Horses</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>560621</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Between pets and people...the communications gap.</ArticleTitle>
<Pagination>
<MedlinePgn>549, 551</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Campbell</LastName>
<ForeName>W E</ForeName>
<Initials>WE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Behavior, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sexual Behavior, Animal</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882100</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Surgery for ectropion in dogs.</ArticleTitle>
<Pagination>
<MedlinePgn>559, 561</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dog Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ectropion</DescriptorName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
<QualifierName MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Methods</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882101</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>7</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Correcting employees.</ArticleTitle>
<Pagination>
<MedlinePgn>582, 585, 587</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Fair</LastName>
<ForeName>T L</ForeName>
<Initials>TL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Personnel Management</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Veterinary Medicine</DescriptorName>
<QualifierName MajorTopicYN="Y">manpower</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>560622</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>7</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Peer review.</ArticleTitle>
<Pagination>
<MedlinePgn>589-93</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Denholm</LastName>
<ForeName>B E</ForeName>
<Initials>BE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Education, Continuing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Education, Veterinary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Licensure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Peer Review</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Professional Review Organizations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Veterinary Medicine</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329097</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>7</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Toxicity of aminoglycoside antibiotics.</ArticleTitle>
<Pagination>
<MedlinePgn>594-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In cats, aminoclycosides cause vestibular damage followed in a few days by renal damage. The reverse is true in the dog, except that streptomycin causes vestibular damage prior to renal damage. To avoid toxicities, therapeutic doses of aminoglycosides should not be given longer than a week and they should be given cautiously in animals with renal impairment. Failure of the kidneys to eliminate aminoglycosides will result in very high blood levels, even with therapeutic doses, that can cause further renal and vestibular damage. The oral administration of aminoglycosides is seldom dangerous when normal therapeutic doses are employed. Although it is remote, the possibility exists that animals with renal impairment and intestinal obstruction may become intoxicated. Kanamycin is less nephrotoxic to dogs than neomycin and it is less destructive to the auditory nerve than vestibular damage than streptomycin. Gentamicin in cats is twice as toxic to the vestibular apparatus as streptomycin and more toxic to the cochlea than streptomycin or dihydrostreptomycin. Neomycin is more toxic than kanamycin, gentamicin, and streptomycin to both cats and dogs. Amikacin causes renal damage in dogs similar to other aminoglycosides. It also causes vestibular damage.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Clark</LastName>
<ForeName>C H</ForeName>
<Initials>CH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Aminoglycosides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Gentamicins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>1404-04-2</RegistryNumber>
<NameOfSubstance>Neomycin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>57-92-1</RegistryNumber>
<NameOfSubstance>Streptomycin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>59-01-8</RegistryNumber>
<NameOfSubstance>Kanamycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aminoglycosides</DescriptorName>
<QualifierName MajorTopicYN="Y">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ataxia</DescriptorName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cat Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Deafness</DescriptorName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dog Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gentamicins</DescriptorName>
<QualifierName MajorTopicYN="N">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heart Rate</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kanamycin</DescriptorName>
<QualifierName MajorTopicYN="N">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kidney Tubular Necrosis, Acute</DescriptorName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neomycin</DescriptorName>
<QualifierName MajorTopicYN="N">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rabbits</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Respiratory Paralysis</DescriptorName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Streptomycin</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N">toxicity</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>41</NumberOfReferences>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407441</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>7</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Diabetic ketoacidosis.</ArticleTitle>
<Pagination>
<MedlinePgn>601-6</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Feldman</LastName>
<ForeName>E C</ForeName>
<Initials>EC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ettinger</LastName>
<ForeName>S J</ForeName>
<Initials>SJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Ketones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>11061-68-0</RegistryNumber>
<NameOfSubstance>Insulin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7447-40-7</RegistryNumber>
<NameOfSubstance>Potassium Chloride</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diabetic Ketoacidosis</DescriptorName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N">urine</QualifierName>
<QualifierName MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Dog Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glycosuria</DescriptorName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infusions, Parenteral</DescriptorName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Insulin</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ketones</DescriptorName>
<QualifierName MajorTopicYN="N">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Potassium Chloride</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407442</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>7</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Esophageal diverticula in a dog.</ArticleTitle>
<Pagination>
<MedlinePgn>606, 613</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Iwasaki</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>de Alvarenga</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>de Martin</LastName>
<ForeName>B W</ForeName>
<Initials>BW</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diverticulum, Esophageal</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
<QualifierName MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Dog Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>560623</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>7</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Intra-abdominal soft-tissue calcifications.</ArticleTitle>
<Pagination>
<MedlinePgn>619-23</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ackerman</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Silverman</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Calcinosis</DescriptorName>
<QualifierName MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dog Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Liver Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nephrocalcinosis</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Prostatic Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Urinary Bladder Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882102</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>7</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Interaction of hoof with ground.</ArticleTitle>
<Pagination>
<MedlinePgn>624-5</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rooney</LastName>
<ForeName>J R</ForeName>
<Initials>JR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Biomechanics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hoof and Claw</DescriptorName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Horses</DescriptorName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Locomotion</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>560624</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>7</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Guard dog vs. family dog.</ArticleTitle>
<Pagination>
<MedlinePgn>626, 628</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Campbell</LastName>
<ForeName>W E</ForeName>
<Initials>WE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aggression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Behavior, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Dogs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Emotions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Social Behavior</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196170</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2005</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0362-8140</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>58</Volume>
<Issue>7</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Modern veterinary practice</Title>
</Journal>
<ArticleTitle>Respiratory disease in horses.</ArticleTitle>
<Pagination>
<MedlinePgn>635, 637, 639</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mod Vet Pract</MedlineTA>
<NlmUniqueID>7802904</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Herpesviridae Infections</DescriptorName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Herpesvirus 1, Equid</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Horse Diseases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Horses</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
<QualifierName MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName MajorTopicYN="N">veterinary</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329098</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2005</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Genetic analysis of mutations affecting ribonuclease II in Escherichia coli.</ArticleTitle>
<Pagination>
<MedlinePgn>1-4</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Exonuclease activity in an Escherichia coli K12 mutant S296 is less than 1% of that in the wild type strain (Nikolaev et al., 1976). Another mutant N464 has thermolabile ribonuclease II (Castles and Singer, 1968; Kuwano et al., 1969). Genetic analysis of these mutants by Hfr conjugation and P1 transduction indicates that the structural gene (rnb) for ribonuclease II is located near the pyrF gene (28 min on the E. coli genetic map of Bachmann, Low and Taylor (1976)), and the most probable gene order is tyrT-trp-pyrF-rnb.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ono</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kuwano</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 3.1.-</RegistryNumber>
<NameOfSubstance>Endonucleases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.-</RegistryNumber>
<NameOfSubstance>Ribonucleases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosome Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosomes, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Endonucleases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName MajorTopicYN="N">growth &amp; development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Genes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribonucleases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Temperature</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transduction, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329099</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Host-dependent modification of bacteriophage T7 and SAMase-negative T3 derivatives affecting their adsorption ability.</ArticleTitle>
<Pagination>
<MedlinePgn>107-10</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>When passaging phage T7 and SAMase-negative T3 mutants between E. coli strains with identical (EcoB) or without (EcoO) DNA host specificity, phenotypically a host-controlled modification and restriction is observed. This phenomenon is not due to &quot;classical&quot; modification and restriction of the bacteriophage DNA but depends on the reversibly altered adsorption capacity of the phages on the different host strains.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Krüger</LastName>
<ForeName>D H</ForeName>
<Initials>DH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hansen</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schroeder</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Presber</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.-</RegistryNumber>
<NameOfSubstance>Endonucleases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.21.-</RegistryNumber>
<NameOfSubstance>DNA Restriction Enzymes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.1.1.-</RegistryNumber>
<NameOfSubstance>Carboxy-Lyases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.1.1.50</RegistryNumber>
<NameOfSubstance>Adenosylmethionine Decarboxylase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosylmethionine Decarboxylase</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adsorption</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carboxy-Lyases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Coliphages</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA Restriction Enzymes</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA Viruses</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">DNA, Viral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Endonucleases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenotype</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887068</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Mitochondrial genes in Podospora anserina: recombination and linkage.</ArticleTitle>
<Pagination>
<MedlinePgn>11-21</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A fifth cytoplasmic mutation (capr 1) obtained in Podospora anserina is described. In addition to chloramphenicol resistance it confers a strong deficiency in cytochrome aa3 and impairs the germination of ascospores. Genetic analysis shows: 1) strict maternal inheritance of (capr 1) allele; 2) selection against the (capr 1) allele as well in sexual crosses as during vegetative growth; 3) complete reversion of this selection by even low concentration of CAP. On the basis of their cytoplasmic inheritance and altered cytochrome spectra the five cytoplasmic mutations are assumed to be mitochondrial. Analysis of crosses between them allows to class them in 3 loci, 2 of which being closely linked.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Belcour</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Begel</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>56-75-7</RegistryNumber>
<NameOfSubstance>Chloramphenicol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Alleles</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Ascomycota</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chloramphenicol</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosome Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Crosses, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Resistance, Microbial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Genes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Linkage (Genetics)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mitochondria</DescriptorName>
<QualifierName MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Recombination, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887069</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Inhibitors of mitochondrial function prevent senescence in the ascomycete Podosprora anserina.</ArticleTitle>
<Pagination>
<MedlinePgn>111-3</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The onset of senescence, i.e. decrease of growth rate followed by cellular death, is prevented when inhibitors of mitochondrial function (ethidium-bromide, streptomycin, tiamulin) are present in the culture medium. If mycelia are transferred to a medium not containing one of these substances, senescence occurs after the usual time interval (30 d at 26 degrees C). Inhibitors of cytoplasmic protein synthesis such as emetine and cycloheximide have no effect in preventing senescence.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tudzynski</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Esser</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Culture Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>3546-21-2</RegistryNumber>
<NameOfSubstance>Ethidium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>57-92-1</RegistryNumber>
<NameOfSubstance>Streptomycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ascomycota</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Culture Media</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ethidium</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mitochondria</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Streptomycin</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329100</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Dependence of DNA dark repair on protein synthesis in Escherichia coli.</ArticleTitle>
<Pagination>
<MedlinePgn>23-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We investigated the influence of amino-acidless treatments applied prior and after UV irradiation (AA-irradiated AA+; AA-irradiated A-; AA+ irradiated AA-) on survival, dimer excision, postirradiation DNA degradation, DNA synthesis and sedimentation profiles of parental DNA of E. coli B/r Hcr+ cells. In dependence on the treatment applied, the fluence 50 J/m2 yielded distinctly different fractions of survivors within 0,03-85%. In all cases dimers were completely excised. The rate of DNA degradation was similar during a 30-40 min period after UV during which the bulk of dimers was excised. Degradation ceased, however, earlier in the prestarved cells than in exponentially growing ones; it was prolonged by aminoacidless postincubation. Sedimentation profiles of parental DNA did not differ during the whole period of dimer excision. In AA+ AA- cells DNA synthesis was not restored for several hours after addition of amino acids. In AA- AA- cells addition of amino acids resulted in a fast resumption of DNA synthesis. We conclude that removal of dimers and repair of gaps were similar in all cases. We believe that aminoacidless treatments influence production and repair of damage to the sites of DNA replication. The treatment appears to prevent this damage when applied before UV irradiation, but interferes with its restoration when applied after UV irradiation. Consequently, the former treatment increases survival of cells while the latter produces an opposite effect.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sedliaková</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Prachar</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Masek</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Amino Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Bacterial</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Amino Acids</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">DNA Repair</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Darkness</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Ultraviolet Rays</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887070</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2001</Year>
<Month>03</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Characterization of glycerol nonutilizing and protoperithecial mutants of Neurospora.</ArticleTitle>
<Pagination>
<MedlinePgn>29-38</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Mutants defective in polyol metabolism and/or in protoperithecial development were selected in Neurospora tetrasperma, a species in which protoperithecial development occurs at nonpermissively high temperature if certain polyols are used in lieu of sucrose as carbon source. Mutants selected for nonutilization of one of the four polyols tested, glycerol, mannitol, sorbitol, or xylitol, were usually found to be nonutilizers of the other three polyols as well. Mutants blocked at various stages of protoperithecial development complemented pairwise to produce more advanced developmental stages, usually mature protoperithecia and, when of opposite mating type, mature perithecia. About one-third of the mutants manifested both polyol auxotrophy and defective protoperithecial development upon initial isolation, but protoperithecial defectiveness in such mutants usually showed erratic segregation in crosses and/or instability to repeated vegetative transfer, whereas polyol auxotrophy usually did not and was, therefore, studied further. Two glycerol nonutilizing strains were introgressed into N. crassa to facilitate genetic analysis. One, glp-4, lacked both inducible and constitutive glycerol kinase and mapped to linkage group VI, between ad-1 and rib-1; the other, glp-5, lacked glyceraldehyde kinase and mapped to linkage group I, proximal to ad-9. Another mutant, gly-u(234), has been reported by other investigators to lack inducible glycerol kinase but to map to linkage group I, distal to ad-9.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Viswanath-Reddy</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bennett</LastName>
<ForeName>S N</ForeName>
<Initials>SN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Howe</LastName>
<ForeName>H B</ForeName>
<Initials>HB</Initials>
<Suffix>Jr</Suffix>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>50-70-4</RegistryNumber>
<NameOfSubstance>Sorbitol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>56-81-5</RegistryNumber>
<NameOfSubstance>Glycerol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>69-65-8</RegistryNumber>
<NameOfSubstance>Mannitol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>87-99-0</RegistryNumber>
<NameOfSubstance>Xylitol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosome Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Genetic Complementation Test</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glycerol</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Linkage (Genetics)</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mannitol</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neurospora</DescriptorName>
<QualifierName MajorTopicYN="N">growth &amp; development</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sorbitol</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Xylitol</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329101</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Host factor for coliphage Q beta RNA replication: presence in procaryotes and association with the 30S ribosomal subunit in Escherichia coli.</ArticleTitle>
<Pagination>
<MedlinePgn>39-43</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The Host Factor required for in vitro coliphage Q beta RNA replication, a heat-stable RNA binding protein present in uninfected Escherichia coli, has been detected by both immunological and functional tests in Acinetobacter calcoaceticus, Klebsiella pneumoniae, Pseudomonas aeruginosa and Pseudomonas putida. It was not detectable by these criteria in Bacillus stearothermophilus, Bacillus subtilis, Caulobacter crescentus, Micrococcus lysodeikticus, Rhodopseudomonas capsulata or Saccharomyces cerevisiae. In Escherichia coli the Host Factor protein has been shown to be associated with ribosomes. It is demonstrated here that this association is specific for the 30S ribosomal subunit.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>DuBow</LastName>
<ForeName>M S</ForeName>
<Initials>MS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ryan</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Young</LastName>
<ForeName>R A</ForeName>
<Initials>RA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Blumenthal</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Carrier Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acinetobacter</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carrier Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Coliphages</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Klebsiella pneumoniae</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pseudomonas</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA Viruses</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">RNA, Viral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribosomes</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Virus Replication</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329102</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Trans-dominance of dnaA mutants in Escherichia coli.</ArticleTitle>
<Pagination>
<MedlinePgn>45-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Temperature sensitivity of growth and DNA synthesis was tested in merogenotes heterozygous for the dnaA allele. All combinations tested (F dnaA+/dnaA5, F dnaA+/dnaA46, F dnaA+/dnaA204, F dnaA5/dnaA+, F dnaA204/dnaA+) were temperature sensitive. The mutant dnaA allele is thus trans-dominant to the wild type allele.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zahn</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tippe-Schindler</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Messer</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Bacterial</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Alleles</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">DNA, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="N">growth &amp; development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Genes, Dominant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Genetic Complementation Test</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heterozygote</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Temperature</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329103</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>05</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Incompatibility and bacteriophage inhibition properties of N-1, a plasmid belonging to the H2 incompatibility group.</ArticleTitle>
<Pagination>
<MedlinePgn>5-10</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>N-1, a plasmid isolated from a strain of Shigella flexneri in Japan more than 10 years ago, mediates the phage inhibition phenotype which has recently been found to be characteristic of plasmids of the H2 incompatibility group. Using the criteria of phage inhibition, surface exclusion and incompatibility, the N-1 plasmid is shown to be closely related to H2 plasmids isolated from non-typhoid salmonella and distantly related to H1 plasmids isolated from Salmonella typhi. Plasmids of other incompatibility groups did not show the H2 type of phage inhibition.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>D E</ForeName>
<Initials>DE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Grant</LastName>
<ForeName>R B</ForeName>
<Initials>RB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antigens, Bacterial</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Bacterial</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antigens, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Bacteriophages</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Extrachromosomal Inheritance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Flagella</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nucleic Acid Hybridization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Plasmids</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Shigella flexneri</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329104</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Transcription of insertion elements IS1 and IS2 in vitro.</ArticleTitle>
<Pagination>
<MedlinePgn>51-60</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Insertion elements IS1 and IS2 integrated within the gal operator-promoter region, an IS1 element in gene galT and insertions IS1 and IS2 integrated in the xycIIOP region of phage lambda were transcribed in vitro with E. coli RNA-polymerase. The insertion elements are transcribed exclusively by polymerase molecules started at the gal promoter and the lambdaPR promoter respectively. No promoter exists on IS1 or IS2 which can be recognized by RNA-polymerase in the pure in vitro transcription system used. Both insertions apparently are transcribed with a lower elongation rate than gal operon DNA or lambdaDNA. RNAs transcribed from the termini of IS1 and IS2 respectively were analysed by hybridization experiments. They are different in sequence.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Besemer</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Molzberger</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Bacterial</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Bacterial</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.7.6</RegistryNumber>
<NameOfSubstance>DNA-Directed RNA Polymerases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA-Directed RNA Polymerases</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Genes, Regulator</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nucleic Acid Hybridization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Operon</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Peptide Chain Elongation, Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Peptide Chain Initiation, Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Transcription, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18658</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>A comparison of the genetic and physical size of the streptomycin resistance locus in Pneumococcus.</ArticleTitle>
<Pagination>
<MedlinePgn>61-73</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Polyacrylamide gel electrophoresis of the 30S ribosomal proteins derived from six streptomycin resistant strains indicates that each mutation alters the same ribosomal protein (str-r protein). Preliminary data utilizing SDS gels indicates that the str-r protein has a molecular weight between 10,000 and 20,000 daltons. No significant differences could be detected between the molecular weight of the str-r protein when it is derived either from a sensitive or from a resistant strain, including those derived from strains carrying multisite mutations of different genetic size. We have estimated the size of the multisite str-r mutations to be less than 30 base pairs. Two factor crosses with str-r markers in the trans position demonstrate recombination frequencies expected of closely linked, intragenic markers although cotransfer frequencies, of these same markers from the cis position, are very low. It is concluded that the cotransfer frequencies represent a marker effect and possible explanations are discussed. A reinterpretation of the genetic map of the pneumococcal str-r locus is presented.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rosenthal</LastName>
<ForeName>A L</ForeName>
<Initials>AL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rotheim</LastName>
<ForeName>M B</ForeName>
<Initials>MB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Ribosomal Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>57-92-1</RegistryNumber>
<NameOfSubstance>Streptomycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Chromosome Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosomes, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Drug Resistance, Microbial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Molecular Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribosomal Proteins</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Streptococcus pneumoniae</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Streptomycin</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transformation, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329105</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>The effect of the ribosomal protein S1 from Escherichia coli on the synthesis in vitro of bacterial-, DNA phage- and RNA phage proteins.</ArticleTitle>
<Pagination>
<MedlinePgn>75-80</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Using an in vitro preparation for protein synthesis, we have studied the effect of the ribosomal protein S1 from Escherichia coli on the synthesis of the coat protein of the RNA-containing phages Qbeta and MS2, on that of an &quot;early&quot; and a &quot;late&quot; enzyme encoded by the DNA containing phage T7, and on that of anthranilate synthetase, an enzyme encoded by the bacterial tryptophan operon. Our results indicate that for the synthesis of these five proteins the presence of S1 is required. From these results we conclude that S1 is an essential protein for the translation of bacterial and bacteriophage messenger RNA.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>van Dieijen</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>van Knippenberg</LastName>
<ForeName>P H</ForeName>
<Initials>PH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>van Duin</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Koekman</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pouwels</LastName>
<ForeName>P H</ForeName>
<Initials>PH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Bacterial</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Ribosomal Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.7.6</RegistryNumber>
<NameOfSubstance>DNA-Directed RNA Polymerases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.1.3.27</RegistryNumber>
<NameOfSubstance>Anthranilate Synthase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Anthranilate Synthase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Coliphages</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA Viruses</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA-Directed RNA Polymerases</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Operon</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Protein Biosynthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA Viruses</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA, Messenger</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribosomal Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Viral Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329106</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Bacteria with defective rho factors suppress the effects of N mutations in bacteriophage lambda.</ArticleTitle>
<Pagination>
<MedlinePgn>81-5</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A prediction based on the model for N-gene function of bacteriophage lambda proposed by Roberts (1971) is confirmed by showing that a lambdaN- double mutant is able to grow in strains of E. coli with defective rho transcription termination factors. The burst sizes for lambdaN- in these strains range from 5 to 24% the burst sizes for lambdaN+ in the same strain. This low level of suppression is also evident in the levels of synthesis of the lambda exonuclease and is consistent with other evidence that the defect in the rho factors of these strains is only partial. These strains do not suppress the effects of mutations in genes O, P and Q of lambda nor in genes 30 and 43 of bacteriophage T4. The lack of suppression of lambdaQ- is significant because the Q-gene product, like the N-gene product, is believed to function as an anti-terminator of lambda transcription but at termination sites that may not require rho factor action.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Richardson</LastName>
<ForeName>J P</ForeName>
<Initials>JP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fink</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Blanchard</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Macy</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Peptide Termination Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.-</RegistryNumber>
<NameOfSubstance>Exonucleases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Coliphages</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA Viruses</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Exonucleases</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Peptide Chain Termination, Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Peptide Termination Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Protein Biosynthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Suppression, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transcription, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329107</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>A conditional antimutator in E. coli.</ArticleTitle>
<Pagination>
<MedlinePgn>87-97</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A pleiotropic mutation in the purB gene of E. coli is described which lowers the spontaneous mutation frequency of other genes. The antimutator effect is very large for some genetic loci, but is absent at other sites. Both forward and reverse mutations are affected. This mutation in purB is temperature sensitive for both adenine auxotrophy and the antimutator action. Adenine, or adenosine, or low temperature growth abolish the antimutator effect. The mutagenicity of base analogs and nitrosoguanidine at several loci was found to be reduced by this purB mutation. The antimutator effect is recessive in strains merodiploid for the purB region. The frequency of reversion of mutation on F' episomes is affected by the chromosomal antimutator, which therefore acts in trans. Xray and UV sensitivity are normal in this mutant, which is the first antimutator characterized in E. coli.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Geiger</LastName>
<ForeName>J R</ForeName>
<Initials>JR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Speyer</LastName>
<ForeName>J F</ForeName>
<Initials>JF</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Nitrosoguanidines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>58-61-7</RegistryNumber>
<NameOfSubstance>Adenosine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>73-24-5</RegistryNumber>
<NameOfSubstance>Adenine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenine</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosine</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosomes, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">radiation effects</QualifierName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gene Frequency</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Genes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Genes, Recessive</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nitrosoguanidines</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Temperature</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ultraviolet Rays</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329108</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Active protection by bacteriophages T3 and T7 against E. coli B- and K-specific restriction of their DNA.</ArticleTitle>
<Pagination>
<MedlinePgn>99-106</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The bacteriophages T3 and T7 are not modified and restricted by E. coli strains with different host specificity (E. coli B, K, O) in vivo. The phages code for a gene product with the ability to overcome classical restriction (ocr): ocr- mutants are subject to modification and restriction via DNA methylation vs cleavage. The T3 genome possesses recognition sites for the restriction endonuclease R.EcoB which, unless the DNA is B-specifically modified, trigger 5-7 DNA cleavages. The ocr gene function of T3 and T7 is located within the gene 0.3 region of these phages and is not identical with the sam (SAMase) function of T3. The mechanism of ocr protection remains unclear, while it is certain that this protection by the gene 0.3 protein is exerted in the infected cell and not through &quot;over-all&quot; modification in the preceding growth cycle of the phage.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Krüger</LastName>
<ForeName>D H</ForeName>
<Initials>DH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schroeder</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hansen</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rosenthal</LastName>
<ForeName>H A</ForeName>
<Initials>HA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.-</RegistryNumber>
<NameOfSubstance>Endonucleases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.21.-</RegistryNumber>
<NameOfSubstance>DNA Restriction Enzymes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.1.1.50</RegistryNumber>
<NameOfSubstance>Adenosylmethionine Decarboxylase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosylmethionine Decarboxylase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Coliphages</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA Restriction Enzymes</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA Viruses</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">DNA, Viral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Endonucleases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Genes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenotype</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329109</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2005</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>A new ribosomal protein locus in Escherichia coli: the gene for protein S6 maps at 97 min.</ArticleTitle>
<Pagination>
<MedlinePgn>115-20</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A mutant of E. coli selected for temperature-sensitive growth on rich medium harbored an altered ribosomal protein S6 (Isono et al., 1976). This mutant was found to  possess at least two mutations, one being responsible for the temperature-sensitivity and the other for the S6 alteration. Crosses with various Hfr strains as well as transductions with P 1kc revealed that the former mutation mapped at 98 min and the latter at 97 min. Furthermore, rec A derivatives of this mutant heteromerodiploid for this region possessed both the wild type and themutant forms of S6. Thus it was established that the gene at 97 min was indeed the structural gene for protein S6 (rpsF) and not a gene modifying it.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Isono</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kitakawa</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Ribosomal Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Chromosome Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosomes, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Crosses, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Genes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribosomal Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Temperature</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transduction, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329110</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Functional inactivation rates of the messenger RNA molecules coding for the individual ribosomal proteins in Escherichia coli.</ArticleTitle>
<Pagination>
<MedlinePgn>121-7</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Barnsley</LastName>
<ForeName>P G</ForeName>
<Initials>PG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sells</LastName>
<ForeName>B H</ForeName>
<Initials>BH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Bacterial</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Ribosomal Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.2.1.-</RegistryNumber>
<NameOfSubstance>Galactosidases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Galactosidases</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Genetic Code</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Peptide Chain Elongation, Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">RNA, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">RNA, Messenger</DescriptorName>
<QualifierName MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribosomal Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407443</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Expression of an excision repair gene in transformation of Bacillus subtilis.</ArticleTitle>
<Pagination>
<MedlinePgn>129-33</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>DNA of Bacillus subtilis proficient in excision repair (hcr+) was introduced into Angiografinpurified competent cells of an excision repair-deficient strains UVS-1 (hcr-1). The hcr+ gene was found to affect the UV-survival curve of the cells, giving rise to a UV-resistant component. However, a considerable number of colonies of the UV-resistant component consisted of cells that were not transformed to hcr+ as judged by their sensitivity to mitomycin C (MC), UV, and by their ability to reactivate UV-irradiated M2 phages. This suggests that the hcr gene may be expressed without integration. The recA function of B. subtilis was necessary for expression of UV resistance to occur. When DNA-treated cells were selected for met+ recombinants, the UV-resistant component was again found on the UV-survival curve and about half of the colonies of the UV-resistant component consisted of Hcr- cells. This result was explained by an integration-segregation model for hcr+ and met+ genes. The effect of the hcr+ gene was seen even when DNA was added after cells were irradiated with UV, although this effect was gradually diminished by delaying the time of DNA addition. A complementation effect was found between two excision repair mutations residing in two distant loci, using hcr-114 DNA as a donor and hcr-1 cells as a recipient.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tanooka</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Takahashi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Bacterial</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Bacillus subtilis</DescriptorName>
<QualifierName MajorTopicYN="N">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">DNA Repair</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">DNA, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Genes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Genetic Complementation Test</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Recombination, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transformation, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ultraviolet Rays</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329111</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Internal reinitiation of translation in polar mutants of the trpB gene of Salmonella typhimurium.</ArticleTitle>
<Pagination>
<MedlinePgn>135-43</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tanemura</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bauerle</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Bacterial</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>73-22-3</RegistryNumber>
<NameOfSubstance>Tryptophan</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.4.2.18</RegistryNumber>
<NameOfSubstance>Anthranilate Phosphoribosyltransferase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Anthranilate Phosphoribosyltransferase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosome Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Genes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Genetic Code</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Operon</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Peptide Chain Initiation, Translational</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Protein Biosynthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA, Messenger</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Salmonella typhimurium</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transcription, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tryptophan</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329112</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>A mutant of Saccharomyces cerevisiae that exhibits multiple isoacceptors for several of its transfer RNAs.</ArticleTitle>
<Pagination>
<MedlinePgn>145-51</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A strain of Saccharomyces cerevisiae, known to produce multiple isoaccepting forms of several tRNA's which differ from a standard wild type strain, has been studied genetically. The multiple isoaccepting tRNA phenotype behaves as if it is caused by a single recessive mutation. Five tetrads were analyzed and all showed a 2:2 segregation of mutant to wild type profiles for Phe-tRNA Phe. Furthermore, the multiple isoacceptors for the other tRNA's in the mutant strain are probably caused by the same mutation, since Tyr-tRNA Tyr and Val-tRNA Val also exhibit 2:2 segregation for mutant versus wild type tRNA profiles and the segregation pattern is the same as that for Phe-tRNA Phe.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bell</LastName>
<ForeName>J B</ForeName>
<Initials>JB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lo</LastName>
<ForeName>R Y</ForeName>
<Initials>RY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Quah</LastName>
<ForeName>S K</ForeName>
<Initials>SK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>9014-25-9</RegistryNumber>
<NameOfSubstance>RNA, Transfer</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Genes, Recessive</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">RNA, Transfer</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Saccharomyces cerevisiae</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887071</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Nature of the plasmid-linked penicillinase regulatory region in Staphylococcus aureus.</ArticleTitle>
<Pagination>
<MedlinePgn>153-7</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Imsande</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lilleholm</LastName>
<ForeName>J L</ForeName>
<Initials>JL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>73-22-3</RegistryNumber>
<NameOfSubstance>Tryptophan</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.5.2.-</RegistryNumber>
<NameOfSubstance>Penicillinase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosome Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosomes, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Extrachromosomal Inheritance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Genes, Regulator</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Penicillinase</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Plasmids</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Staphylococcus aureus</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tryptophan</DescriptorName>
<QualifierName MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329113</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Structural dynamics of bacterial ribosomes. VI. Denaturation of active ribosomes by Mg2+ dependent conformational transitions.</ArticleTitle>
<Pagination>
<MedlinePgn>159-68</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stahli</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Noll</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Bacterial</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Ribosomal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7439-95-4</RegistryNumber>
<NameOfSubstance>Magnesium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrostatic Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Magnesium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nucleic Acid Denaturation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Protein Conformation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">RNA, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">RNA, Ribosomal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribosomes</DescriptorName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329114</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>05</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Glucosamine resistance in yeast. II. Cytoplasmic determinants conferring resistance.</ArticleTitle>
<Pagination>
<MedlinePgn>169-77</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Two cytoplasmic, glucosamine resistant (GR) mutants of Saccharomyces cerevisiae, GR6 and GR10, were crossed to strains bearing known mitochondrial markers. Analysis of vegetative and meiotic segregation patterns in these crosses suggested that the glucosamine resistance conferring factor did not reside on mitDNA. This was confirmed by ethidium bromide treatments which completely abolished oligomycin resistance due to a mitochondrial mutation at the OL12 locus but which failed to eliminate the GR factor present in the same strain. Comparison of GR6 and GR10 to some other known cytoplasmic determinants suggested that while glucosamine resistance is not related to the killer plasmid it may be allelic to the URE3 determinant and/or to the PSI factor.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kunz</LastName>
<ForeName>B A</ForeName>
<Initials>BA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ball</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>3416-24-8</RegistryNumber>
<NameOfSubstance>Glucosamine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>3546-21-2</RegistryNumber>
<NameOfSubstance>Ethidium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-49-2</RegistryNumber>
<NameOfSubstance>DNA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosome Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Drug Resistance, Microbial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ethidium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glucosamine</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mitochondria</DescriptorName>
<QualifierName MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Plasmids</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329115</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>On the ability of Salmonella typhimurium cells to form deoxycytidine nucleotides.</ArticleTitle>
<Pagination>
<MedlinePgn>179-83</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>It is known that cdd- S. typhimurium mutants selected for resistance to 5-fluorodeoxycytidine (FdCyd) possess no deoxycytidine kinase activity. The present study postulates that this method of screening selects double mutants defective in cytidine deaminase and in deoxycytidine kinase. To prove this hypothesis, the cdd mutant of S. typhimurium was constructed by P1-mediated transfer of ccd- gene into a new genetic background, and the activity of deoxycytidine kinase was assayed. Transductants exhibited no deoxycytidine kinase activity, showing that the absence of this enzyme is not limited to a specific cdd- mutant, but includes all strains of S. typhimurium. The toxicity of FdCyd for the bacterial strains possessing deoxycytidine kinase, as well as the role of nucleoside phosphorylase in nucleotide formation by S. typhimurium, is discussed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Janion</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Nucleotides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>951-77-9</RegistryNumber>
<NameOfSubstance>Deoxycytidine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.-</RegistryNumber>
<NameOfSubstance>Phosphotransferases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.5.4.5</RegistryNumber>
<NameOfSubstance>Cytidine Deaminase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cytidine Deaminase</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Deoxycytidine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nucleotides</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phosphotransferases</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Salmonella typhimurium</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transduction, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329116</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Repression of inducible enzyme synthesis in a mutant of Escherichia coli K 12 deleted for the ptsH gene.</ArticleTitle>
<Pagination>
<MedlinePgn>185-90</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The genome of lambda phage with thermosensitive repressor was inserted into the pts region of the Escherichia coli chromosome. This lysogenic culture possessed the PTS1 phenotype at 30 degrees C. A mutant strain with a deletion covering the ptsH gene was isolated after a prophage curing procedure. The deletion nature of the pts mutation was confirmed in genetical and biochemical experiments. The deletion covered a small fragment of the bacterial genome not extending in the ptsI and lig genes. The isolated deltaptsH mutant possessed all characteristics of known pts mutants: pleiotropical disturbances of transport and utilization of a number of carbohydrates, repression of the enzyme inducible synthesis, and resistance to glucose catabolite repression. From these and other data we can conclude that the phosphorylated form of the heat-stable protein HPr is involved (directly or indirectly) in activation of the DNA transcription process.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gershanovitch</LastName>
<ForeName>V N</ForeName>
<Initials>VN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ilyina</LastName>
<ForeName>T S</ForeName>
<Initials>TS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rusina</LastName>
<ForeName>O Y</ForeName>
<Initials>OY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yourovitskaya</LastName>
<ForeName>N V</ForeName>
<Initials>NV</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bolshakova</LastName>
<ForeName>T N</ForeName>
<Initials>TN</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Bacterial</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>73-89-2</RegistryNumber>
<NameOfSubstance>Phosphoenolpyruvate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.-</RegistryNumber>
<NameOfSubstance>Phosphotransferases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosome Deletion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Coliphages</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Enzyme Repression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Genes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lysogeny</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phosphoenolpyruvate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phosphotransferases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transcription, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407444</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2005</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Investigations on the organization of genetic loci in Drosophila melanogaster: lethal mutations affecting 6-phosphogluconate dehydrogenase and their suppression.</ArticleTitle>
<Pagination>
<MedlinePgn>191-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The molecular nature of lethal and semilethal mutations in the Pgd locus of D. melanogaster coding for 6-phosphogluconate dehydrogenase (6PGD) was studied. All the 11 mutations affect the structural gene of the Pgd locus: 3 semilethal mutations resulted in altered 6PGD molecules with decreased catalytic activities; the rest 8 lethals were &quot;null&quot; alleles characterized by mutant polypeptides capable of reacting with antisera against highly purified 6PGD. &quot;Null&quot; or low activity alleles for glucose-6-phosphate dehydrogenase induced by ethyl methanesulfonate were shown to be suppressores for the lethal mutations in the Pgd locus. A monocistronic type of organization of the Pgd locus is suggested taking into account the biochemical mechanism of suppression of the Pgd-lethals and their location in the structural gene coding for 6PGD.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gvozdev</LastName>
<ForeName>V A</ForeName>
<Initials>VA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gerasimova</LastName>
<ForeName>T I</ForeName>
<Initials>TI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kogan</LastName>
<ForeName>G L</ForeName>
<Initials>GL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rosovsky</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 1.1.1.43</RegistryNumber>
<NameOfSubstance>Phosphogluconate Dehydrogenase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.1.1.49</RegistryNumber>
<NameOfSubstance>Glucosephosphate Dehydrogenase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Chromosome Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drosophila melanogaster</DescriptorName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Genes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Genes, Lethal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glucosephosphate Dehydrogenase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phosphogluconate Dehydrogenase</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Suppression, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329117</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>A new ribosomal mutation which affects the two ribosomal subunits in Escherichia coli.</ArticleTitle>
<Pagination>
<MedlinePgn>199-204</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A new ribosomal mutant resistant to erythromycin is described. The product of the gene eryC seems to be implicated in the assembly of the two ribosomal subunits, particularly in the maturation process of the RNA 23S and 16S.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pardo</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rosset</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Bacterial</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Ribosomal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>114-07-8</RegistryNumber>
<NameOfSubstance>Erythromycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosome Mapping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosomes, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Resistance, Microbial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythromycin</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Genes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA, Bacterial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA, Ribosomal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribosomes</DescriptorName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329118</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of mutant host RNA polymerase on the bifunctional activities of P22 gene c1.</ArticleTitle>
<Pagination>
<MedlinePgn>205-10</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The product of phage P22 gene c1 has two functions: (1) it promotes synthesis of repressor and (2) during the first minutes of infection it retards expression of some lytic genes. We call the second, negative function &quot;c1 retardation&quot;. We investigated c1 retardation in a mutant host of Salmonella typhimurium that is resistant to rifampicin and carries an altered RNA polymerase. No c1 retardation of DNA synthesis was detectable in this  host after infection with wild-type phages. This elimination of the normally detectable c1 function leads to the conclusion that the mutant RNA polymerase interferes with the expression of c1 gene activity. Wild-type genes form clear plaques on the mutant host. Mutants of P22 called cly were isolated by others. These mutants form turbid plaques on the altered RNA polymerase host. Infections with P22 cly in the mutant host resulted in detectable c1 retardation. The cly mutation therefore restores c1 activity in a host which wild-type c1 is not expressed. Two spontaneous mutants were isolated from the mutant host. These two strains allowed partial expression of c1 retardation, although they remained rifampicin resistant. We interpret our data to indicate that expression of the normal functions of the gene c1 product requires an interaction of that product with the host RNA polymerase.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tokuno</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Roth</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weinberger</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gough</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Bacterial</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>13292-46-1</RegistryNumber>
<NameOfSubstance>Rifampin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.7.6</RegistryNumber>
<NameOfSubstance>DNA-Directed RNA Polymerases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA-Directed RNA Polymerases</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Resistance, Microbial</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Genes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lysogeny</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rifampin</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Salmonella Phages</DescriptorName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Salmonella typhimurium</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407445</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>DNA repair in Bacillus subtilis. I. The presence of an inducible system.</ArticleTitle>
<Pagination>
<MedlinePgn>211-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Following UV irradiation of Bacillus subtilis there is a coordinate induction of: 1) a new protein, 2) a W-reactivation system, 3) a DNA modification system, and 4) prophages. These functions are induced following UV irradiation of repair proficient bacteria and mutants deficient in excision repair (UVR-1) and DNA polymerase I activity (polA5). However, they are not induced, or are impaired in their ability to be induced in bacteria containing the recA1 and the recG13 mutations. This inducible system is compared to the SOS system observed in E. coli.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yasbin</LastName>
<ForeName>R E</ForeName>
<Initials>RE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Bacterial</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacillus subtilis</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacteriophages</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">DNA Repair</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lysogeny</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Ultraviolet Rays</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Virus Replication</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407446</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>DNA repair in Bacillus subtilis. II. Activation of the inducible system in competent bacteria.</ArticleTitle>
<Pagination>
<MedlinePgn>219-25</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Competent B. subtilis are more UV sensitive than the non-competent population of the culture. This increased sensitivity is lose in mutants unable to induce the 'SOS system' (recA1,, recG13), in mutants defective in the induction of prophage PBSX (xin), and in late stage competent cells. Moreover, bacteriophage phi 105 produced from transfected cells are less restricted on strain YB880 than bacteriophage produced from infected cells. Therefore, competent cells (those capable of being transfected) have a DNA modification system, whereas the average log phase cell does not. These data support the hypothesis that the development of competence is correlated with the activation of derepression of the &quot;SOS&quot; system in B. subtilis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yasbin</LastName>
<ForeName>R E</ForeName>
<Initials>RE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Bacterial</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacillus subtilis</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacteriophages</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">DNA Repair</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lysogeny</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transformation, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Ultraviolet Rays</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Virus Replication</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887072</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-8925</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>153</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>Molecular &amp; general genetics : MGG</Title>
<ISOAbbreviation>Mol. Gen. Genet.</ISOAbbreviation>
</Journal>
<ArticleTitle>A selection procedure for obtaining conditional gametogenic mutants using a photosynthetically incompetent strain of Chlamydomonas reinhardi.</ArticleTitle>
<Pagination>
<MedlinePgn>227-30</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A new selection procedure has beed developed for the isolation of temperature sensitive gametogenic mutants in Chlamydomonas reinhardi. This technique makes use of pet-10-1, a mutant strain incapable of photosynthetic electron transport, and the redox dye, methyl viologen. Two mutants found by this method are discussed. The first, gam-4, does not agglutinate at 35 degrees, whereas the second, gam-5, is capable of sexual agglutination, but not of zygote formation at the restrictive temperature. Both mutants appear to be inherited in a Mendelian fashion and are expressed in mating type (+) and mating type (-).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Forest</LastName>
<ForeName>C L</ForeName>
<Initials>CL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Togasaki</LastName>
<ForeName>R K</ForeName>
<Initials>RK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mol Gen Genet</MedlineTA>
<NlmUniqueID>0125036</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>4685-14-7</RegistryNumber>
<NameOfSubstance>Paraquat</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Agglutination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Chlamydomonas</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germ Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Paraquat</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Photosynthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Temperature</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196171</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Mechanism of polyribonucleotide inhibition of ribonucleic acid tumor virus replication: effect of poly(inosinic acid) on the synthesis of proviral deoxyribonucleic acid of murine leukemia virus.</ArticleTitle>
<Pagination>
<MedlinePgn>585-97</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Arya</LastName>
<ForeName>S K</ForeName>
<Initials>SK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Polyribonucleotides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>25249-22-3</RegistryNumber>
<NameOfSubstance>Poly I</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-49-2</RegistryNumber>
<NameOfSubstance>DNA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.7.7</RegistryNumber>
<NameOfSubstance>DNA-Directed DNA Polymerase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA, Viral</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA-Directed DNA Polymerase</DescriptorName>
<QualifierName MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Depression, Chemical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Leukemia Virus, Murine</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nucleic Acid Hybridization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Poly I</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Polyribonucleotides</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Virus Replication</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329119</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Inhibition of p-chloromercuribenzoate- and glucose-induced insulin release in vitro by methylene blue, diamide, and tert-butyl hydroperoxide.</ArticleTitle>
<Pagination>
<MedlinePgn>598-605</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ammon</LastName>
<ForeName>H P</ForeName>
<Initials>HP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Akhtar</LastName>
<ForeName>M S</ForeName>
<Initials>MS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Niklas</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hegner</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Azo Compounds</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Chloromercuribenzoates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Peroxides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>10465-78-8</RegistryNumber>
<NameOfSubstance>Diamide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>11061-68-0</RegistryNumber>
<NameOfSubstance>Insulin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-99-7</RegistryNumber>
<NameOfSubstance>Glucose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>61-73-4</RegistryNumber>
<NameOfSubstance>Methylene Blue</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Azo Compounds</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chloromercuribenzoates</DescriptorName>
<QualifierName MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diamide</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glucose</DescriptorName>
<QualifierName MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Insulin</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Islets of Langerhans</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Methylene Blue</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pancreas</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Perfusion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Peroxides</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196172</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Forces and structural limitations of binding of thyrotrophin-releasing factor to the thyrotrophin-releasing receptor: the pyroglutamic acid moiety.</ArticleTitle>
<Pagination>
<MedlinePgn>606-14</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Goren</LastName>
<ForeName>H J</ForeName>
<Initials>HJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bauce</LastName>
<ForeName>L G</ForeName>
<Initials>LG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vale</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Pyrrolidinones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Receptors, Cell Surface</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>24305-27-9</RegistryNumber>
<NameOfSubstance>Thyrotropin-Releasing Hormone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9002-71-5</RegistryNumber>
<NameOfSubstance>Thyrotropin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>98-79-3</RegistryNumber>
<NameOfSubstance>Pyrrolidonecarboxylic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrogen Bonding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pyrrolidinones</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pyrrolidonecarboxylic Acid</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Receptors, Cell Surface</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Thermodynamics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Thyrotropin</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Thyrotropin-Releasing Hormone</DescriptorName>
<QualifierName MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18659</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Interactions of biogenic amines with organic phosphate: a proposed model in vitro for study of biological interactions by 31P nuclear magnetic resonance.</ArticleTitle>
<Pagination>
<MedlinePgn>615-20</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Katz</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yeh</LastName>
<ForeName>H J</ForeName>
<Initials>HJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Johnson</LastName>
<ForeName>D F</ForeName>
<Initials>DF</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Biogenic Amines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Organophosphorus Compounds</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Biogenic Amines</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Organophosphorus Compounds</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407447</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Nuclear magnetic resonance studies of the enzymatic hydrolysis of acetylcholine: a critical comment.</ArticleTitle>
<Pagination>
<MedlinePgn>621-4</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Krishnan</LastName>
<ForeName>K S</ForeName>
<Initials>KS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Balaram</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>51-84-3</RegistryNumber>
<NameOfSubstance>Acetylcholine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>62-49-7</RegistryNumber>
<NameOfSubstance>Choline</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.1.7</RegistryNumber>
<NameOfSubstance>Acetylcholinesterase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acetylcholine</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acetylcholinesterase</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Brain</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
<QualifierName MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Choline</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Haplorhini</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrolysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Membranes</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18660</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Studies on the microsomal formation of arylating metabolites of acetaminophen and phenacetin.</ArticleTitle>
<Pagination>
<MedlinePgn>625-33</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hinson</LastName>
<ForeName>J A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nelson</LastName>
<ForeName>S D</ForeName>
<Initials>SD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mitchell</LastName>
<ForeName>J R</ForeName>
<Initials>JR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Oxygen Isotopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>103-90-2</RegistryNumber>
<NameOfSubstance>Acetaminophen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-06-6</RegistryNumber>
<NameOfSubstance>Phenobarbital</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>53-59-8</RegistryNumber>
<NameOfSubstance>NADP</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>56-49-5</RegistryNumber>
<NameOfSubstance>Methylcholanthrene</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>62-44-2</RegistryNumber>
<NameOfSubstance>Phenacetin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>70-18-8</RegistryNumber>
<NameOfSubstance>Glutathione</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9035-51-2</RegistryNumber>
<NameOfSubstance>Cytochrome P-450 Enzyme System</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.-</RegistryNumber>
<NameOfSubstance>Mixed Function Oxygenases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acetaminophen</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cricetinae</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glutathione</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mass Spectrometry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mesocricetus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Methylcholanthrene</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microsomes, Liver</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mixed Function Oxygenases</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">NADP</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oxygen Isotopes</DescriptorName>
<QualifierName MajorTopicYN="N">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenacetin</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenobarbital</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887073</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Intramolecular determination of substituent effects in hydroxylations catalyzed by cytochrome P-450.</ArticleTitle>
<Pagination>
<MedlinePgn>634-9</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hjelmeland</LastName>
<ForeName>L M</ForeName>
<Initials>LM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Aronow</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Trudell</LastName>
<ForeName>J R</ForeName>
<Initials>JR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Benzene Derivatives</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>74-98-6</RegistryNumber>
<NameOfSubstance>Propane</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9035-51-2</RegistryNumber>
<NameOfSubstance>Cytochrome P-450 Enzyme System</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Benzene Derivatives</DescriptorName>
<QualifierName MajorTopicYN="N">chemical synthesis</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromatography, Gas</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gas Chromatography-Mass Spectrometry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydroxylation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microsomes, Liver</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Propane</DescriptorName>
<QualifierName MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N">chemical synthesis</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196173</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Inhibition of serotonin of amino acid release and protein degradation in skeletal muscle.</ArticleTitle>
<Pagination>
<MedlinePgn>640-51</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Garber</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Amino Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Muscle Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-67-9</RegistryNumber>
<NameOfSubstance>Serotonin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>56-41-7</RegistryNumber>
<NameOfSubstance>Alanine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>56-85-9</RegistryNumber>
<NameOfSubstance>Glutamine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>60-92-4</RegistryNumber>
<NameOfSubstance>Cyclic AMP</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Alanine</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Amino Acids</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cyclic AMP</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Depression, Chemical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glutamine</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Muscle Proteins</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Muscles</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Serotonin</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>560625</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Active dimers of dopamine beta-hydroxylase in human plasma.</ArticleTitle>
<Pagination>
<MedlinePgn>652-61</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rosenberg</LastName>
<ForeName>R C</ForeName>
<Initials>RC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lovenberg</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 1.14.17.1</RegistryNumber>
<NameOfSubstance>Dopamine beta-Hydroxylase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cattle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Centrifugation, Density Gradient</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromatography, Gel</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dopamine beta-Hydroxylase</DescriptorName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Molecular Weight</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887074</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Adenosine-sensitive adenylate cyclase in rat striatal homogenates and its relationship to dopamine- and Ca2+-sensitive adenylate cyclases.</ArticleTitle>
<Pagination>
<MedlinePgn>662-70</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Prémont</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Perez</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bockaert</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Receptors, Drug</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Xanthines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>29193-86-0</RegistryNumber>
<NameOfSubstance>Phenylisopropyladenosine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>51-61-6</RegistryNumber>
<NameOfSubstance>Dopamine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>58-55-9</RegistryNumber>
<NameOfSubstance>Theophylline</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>58-61-7</RegistryNumber>
<NameOfSubstance>Adenosine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-70-2</RegistryNumber>
<NameOfSubstance>Calcium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.5.4.4</RegistryNumber>
<NameOfSubstance>Adenosine Deaminase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.6.1.1</RegistryNumber>
<NameOfSubstance>Adenylate Cyclase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosine</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosine Deaminase</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenylate Cyclase</DescriptorName>
<QualifierName MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Calcium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Corpus Striatum</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dopamine</DescriptorName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenylisopropyladenosine</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Receptors, Drug</DescriptorName>
<QualifierName MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Theophylline</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Xanthines</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196174</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Stimulation of microsomal calcium uptake and protein phosphorylation by adenosine cyclic 3', 5'-monophosphate in rat uterus.</ArticleTitle>
<Pagination>
<MedlinePgn>671-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nishikori</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Takenaka</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Maeno</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Organophosphorus Compounds</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>362-74-3</RegistryNumber>
<NameOfSubstance>Bucladesine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-56-6</RegistryNumber>
<NameOfSubstance>Oxytocin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>56-65-5</RegistryNumber>
<NameOfSubstance>Adenosine Triphosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>60-92-4</RegistryNumber>
<NameOfSubstance>Cyclic AMP</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-70-2</RegistryNumber>
<NameOfSubstance>Calcium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.3.99.1</RegistryNumber>
<NameOfSubstance>Succinate Dehydrogenase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosine Triphosphate</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bucladesine</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Calcium</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cyclic AMP</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Membranes</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microsomes</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mitochondria</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Organophosphorus Compounds</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oxytocin</DescriptorName>
<QualifierName MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Stimulation, Chemical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Succinate Dehydrogenase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Uterine Contraction</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Uterus</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196175</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Altered responsiveness of cerebral beta adrenoceptors assessed by adenosine cyclic 3',5'-monophosphate formation and (3H)propranolol binding.</ArticleTitle>
<Pagination>
<MedlinePgn>679-89</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Nahorski</LastName>
<ForeName>S R</ForeName>
<Initials>SR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Biogenic Amines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hydroxydopamines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Receptors, Adrenergic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Receptors, Adrenergic, beta</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-55-5</RegistryNumber>
<NameOfSubstance>Reserpine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>51-45-6</RegistryNumber>
<NameOfSubstance>Histamine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>525-66-6</RegistryNumber>
<NameOfSubstance>Propranolol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>60-92-4</RegistryNumber>
<NameOfSubstance>Cyclic AMP</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7683-59-2</RegistryNumber>
<NameOfSubstance>Isoproterenol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.4.17</RegistryNumber>
<NameOfSubstance>3',5'-Cyclic-AMP Phosphodiesterases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.6.1.1</RegistryNumber>
<NameOfSubstance>Adenylate Cyclase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">3',5'-Cyclic-AMP Phosphodiesterases</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenylate Cyclase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Biogenic Amines</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Brain</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chickens</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cyclic AMP</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Histamine</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydroxydopamines</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Isoproterenol</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Membranes</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Propranolol</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Receptors, Adrenergic</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Receptors, Adrenergic, beta</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Reserpine</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18661</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.</ArticleTitle>
<Pagination>
<MedlinePgn>690-7</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Levin</LastName>
<ForeName>R M</ForeName>
<Initials>RM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weiss</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Carrier Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Cations, Divalent</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Nerve Tissue Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Serum Albumin, Bovine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>117-89-5</RegistryNumber>
<NameOfSubstance>Trifluoperazine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-70-2</RegistryNumber>
<NameOfSubstance>Calcium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.4.-</RegistryNumber>
<NameOfSubstance>Phosphoric Diester Hydrolases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.4.17</RegistryNumber>
<NameOfSubstance>3',5'-Cyclic-AMP Phosphodiesterases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">3',5'-Cyclic-AMP Phosphodiesterases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Brain</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Calcium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carrier Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cations, Divalent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cattle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Enzyme Activation</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phosphoric Diester Hydrolases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Serum Albumin, Bovine</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Trifluoperazine</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18662</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>The reduction of polyhalogenated methanes by liver microsomal cytochrome P450.</ArticleTitle>
<Pagination>
<MedlinePgn>698-705</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wolf</LastName>
<ForeName>C R</ForeName>
<Initials>CR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mansuy</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nastainczyk</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Deutschmann</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ullrich</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Benzopyrenes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hydrocarbons, Halogenated</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-06-6</RegistryNumber>
<NameOfSubstance>Phenobarbital</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>53-59-8</RegistryNumber>
<NameOfSubstance>NADP</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>630-08-0</RegistryNumber>
<NameOfSubstance>Carbon Monoxide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7782-44-7</RegistryNumber>
<NameOfSubstance>Oxygen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9035-51-2</RegistryNumber>
<NameOfSubstance>Cytochrome P-450 Enzyme System</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Benzopyrenes</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carbon Monoxide</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Enzyme Induction</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrocarbons, Halogenated</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Light</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microsomes, Liver</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">NADP</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oxygen</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenobarbital</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spectrophotometry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spectrophotometry, Infrared</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329120</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>The inhibitory effect of phenanthridines on the synthesis of ribonucleic acid catalyzed by deoxyribonucleic acid-dependent ribonucleic acid polymerase.</ArticleTitle>
<Pagination>
<MedlinePgn>706-18</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Aktipis</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Panayotatos</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Phenanthridines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>13292-46-1</RegistryNumber>
<NameOfSubstance>Rifampin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>3546-21-2</RegistryNumber>
<NameOfSubstance>Ethidium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>63231-63-0</RegistryNumber>
<NameOfSubstance>RNA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-49-2</RegistryNumber>
<NameOfSubstance>DNA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.7.6</RegistryNumber>
<NameOfSubstance>DNA-Directed RNA Polymerases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cattle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA-Directed RNA Polymerases</DescriptorName>
<QualifierName MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ethidium</DescriptorName>
<QualifierName MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenanthridines</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rifampin</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887075</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Repair in vivo of liver deoxyribonucleic acid damaged by hycanthone and related compounds.</ArticleTitle>
<Pagination>
<MedlinePgn>719-25</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sarma</LastName>
<ForeName>D S</ForeName>
<Initials>DS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zubroff</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rajalakshmi</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Thioxanthenes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>3105-97-3</RegistryNumber>
<NameOfSubstance>Hycanthone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-49-2</RegistryNumber>
<NameOfSubstance>DNA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cattle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Centrifugation, Density Gradient</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">DNA Repair</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heat</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hycanthone</DescriptorName>
<QualifierName MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Liver</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nucleic Acid Denaturation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Thioxanthenes</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887076</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>The fluorescent labeling of mitochondrial monoamine oxidase.</ArticleTitle>
<Pagination>
<MedlinePgn>726-34</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rando</LastName>
<ForeName>R R</ForeName>
<Initials>RR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Dansyl Compounds</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Monoamine Oxidase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>555-57-7</RegistryNumber>
<NameOfSubstance>Pargyline</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.4.3.4</RegistryNumber>
<NameOfSubstance>Monoamine Oxidase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dansyl Compounds</DescriptorName>
<QualifierName MajorTopicYN="N">chemical synthesis</QualifierName>
<QualifierName MajorTopicYN="N">diagnostic use</QualifierName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mitochondria, Liver</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Monoamine Oxidase</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Monoamine Oxidase Inhibitors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pargyline</DescriptorName>
<QualifierName MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N">chemical synthesis</QualifierName>
<QualifierName MajorTopicYN="N">diagnostic use</QualifierName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spectrometry, Fluorescence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spectrophotometry, Ultraviolet</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Swine</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196176</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Postsynaptic induction of serotonin N-acetyltransferase activity and the control of cyclic nucleotide metabolism in organ cultures of the rat pineal.</ArticleTitle>
<Pagination>
<MedlinePgn>735-45</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Minneman</LastName>
<ForeName>K P</ForeName>
<Initials>KP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Toxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Nucleotides, Cyclic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Xanthines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-67-9</RegistryNumber>
<NameOfSubstance>Serotonin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>51-41-2</RegistryNumber>
<NameOfSubstance>Norepinephrine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>60-92-4</RegistryNumber>
<NameOfSubstance>Cyclic AMP</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>630-60-4</RegistryNumber>
<NameOfSubstance>Ouabain</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>66-81-9</RegistryNumber>
<NameOfSubstance>Cycloheximide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-09-7</RegistryNumber>
<NameOfSubstance>Potassium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7665-99-8</RegistryNumber>
<NameOfSubstance>Cyclic GMP</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.3.1.-</RegistryNumber>
<NameOfSubstance>Acetyltransferases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.4.-</RegistryNumber>
<NameOfSubstance>Phosphoric Diester Hydrolases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.6.1.1</RegistryNumber>
<NameOfSubstance>Adenylate Cyclase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acetyltransferases</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenylate Cyclase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Toxins</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cyclic AMP</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cyclic GMP</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cycloheximide</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Enzyme Induction</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nerve Degeneration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Norepinephrine</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nucleotides, Cyclic</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Organ Culture Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ouabain</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phosphoric Diester Hydrolases</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pineal Gland</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Potassium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Serotonin</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Synapses</DescriptorName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vibrio cholerae</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Xanthines</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887077</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effect of desmethylimipramine on the release of (3H)norepinephrine induced by various agents in hypothalamic synaptosomes.</ArticleTitle>
<Pagination>
<MedlinePgn>746-58</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Raiteri</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>del Carmine</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bertollini</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Sympathomimetics</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-47-5</RegistryNumber>
<NameOfSubstance>Desipramine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-55-5</RegistryNumber>
<NameOfSubstance>Reserpine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>51-41-2</RegistryNumber>
<NameOfSubstance>Norepinephrine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-09-7</RegistryNumber>
<NameOfSubstance>Potassium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-23-5</RegistryNumber>
<NameOfSubstance>Sodium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-70-2</RegistryNumber>
<NameOfSubstance>Calcium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Calcium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Desipramine</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Interactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hypothalamus</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Norepinephrine</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Potassium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Reserpine</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sodium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sympathomimetics</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Synaptosomes</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887078</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Effects of cadmium on microsomal hemoproteins and heme oxygenase in rat liver.</ArticleTitle>
<Pagination>
<MedlinePgn>759-65</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Krasny</LastName>
<ForeName>H C</ForeName>
<Initials>HC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Holbrook</LastName>
<ForeName>D J</ForeName>
<Initials>DJ</Initials>
<Suffix>Jr</Suffix>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Cytochromes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>114-25-0</RegistryNumber>
<NameOfSubstance>Biliverdine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>14875-96-8</RegistryNumber>
<NameOfSubstance>Heme</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>630-08-0</RegistryNumber>
<NameOfSubstance>Carbon Monoxide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-43-9</RegistryNumber>
<NameOfSubstance>Cadmium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9035-51-2</RegistryNumber>
<NameOfSubstance>Cytochrome P-450 Enzyme System</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.-</RegistryNumber>
<NameOfSubstance>Mixed Function Oxygenases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.-</RegistryNumber>
<NameOfSubstance>Oxidoreductases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.14.-</RegistryNumber>
<NameOfSubstance>Aniline Hydroxylase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.5.3.-</RegistryNumber>
<NameOfSubstance>Aminopyrine N-Demethylase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aminopyrine N-Demethylase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aniline Hydroxylase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Biliverdine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cadmium</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carbon Monoxide</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cytochromes</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heme</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microsomes, Liver</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mixed Function Oxygenases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oxidoreductases</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196177</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-895X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>13</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Molecular pharmacology</Title>
<ISOAbbreviation>Mol. Pharmacol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Spin-labeled narcotics.</ArticleTitle>
<Pagination>
<MedlinePgn>766-73</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>W Y</ForeName>
<Initials>WY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Abood</LastName>
<ForeName>L G</ForeName>
<Initials>LG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gates</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kreilick</LastName>
<ForeName>R W</ForeName>
<Initials>RW</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Mol Pharmacol</MedlineTA>
<NlmUniqueID>0035623</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Morphine Derivatives</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Narcotics</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Spin Labels</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>76-57-3</RegistryNumber>
<NameOfSubstance>Codeine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Brain</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Codeine</DescriptorName>
<QualifierName MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N">chemical synthesis</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Electron Spin Resonance Spectroscopy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Methods</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Morphine Derivatives</DescriptorName>
<QualifierName MajorTopicYN="N">chemical synthesis</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Narcotics</DescriptorName>
<QualifierName MajorTopicYN="Y">chemical synthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spin Labels</DescriptorName>
<QualifierName MajorTopicYN="N">chemical synthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Synaptic Membranes</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887079</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>15</Volume>
<Issue>3</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>The physical state of water and ions in living cells and a new theory of the energization of biological work performance by ATP.</ArticleTitle>
<Pagination>
<MedlinePgn>159-72</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ling</LastName>
<ForeName>G N</ForeName>
<Initials>GN</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Diphosphoglyceric Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hemoglobins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Inosine Nucleotides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>56-65-5</RegistryNumber>
<NameOfSubstance>Adenosine Triphosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>630-60-4</RegistryNumber>
<NameOfSubstance>Ouabain</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-09-7</RegistryNumber>
<NameOfSubstance>Potassium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-23-5</RegistryNumber>
<NameOfSubstance>Sodium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-70-2</RegistryNumber>
<NameOfSubstance>Calcium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7732-18-5</RegistryNumber>
<NameOfSubstance>Water</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosine Triphosphate</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Calcium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cells</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chemistry, Physical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diphosphoglyceric Acids</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Energy Metabolism</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hemoglobins</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Inosine Nucleotides</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Muscles</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ouabain</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oxygen Consumption</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Potassium</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sodium</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Water</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887080</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>15</Volume>
<Issue>3</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Dose any enzyme follow the Michaelis-Menten equation?</ArticleTitle>
<Pagination>
<MedlinePgn>173-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A literature search has been conducted to see to what extent steady-state kinetics studies in the period 1965-1976 have revealed deviations from Michaelis-Menten kinetics. It was found that over 800 enzymes have been reported as giving complex curves for a variety of reasons and a group by group classification of all these enzymes has been carried out listing all the types of variations reported and the authors' explanations. In addition, for highly complex curves, we have determined the minimum degree of the rate equation. There were very few determined attempts to demonstrate adherence to the Michaelis-Menten equation over a wide variety of experimental conditions and substrate concentration and almost invariably detailed experimental work revealed unsuspected complexities. For these reasons, it is concluded that the assumption that most enzymes follow the Michaelis-Menten equation can not be supported by an appeal to the literature.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hill</LastName>
<ForeName>C M</ForeName>
<Initials>CM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Waight</LastName>
<ForeName>R D</ForeName>
<Initials>RD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bardsley</LastName>
<ForeName>W G</ForeName>
<Initials>WG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Enzymes</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Enzymes</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Kinetics</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196178</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>15</Volume>
<Issue>3</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Covalent phosphorylation in the regulation glycogen synthase activity.</ArticleTitle>
<Pagination>
<MedlinePgn>179-200</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Roach</LastName>
<ForeName>R J</ForeName>
<Initials>RJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Larner</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Amino Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Glucosephosphates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Phosphates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Sulfates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Uracil Nucleotides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>11061-68-0</RegistryNumber>
<NameOfSubstance>Insulin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>51-43-4</RegistryNumber>
<NameOfSubstance>Epinephrine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>60-92-4</RegistryNumber>
<NameOfSubstance>Cyclic AMP</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-92-5</RegistryNumber>
<NameOfSubstance>Glucagon</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.4.1.11</RegistryNumber>
<NameOfSubstance>Glycogen Synthase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.37</RegistryNumber>
<NameOfSubstance>Protein Kinases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Amino Acids</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cyclic AMP</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Epinephrine</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glucagon</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glucosephosphates</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glycogen Synthase</DescriptorName>
<QualifierName MajorTopicYN="N">isolation &amp; purification</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Insulin</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Molecular Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Organ Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phosphates</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Protein Kinases</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sulfates</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Uracil Nucleotides</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18663</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2005</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>15</Volume>
<Issue>3</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Glutamate dehydrogenases from Chlorella: forms, regulation and properties.</ArticleTitle>
<Pagination>
<MedlinePgn>201-12</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shatilov</LastName>
<ForeName>V R</ForeName>
<Initials>VR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kretovich</LastName>
<ForeName>W L</ForeName>
<Initials>WL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Cations, Monovalent</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Chloromercuribenzoates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Isoenzymes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Ketoglutaric Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Nitrates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Quaternary Ammonium Compounds</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>53-59-8</RegistryNumber>
<NameOfSubstance>NADP</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>53-84-9</RegistryNumber>
<NameOfSubstance>NAD</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>57-13-6</RegistryNumber>
<NameOfSubstance>Urea</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>60-24-2</RegistryNumber>
<NameOfSubstance>Mercaptoethanol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.4.1.2</RegistryNumber>
<NameOfSubstance>Glutamate Dehydrogenase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.40</RegistryNumber>
<NameOfSubstance>Pyruvate Kinase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cations, Monovalent</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chlorella</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chloromercuribenzoates</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Enzyme Induction</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glutamate Dehydrogenase</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heat</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Isoenzymes</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ketoglutaric Acids</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mercaptoethanol</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">NAD</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">NADP</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nitrates</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pyruvate Kinase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Quaternary Ammonium Compounds</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Urea</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196179</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>15</Volume>
<Issue>3</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>In vitro metabolism of vitamin D3 by isolated liver cells.</ArticleTitle>
<Pagination>
<MedlinePgn>213-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Liver cells were prepared from rats fed a rachitogenic diet to investigate the hepatic metabolism of [alpha-1,2-3H2] vitamin D3. Rat hepatocytes suspended in Hanks medium rapidly took up labeled vitamin D3 from the incubation medium and converted this sterol to various metabolites, including 25-hydroxy vitamin D3 (25-OH-D3). There was steady increment in the cellular production of 25-OH-D3 and of the more polar metabolites of vitamin D3 over 3 hr of incubation as determined by thin layer chromatography. Neither the addition of cyclic nucleotides or dexamethasone to, nor the removal of calcium or phosphate from the medium resulted in changes in the rate of conversion of vitamin D3 to its products. Rats pretreated with sodium diphenylhydantoin converted labeled vitamin D3 to its metabolites at the same rate as control rats. These data indicate that isolated liver cells retain the capacity for vitamin D3 hydroxylation, but suggest that the rate of this process does not undergo rapid changes in response to metabolic stimulation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Reitano</LastName>
<ForeName>J F</ForeName>
<Initials>JF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reed</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rostron</LastName>
<ForeName>P L</ForeName>
<Initials>PL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Intenzo</LastName>
<ForeName>C M</ForeName>
<Initials>CM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Capuzzi</LastName>
<ForeName>D M</ForeName>
<Initials>DM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hydroxycholecalciferols</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>67-97-0</RegistryNumber>
<NameOfSubstance>Cholecalciferol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cholecalciferol</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydroxycholecalciferols</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Liver</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vitamin D Deficiency</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196180</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>15</Volume>
<Issue>3</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Activation of rat erythrocyte phosphofructokinase by AMP and by non-physiological concentrations of cyclic AMP.</ArticleTitle>
<Pagination>
<MedlinePgn>219-23</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Cyclic AMP (300 micron) activates phosphofructokinase from dialyzed haemolysates of mature rat erythrocytes. The main conclusions are: a) Cyclic AMP, at pH 7.1 and low concentrations of fructose-6-phosphate, is able to reverse the inhibition produced by different amounts of ATP (up to 1.5 mM). b) The cyclic nucleotide is a positive allosteric effector of the enzyme as shown by the displacement of sigmoidal fructose-6-phosphate saturation curve to hyperbolic kinetics in the presence of inhibitory concentrations (1.5 mM) of ATP.c) Cyclic AMP has no significant influence as deinhibitor of phosphofructokinase either at pH 7.1 and non-inhibitory levels (0.25 mM) of ATP or at pH 8.1 and inhibitory (1.5 mM) or non-inhibitory (0.25 mM) concentrations of ATP. Similar conclusions were obtained with 300 micron AMP but not at a lower concentration (3 micron) with both nucleotides. The comparison of cyclic AMP result with those obtained under similar concentrations of AMP suggest that cyclic AMP is really only an &quot;in vitro&quot; modulator of the enzyme from rat erythrocytes, presumably at an AMP regulatory stie, since non-physiological concentrations are required to act as deinhibitor.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pinilla</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Luque</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>56-65-5</RegistryNumber>
<NameOfSubstance>Adenosine Triphosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>60-92-4</RegistryNumber>
<NameOfSubstance>Cyclic AMP</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>61-19-8</RegistryNumber>
<NameOfSubstance>Adenosine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.11</RegistryNumber>
<NameOfSubstance>Phosphofructokinase-1</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosine Monophosphate</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosine Triphosphate</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cyclic AMP</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Enzyme Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythrocytes</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phosphofructokinase-1</DescriptorName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18664</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>31</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Organization of purpine degradation in the liver of a teleost (carp; Cyprinus carpio L.). A study of its subcellular distribution.</ArticleTitle>
<Pagination>
<MedlinePgn>17-21</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Carp liver was fractionated by differential and density gradient centrifugation and assayed for enzymes of purine catabolism. While urate oxidase is an exclusively peroxisomal enzyme, only a very small percentage of the enzymes xanthine oxidase, allantoinase and allantoicase is associated with subcellular or ganelle fractions. There is no general purine catabolizing subcellular compartment. There is some but not yet conclusive evidence for the assumption that urate oxidase is a membrane bound enzyme.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Goldenberg</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Purines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.11.1.6</RegistryNumber>
<NameOfSubstance>Catalase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.17.3.2</RegistryNumber>
<NameOfSubstance>Xanthine Oxidase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.7.3.3</RegistryNumber>
<NameOfSubstance>Urate Oxidase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.9.3.1</RegistryNumber>
<NameOfSubstance>Electron Transport Complex IV</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.-</RegistryNumber>
<NameOfSubstance>Esterases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.3.2</RegistryNumber>
<NameOfSubstance>Acid Phosphatase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.5.-</RegistryNumber>
<NameOfSubstance>Amidohydrolases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acid Phosphatase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Amidohydrolases</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carps</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Catalase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cyprinidae</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Electron Transport Complex IV</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Esterases</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Liver</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Organoids</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Purines</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Subcellular Fractions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Urate Oxidase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Xanthine Oxidase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196181</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>31</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Preparation and characterization of isolated parenchymal cells from guinea pig liver.</ArticleTitle>
<Pagination>
<MedlinePgn>23-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>1. A method is described for the preparation of isolated cells from guinea pig liver. This involved perfusion in situ, in the non-physiological direction, with collagenase. 2. The cell yield was 20--30%, comparable with those from the livers of other species. 3. The ratio of lactate dehydrogenase to glutamate dehydrogenase in the cells was similar to that in vivo, indicating that there was negligible leakage of cytoplasmic enzymes. 4. The concentrations of K+ and adenine nucleotides were initially lower than in the perfused liver; normal values were obtained on incubation, particularly in the presence of substrate. 5. The L-lactate: pyruvate ratio is 16:1, close to established values. The total beta-hydroxybutyrate: acetoacetate ratio indicates that the mitochondrial redox state is more oxidised than in the perfused liver, but the intracellular ratio is similar to that of the intact liver. 6. Rates of gluconeogenesis and ureogenesis, are within the physiological range. Maximal gluconeogeneis from L-lactate was preceded by a lag period. L-lysine stimulated glucose production from L-lactate but did not abolish the lag phase. 7. The effects of aminooxyacetate and octanoate on L-lactate gluconeogenesis were similar to those in the perfused liver.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Elliott</LastName>
<ForeName>K R</ForeName>
<Initials>KR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pogson</LastName>
<ForeName>C I</ForeName>
<Initials>CI</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Adenine Nucleotides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Lactates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Octanoic Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-99-7</RegistryNumber>
<NameOfSubstance>Glucose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>53-84-9</RegistryNumber>
<NameOfSubstance>NAD</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>57-13-6</RegistryNumber>
<NameOfSubstance>Urea</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>645-88-5</RegistryNumber>
<NameOfSubstance>Aminooxyacetic Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-09-7</RegistryNumber>
<NameOfSubstance>Potassium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.1.1.27</RegistryNumber>
<NameOfSubstance>L-Lactate Dehydrogenase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.4.1.2</RegistryNumber>
<NameOfSubstance>Glutamate Dehydrogenase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenine Nucleotides</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aminooxyacetic Acid</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Count</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Separation</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Cells, Cultured</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gluconeogenesis</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glucose</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glutamate Dehydrogenase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Guinea Pigs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">L-Lactate Dehydrogenase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lactates</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Liver</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">NAD</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Octanoic Acids</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Potassium</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Urea</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887081</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>31</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Myo-inositol dehydrogenase(s) from Acetomonas oxydans.</ArticleTitle>
<Pagination>
<MedlinePgn>3-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Experimental studies have been undertaken with a view of isolation of the enzyme(s) responsible for the stereospecific oxidation of myo-inositol. A partial fractionation has been achieved and the properties of this extract examined. Results show that the active enzyme may well have a cytochrome component and there is indication that the stereospecificity of Acetomonas oxydans results from permease as opposed to dehydrogenase activity. Kinetic experiments suggest that only one type of active enzyme site is involved in the dehydrogenation of myo-inositol.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Criddle</LastName>
<ForeName>W J</ForeName>
<Initials>WJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fry</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Keaney</LastName>
<ForeName>M M</ForeName>
<Initials>MM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lucas</LastName>
<ForeName>C M</ForeName>
<Initials>CM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tovey</LastName>
<ForeName>J A</ForeName>
<Initials>JA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Cytochromes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>6917-35-7</RegistryNumber>
<NameOfSubstance>Inositol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>956-48-9</RegistryNumber>
<NameOfSubstance>2,6-Dichloroindophenol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.1.-</RegistryNumber>
<NameOfSubstance>Alcohol Oxidoreductases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">2,6-Dichloroindophenol</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Alcohol Oxidoreductases</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Fractionation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cytochromes</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Inositol</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Molecular Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oxidation-Reduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oxygen Consumption</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pseudomonadaceae</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Stereoisomerism</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887082</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>31</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Interactions of lanthanum with purified and intact cell acetylcholinesterase of Electrophorus electricus.</ArticleTitle>
<Pagination>
<MedlinePgn>31-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The effects of lanthanum on the activity of purified preparations of acetylcholinesterase (AChE) from the electric organ of E. electricus and on the activity of AChE in intact electroplaques from the same species were studied. 0.1 mM LaCl3 produced an initial inhibition of purified AChE which was followed by a delayed activation of the enzyme. Upon pretreatment of purified enzyme with LaCl3, initial activity was markedly increased. LaCl3 exerted a marked, concentration-dependent inhibition of intact cell AChE. La3+ and Ca2+ appear to interact competitively. In the presence of both 10 mM CaCl2 and 0.1 mM LaCl3, the initial activitity of purified AChE was increased at lower ACh concentrations and inhibited at ACh concentrations greater than 3 X 10(-4) M. Inhibition of intact cell enzyme by 0.1 mM LaCl3 was relieved by increasing the CaCl2 concentration to 10 mM at ACh concentrations less than 2 X 10(-4) M. The data were analyzed assuming Michaelis-Menten kinetics and interpreted with reference to the differential binding of divalent and trivalent cations to regulatory anionic sites which are separate and distinct from the anionic site of the active center of the enzyme.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Marquis</LastName>
<ForeName>J K</ForeName>
<Initials>JK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Webb</LastName>
<ForeName>G D</ForeName>
<Initials>GD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>51-84-3</RegistryNumber>
<NameOfSubstance>Acetylcholine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7439-91-0</RegistryNumber>
<NameOfSubstance>Lanthanum</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-70-2</RegistryNumber>
<NameOfSubstance>Calcium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.1.7</RegistryNumber>
<NameOfSubstance>Acetylcholinesterase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acetylcholine</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acetylcholinesterase</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Calcium</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell-Free System</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Electric Organ</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Electrophorus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrolysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lanthanum</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196182</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>31</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Changes in the collagenolytic activity released by primary VX-2 carcinoma cultures as a function of tumor growth.</ArticleTitle>
<Pagination>
<MedlinePgn>37-42</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Serum-free media of minced tissue cultures of VX-2 rabbit carcinoma contained a specific collagenolytic activity capable of releasing soluble radioactive peptides from [14C]-labeled collagen fibrils. It was also capable of reducing the viscosity of acid-soluble collagen solutions by cleaving the tropocollagen (TC) molecules primarily at one site to TCA (75%) and TCB (25%) fragments. Three chromatographic fractions were separated by gel filtration: F1, (MW 85-110,000) present in larger amounts in early cultures of younger tumor tissue; F2, (MW-35-40,000) the major component with maximum production in the day 3 media of younger and advanced tumor tissues; F3, (MW 18-22,000) the minor component. Early cultures of younger tumor tissue contained a latent collagenase and were subject to trypsin activation suggesting the presence of inactive enzyme precursors or an enzyme-inhibitor complex.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dabbous</LastName>
<ForeName>M K</ForeName>
<Initials>MK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sobhy</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Roberts</LastName>
<ForeName>A N</ForeName>
<Initials>AN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brinkley</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Culture Media</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Enzyme Precursors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-34-5</RegistryNumber>
<NameOfSubstance>Collagen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.21.4</RegistryNumber>
<NameOfSubstance>Trypsin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.24.3</RegistryNumber>
<NameOfSubstance>Microbial Collagenase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Division</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Collagen</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Culture Media</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Culture Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Enzyme Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Enzyme Precursors</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrolysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microbial Collagenase</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neoplasm Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Neoplasms, Experimental</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rabbits</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Trypsin</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887083</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>31</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>The control by RNA of pyruvate kinase activity in human skeletal muscle.</ArticleTitle>
<Pagination>
<MedlinePgn>43-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Baranowska</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Baranowski</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Ribonucleoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>63231-63-0</RegistryNumber>
<NameOfSubstance>RNA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.40</RegistryNumber>
<NameOfSubstance>Pyruvate Kinase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Crystallography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Muscles</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pyruvate Kinase</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribonucleoproteins</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196183</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>31</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Experimental phenylketonuria: metabolic studies in rat liver.</ArticleTitle>
<Pagination>
<MedlinePgn>9-16</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The &quot;in vivo&quot; effects of L-phenylalanine on the gluconeogenic pathway in the liver of fasted rats with experimentally induced phenylketonuria-like characteristics have been investigated. Significant increases of the fructose 6-phosphate, glucose 6-phosphate and glucose concentrations were observed. The study of the effect of L-phenylalanine on the cytoplasmic and mitochondrial redox state and energy charge showed an increase in the mitochondrial NAD+/NADH ratio while the energy charge was virtually unchanged. The effects of phenylalanine and its metabolic derivatives (phenylacetate, phenylethylamine, phenyl-lactate, o-hydroxyphenylacetate and phenylpyruvate) on the activity of lactate dehydrogenase (EC 1.1.1.27), malate dehydrogenase (EC 1.1.1.37) and 3-hydroxybutyrate dehydrogenase (EC 1.1.1.30) in rat liver have been also investigated. Phenylpyruvate inhibited the lactate dehydrogenase activity with a Ki of 5.3 mM. Phenylpyruvate also inhibited both the mitochondrial (Ki = 4 mM) and cytoplasmic (Ki = 5 mM) malate dehydrogenase activities. Phenylpyruvate, phenylacetate and o-hydroxyphenylacetate inhibited the 3-hydroxybutyrate dehydrogenase activity with Ki values of 0.7, 6.0 and 9.5 mM respectively.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gimenez</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Benavides</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sanchez-Rubiales</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Valdivieso</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mayor</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Fructosephosphates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Glucosephosphates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Ketone Bodies</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-99-7</RegistryNumber>
<NameOfSubstance>Glucose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>53-84-9</RegistryNumber>
<NameOfSubstance>NAD</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>63-91-2</RegistryNumber>
<NameOfSubstance>Phenylalanine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7424-00-2</RegistryNumber>
<NameOfSubstance>Fenclonine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.1.1.27</RegistryNumber>
<NameOfSubstance>L-Lactate Dehydrogenase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.1.1.30</RegistryNumber>
<NameOfSubstance>Hydroxybutyrate Dehydrogenase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.1.1.37</RegistryNumber>
<NameOfSubstance>Malate Dehydrogenase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fasting</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fenclonine</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fructosephosphates</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gluconeogenesis</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glucose</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glucosephosphates</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydroxybutyrate Dehydrogenase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ketone Bodies</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">L-Lactate Dehydrogenase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Liver</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Malate Dehydrogenase</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">NAD</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenylalanine</DescriptorName>
<QualifierName MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenylketonurias</DescriptorName>
<QualifierName MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Stereoisomerism</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887084</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Protein synthesis in resting and stimulated human lymphocytes.</ArticleTitle>
<Pagination>
<MedlinePgn>105-10</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The ribosomal profiles in lysates from resting and phytohemagglutinin stimulated human lymphocytes have been analyzed by sucrose gradient centrifugation. The percentage of polyribosomes increased during lymphocyte transformation reaching a maximal value of 60 to 70% of the total ribosomes after 72 hours of mitogen addition. This time period coincides with maximal in vivo protein synthesis. On the other hand, in nonstimulated lymphocytes, about 25% of the ribosomal particles appeared as aggregates, independently of the incubation period. Experiments performed with homologous cell free systems containing ribosomes and supernatant fluids prepared from unstimulated or activated lymphocytes demonstrate that the mixtures containing both components from stimulated lymphocytes are several fold more active in polypeptide synthesis than the systems which contain ribosomal particles and cell sap from resting cells. Assays carried out with mixtures combining the components from both sources indicate that the increased activity depends on ribosomes as well as on the supernatant fractions.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Burrone</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Algranati</LastName>
<ForeName>I D</ForeName>
<Initials>ID</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Lectins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>27416-86-0</RegistryNumber>
<NameOfSubstance>Poly U</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>53-79-2</RegistryNumber>
<NameOfSubstance>Puromycin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>56-75-7</RegistryNumber>
<NameOfSubstance>Chloramphenicol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>66-81-9</RegistryNumber>
<NameOfSubstance>Cycloheximide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7439-95-4</RegistryNumber>
<NameOfSubstance>Magnesium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-49-2</RegistryNumber>
<NameOfSubstance>DNA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chloramphenicol</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cycloheximide</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lectins</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Lymphocyte Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lymphocytes</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Magnesium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Poly U</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Protein Biosynthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Puromycin</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA, Messenger</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribosomes</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887085</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Synthesis of dolichol derivatives in human erythrocyte membranes.</ArticleTitle>
<Pagination>
<MedlinePgn>111-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Human erythrocyte membranes contain the enzymes responsible for the synthesis of dolichol-P-glucose, dolichol-P-mannose, dolichol-PP-N-acetylglucosamine, dolichol-PP-NN' diacetylchitobiose and of dolichol-PP-oligosaccharides containing NN' diacetylchitobiose and mannose or the same sugar residues plus glucose. The transfer of the oligosaccharide moieties from the dolichol-PP-oligosaccharides to endogenous proteins could not be detected. These enzymes appeared to be integral membrane proteins.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Martin-Barrientos</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Parodi</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Diterpenes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Phospholipids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>2067-66-5</RegistryNumber>
<NameOfSubstance>Dolichol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diterpenes</DescriptorName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dolichol</DescriptorName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythrocyte Membrane</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythrocytes</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Osmolar Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phospholipids</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887086</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Nuclear protein phosphokinase activities and phosphorylation of chromosomal proteins in embryonic and adult muscles of the chick.</ArticleTitle>
<Pagination>
<MedlinePgn>119-25</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Piras</LastName>
<ForeName>M M</ForeName>
<Initials>MM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Piras</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Nucleoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.37</RegistryNumber>
<NameOfSubstance>Protein Kinases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Nucleus</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chick Embryo</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chickens</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromosomes</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cytosol</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Molecular Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Muscles</DescriptorName>
<QualifierName MajorTopicYN="N">embryology</QualifierName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nucleoproteins</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Protein Kinases</DescriptorName>
<QualifierName MajorTopicYN="N">isolation &amp; purification</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18665</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Enzymatic synthesis of polyprenol monophosphate mannose in insects.</ArticleTitle>
<Pagination>
<MedlinePgn>127-34</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The microsomal fraction of insects was found to contain an enzyme which transfers mannose from guanosine diphosphate mannose to an endogenous or exogenous insect lipid and to other acceptors such as dolichol monophosphate or ficaprenol monophosphate. This activity depended on the presence of Triton X-100 and magnesium ions, the optimal concentration of the latter being 10mM. The optimal temperature of the reaction was 25 degrees C and the maximal activity was obtained at pH 7.9. The mannolipid formed behaved as a monophosphodiester when chromatographed on DEAE-cellulose. Weak acid treatment of the product liberated mannose. Its behaviour both on thin layer and Sephadex G-150 chromatography would indicate the presence of a number of isoprenyl units similar to the dolichol and different from the ficaprenol derivative. Stability to phenol treatment indicated that the lipid fraction of the mannolipid is an alpha-saturated polyprenol phosphate similar to dolichol monophosphate.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Belocopitow</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Marechal</LastName>
<ForeName>L R</ForeName>
<Initials>LR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Quesada Allue</LastName>
<ForeName>L A</ForeName>
<Initials>LA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hexosephosphates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Phospholipids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Polyethylene Glycols</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Terpenes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7439-95-4</RegistryNumber>
<NameOfSubstance>Magnesium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7439-96-5</RegistryNumber>
<NameOfSubstance>Manganese</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-48-4</RegistryNumber>
<NameOfSubstance>Cobalt</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.4.1.-</RegistryNumber>
<NameOfSubstance>Hexosyltransferases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.4.1.-</RegistryNumber>
<NameOfSubstance>Mannosyltransferases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cobalt</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diptera</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Enzyme Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hexosephosphates</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hexosyltransferases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Larva</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Magnesium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Manganese</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mannosyltransferases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microsomes</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phospholipids</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Polyethylene Glycols</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pupa</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Temperature</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Terpenes</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Triatoma</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Triatominae</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196184</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Influence of cyclic 3',5'-adenosine monophosphate on uracil uptake by rifampicin treated Escherichia coli cells.</ArticleTitle>
<Pagination>
<MedlinePgn>135-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Incubation of cells from a wild type strain of E. coli with 0.3 mg/ml rifampicin for 15 minutes lead to a complete inhibition of RNA synthesis measured as the uracil incorporation into the trichloroacetic acid insoluble fraction. In these rifampicin-treated cells [14C]uracil incorporation tended to decrease during a further incubation at 37 degrees. Addition of cyclic AMP increased the inactivation of the system responsible for [14C]uracil uptake. The cyclic nucleotide effect seems to be specific since ATP or 5'AMP did not increase such inactivation.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Judewicz</LastName>
<ForeName>N D</ForeName>
<Initials>ND</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Torres</LastName>
<ForeName>H N</ForeName>
<Initials>HN</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Bacterial</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>13292-46-1</RegistryNumber>
<NameOfSubstance>Rifampin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>56-65-5</RegistryNumber>
<NameOfSubstance>Adenosine Triphosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>60-92-4</RegistryNumber>
<NameOfSubstance>Cyclic AMP</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>61-19-8</RegistryNumber>
<NameOfSubstance>Adenosine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>66-22-8</RegistryNumber>
<NameOfSubstance>Uracil</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosine Monophosphate</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosine Triphosphate</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Biological Transport, Active</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cyclic AMP</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rifampin</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transcription, Genetic</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Uracil</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18666</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>A primer independent activity of rabbit muscle phosphorylase b.</ArticleTitle>
<Pagination>
<MedlinePgn>141-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Rabbit muscle phosphorylase b was found to be capable of forming protein bound alpha-1,4 glucosyl chains upon incubation of the enzyme with appropriate concentrations of glucose-1-phosphate with no primer addition (unprimed synthesis). This activity would only be present in a small fraction of the total muscle phosphorylase b activity, as judged from the high concentrations of enzyme which are required to demonstrate the occurrence of unprimed synthesis. Polyacrylamide gel electrophoresis shows the presence of a phosphorylase isoenzyme capable of accepting glucosyl moieties, giving rise to a glucosylated protein enzymatically active in the chain lengthening of its own glucan.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tandecarz</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lavintman</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cardini</LastName>
<ForeName>C E</ForeName>
<Initials>CE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>9005-79-2</RegistryNumber>
<NameOfSubstance>Glycogen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.4.1.-</RegistryNumber>
<NameOfSubstance>Phosphorylases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glycogen</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Muscles</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phosphorylases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rabbits</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18667</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Sucrose metabolism in green algae. I. The presence of sucrose synthetase and sucrose phosphate synthetase.</ArticleTitle>
<Pagination>
<MedlinePgn>149-52</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The presence of sucrose synthetase and sucrose phosphate synthetase has been demonstrated in two species of green algae: Chlorella vulgaris and Scenedesmus obliquus. Partial purification from crude extracts allowed the determination of the kinetic constants of algae enzymes. They are very similar to the ones reported for enzymes from higher plants.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Duran</LastName>
<ForeName>W R</ForeName>
<Initials>WR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pontis</LastName>
<ForeName>H G</ForeName>
<Initials>HG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Fructosephosphates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>57-50-1</RegistryNumber>
<NameOfSubstance>Sucrose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.4.1.-</RegistryNumber>
<NameOfSubstance>Glucosyltransferases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Algae, Green</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chlorella</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fructosephosphates</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Glucosyltransferases</DescriptorName>
<QualifierName MajorTopicYN="N">isolation &amp; purification</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Plants</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Species Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sucrose</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887087</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>12</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Purification of apo-3-D-(-) hydroxybutyrate dehydrogenase from rat liver mitochondria.</ArticleTitle>
<Pagination>
<MedlinePgn>153-69</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vidal</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Guglielmucci</LastName>
<ForeName>E A</ForeName>
<Initials>EA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Stoppani</LastName>
<ForeName>A O</ForeName>
<Initials>AO</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Apoenzymes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.1.1.30</RegistryNumber>
<NameOfSubstance>Hydroxybutyrate Dehydrogenase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Apoenzymes</DescriptorName>
<QualifierName MajorTopicYN="N">isolation &amp; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydroxybutyrate Dehydrogenase</DescriptorName>
<QualifierName MajorTopicYN="Y">isolation &amp; purification</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Membranes</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mitochondria, Liver</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Molecular Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887088</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Glycosylation of endogenous protein(s) of the rough and smooth microsomes by a lipid sugar intermediate.</ArticleTitle>
<Pagination>
<MedlinePgn>171-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Several problems regarding the protein acceptor of the oligosaccharide from GEA (glucosylated endogenous acceptor) were investigated in the present work using rat liver microsomal subfractions. It was found that the acceptor molecule is present in rough and smooth liver microsomes. Furthermore both fractions have closely similar specific activities. The problem of whether nascent peptides must be ribosome bound for glycosylation to occur was studied. The results suggests that binding of peptides to ribosomes is not a necessary condition for the transfer of GEA oligosaccharide to protein. The increase in specific activity found after partial release of the microsomal vesicular content suggests that the acceptor protein for GEA is membrane bound. Evidence obtained in attempting to elucidate whether nascent or completed chains are glycosylated favours the later possibility.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Idoyaga Vargas</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Carminatti</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Glycolipids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Oligosaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>53-79-2</RegistryNumber>
<NameOfSubstance>Puromycin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>83-44-3</RegistryNumber>
<NameOfSubstance>Deoxycholic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Deoxycholic Acid</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glycolipids</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glycoproteins</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microsomes, Liver</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oligosaccharides</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Puromycin</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribosomes</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887089</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Synthesis of a compound soluble in organic solvents from deoxycytidine triphosphate in permeabilized normal human lymphocytes.</ArticleTitle>
<Pagination>
<MedlinePgn>177-85</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Normal human lymphocytes may be rendered permeable to deoxynucleoside triphosphates. When [3H]dCTP is furnished to permeabilized lymphocytes tow compounds are formed: DNA and a compound soluble in organic solvents. [3H]dCTP incorporation is higher in stimulated lymphocytes than in unstimulated cells. Some characteristics of the system are reported.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mordoh</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fridlender</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Cytosine Nucleotides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Lectins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Solvents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>1032-65-1</RegistryNumber>
<NameOfSubstance>Deoxycytidine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>56-65-5</RegistryNumber>
<NameOfSubstance>Adenosine Triphosphate</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7439-95-4</RegistryNumber>
<NameOfSubstance>Magnesium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-70-2</RegistryNumber>
<NameOfSubstance>Calcium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-49-2</RegistryNumber>
<NameOfSubstance>DNA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosine Triphosphate</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Calcium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Nucleus</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cytosine Nucleotides</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Deoxycytidine Monophosphate</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lectins</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lymphocytes</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Magnesium</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Permeability</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Solvents</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887090</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Porphyrin biosynthesis from prophobilinogen by duck blood hemolysate.</ArticleTitle>
<Pagination>
<MedlinePgn>187-92</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The formation of porphyrins from porphobilinogen by a duck blood hemolysate was examined. The system was found to form mainly protoporphyrin IX and hemin, and accumulated lesser amounts of uroporphyrins, hepatacarboxylic porphyrin, and coproporphyrins. By storage at -20 degrees the accumulation of uroporphyrins and heptacarboxylic porphyrin was increased. Both porphyrins were mainly the type III isomers. By addition of dithiothreitol the porphyrin pattern reversed to the original one formed by the fresh hemolysate. Addition of a number of amines also inhibited the decarboxylating system without affecting the original isomer distribution among the porphyrins. Addition of Fe2+ (3mM) did not affect the porphyrin pattern or the isomer distribution. Addition of Pb2+ (2.5 mM) partially inhibited the decarboxylating system, whereas at higher concentrations (4 mM) it increased the decarboxylation rate of the heptacarboxylic porphyrin. The obtained results are discussed in relation to porphyrin accumulation in porphyria cutanea tarda and in acquired hepatic porphyrias.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Frydman</LastName>
<ForeName>R B</ForeName>
<Initials>RB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Frydman</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Feinstein</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Cyclohexylamines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hydroxylamines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Imidazoles</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Piperidines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Porphyrins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>12125-02-9</RegistryNumber>
<NameOfSubstance>Ammonium Chloride</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>3483-12-3</RegistryNumber>
<NameOfSubstance>Dithiothreitol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>487-90-1</RegistryNumber>
<NameOfSubstance>Porphobilinogen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ammonium Chloride</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cyclohexylamines</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dithiothreitol</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ducks</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythrocytes</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Freezing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hemolysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydroxylamines</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Imidazoles</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Piperidines</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Porphobilinogen</DescriptorName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Porphyrins</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887091</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>A lipid linked oligosaccharide which contains hexosamine, mannose and glucose.</ArticleTitle>
<Pagination>
<MedlinePgn>193-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Previous work showed that liver microsomes catalyze the transfer of glucose from dolichol monophosphate glucose to an endogenous acceptor believed to be a dolichol pyrophosphate derivative of an oligosaccharide. This oligosaccharide has now been prepared on a larger scale so as to permit the determination of its sugars. The purification procedure includes, as a last step, a thin layer chromatography on kieselguhr-silica gel to obviate glucose-containing contaminants. After complete hydrolysis mannose, glucose and a small amount of hexosamine were detected.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tábora</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Behrens</LastName>
<ForeName>N H</ForeName>
<Initials>NH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hexosamines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Lipopolysaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Oligosaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Phospholipids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>31103-86-3</RegistryNumber>
<NameOfSubstance>Mannose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-99-7</RegistryNumber>
<NameOfSubstance>Glucose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glucose</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hexosamines</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Lipopolysaccharides</DescriptorName>
<QualifierName MajorTopicYN="N">isolation &amp; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Liver</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mannose</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Oligosaccharides</DescriptorName>
<QualifierName MajorTopicYN="N">isolation &amp; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phospholipids</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Swine</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196185</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Incorporation and metabolism of stearic, oleic, linoleic and alpha-linolenic acids in minimal deviation hepatoma 7288 C cells.</ArticleTitle>
<Pagination>
<MedlinePgn>197-203</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Minimal Deviation Hepatoma 7288 C cells were cultured in confluent layer with labeled stearic, oleic, linoleic and alpha-linolenic acids. The kinetics of incorporation and conversion to higher homologs was studied. The maximum amounts incorporated in nmoles per mg of cellular protein for stearic, oleic, linoleic and alpha-linolenic acids were 39, 115.6, 90 and 230 respectively. alpha-linolenic acid was converted to octadeca-6,9,12,15-tetraenoic acid (18:1), eicosa-11,14,17-trienoic acid (20:3), eicosa-8,11,14,17 and 5,11,14,17-tetraenoic acids (20:4) and eicosa-5,8,11,14,17-pentaenoic acid (20:5), and also to myristic, palmitic, palmitoleic, stearic and oleic acids. By a mathematical approach, the endogenous pool size of alpha-linolenic acid available for conversion to eicosa-5,8,11,14,17-pentaenoic acid, were calculated. Both values decreased when the cells were preincubated with unlabeled alpha-linolenic acid.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gaspar</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>de Alaniz</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brenner</LastName>
<ForeName>R R</ForeName>
<Initials>RR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Linoleic Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Linolenic Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Oleic Acids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Stearic Acids</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Linoleic Acids</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Linolenic Acids</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Liver Neoplasms</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oleic Acids</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Stearic Acids</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887092</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Synthesis of polyprenol-monophosphate- beta -galactose by acetobacter xylinum.</ArticleTitle>
<Pagination>
<MedlinePgn>205-12</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A particulate enzyme preparation from Acetobacter xylinum synthesizes ficaprenol-monophosphate-beta-galactose from ficaprenol monophosphate (FMP) and UDP-galactose in the presence of detergent. The product has the same properties as those previously reported for the compound formed with the endogenous acceptor. Dolichol-monophosphate (DolMP) is also a good galactose acceptor but the product obtained has different properties. Lipid extracts from Acetobacter contain galactose acceptor capacity which is lost by mild acid treatment. FMP behaves in a similar manner but DolMP is resistant to this treatment. It is concluded that the endogeneous acceptor is an allylic phosphate ester of a polyprenol.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Romero</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Garcia</LastName>
<ForeName>R C</ForeName>
<Initials>RC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dankert</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hexosephosphates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Polyethylene Glycols</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Polysaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Terpenes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>2956-16-3</RegistryNumber>
<NameOfSubstance>Uridine Diphosphate Galactose</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gluconacetobacter xylinus</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hexosephosphates</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Polyethylene Glycols</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Polysaccharides</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Terpenes</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Uridine Diphosphate Galactose</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887093</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Diabetes-induced alteration in subcellular distribution of poly(A)-rich RNA from skeletal muscle.</ArticleTitle>
<Pagination>
<MedlinePgn>213-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Skeletal muscle ribosome preparations from diabetic rats have lower polysome content than those from normal animals. The ratio of poly(A) containing RNA between polysomes and postribosomal supernatant has been measured both in normal and diabetic rats. The results suggest that in diabetic animals there is a greater proportion of free poly(A) containing RNA, in postribosomal supernatant.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>de Pisarev</LastName>
<ForeName>D L</ForeName>
<Initials>DL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Recondo</LastName>
<ForeName>E F</ForeName>
<Initials>EF</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Ribosomal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>24937-83-5</RegistryNumber>
<NameOfSubstance>Poly A</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Fractionation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diabetes Mellitus, Experimental</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Muscles</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nucleic Acid Hybridization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Poly A</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Polyribosomes</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA, Ribosomal</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribosomes</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Subcellular Fractions</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329121</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Luis F. Leloir in the seventh decade of his life.</ArticleTitle>
<Pagination>
<MedlinePgn>61-2</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Caputto</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Biography</PublicationType>
<PublicationType>Historical Article</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Carbohydrates</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CitationSubset>Q</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Argentina</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Biochemistry</DescriptorName>
<QualifierName MajorTopicYN="N">history</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carbohydrates</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">History, 20th Century</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<PersonalNameSubjectList>
<PersonalNameSubject>
<LastName>Leloir</LastName>
<ForeName>L F</ForeName>
<Initials>LF</Initials>
</PersonalNameSubject>
</PersonalNameSubjectList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18668</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Trisialoganglioside synthesis by a chicken brain sialyltransferase. Comparative study with the similar reaction for the synthesis of disialoganglioside.</ArticleTitle>
<Pagination>
<MedlinePgn>63-70</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>An enzyme preparation from embryonic chicken brain catalyzes the transfer of sialic acid from CMP-N-acetylneuraminic acid to ceramide-Glc-Gal(NeuAc-NeuAc)-GalNAc-Gal (GDlb) to form ceramide-Glc-Gal(NeuAc-NeuAc)-GalNAc-Gal-NeuAc (GTlb). The sialyltransferase activity was measured during the development of the embryo, the subcellular distribution of this activity was determined and several kinetic properties of the reaction were examined. A comparative study with the similar reaction involved in the transfer of sialic acid to the terminal galactose in ceramide-Glc-Gal(NeuAc)-GalNAc-Gal (GMl) was made. The results obtained in this comparative study suggest that the transfer of sialic acid in both reactions is catalyzed by the same enzyme.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mestrallet</LastName>
<ForeName>M G</ForeName>
<Initials>MG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cumar</LastName>
<ForeName>F A</ForeName>
<Initials>FA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Caputto</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Gangliosides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Polyethylene Glycols</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Polysorbates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.-</RegistryNumber>
<NameOfSubstance>Transferases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.4.99.-</RegistryNumber>
<NameOfSubstance>Sialyltransferases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Brain</DescriptorName>
<QualifierName MajorTopicYN="N">embryology</QualifierName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cattle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chick Embryo</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chickens</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gangliosides</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Polyethylene Glycols</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Polysorbates</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sialyltransferases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Subcellular Fractions</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transferases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329122</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Polyamines and protein synthesis: studies in various polyamine-requiring mutants of Escherichia coli.</ArticleTitle>
<Pagination>
<MedlinePgn>71-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Different Escherichia coli mutants auxotrophic for polyamines were studied in order to investigate the relationships among polypeptide synthesis in cell-free systems, ribosomal distribution profiles and endogenous polyamine pools. The in vitro protein synthetic activity and the polyribosomal content were reduced in extracts from putrescine-starved cells of the double mutans MA 255 and MA 261, but not in the arginine-conditional auxotroph DK 6. Putrescine addition to the cultures of all these strains previously starved for polyamines, provoked a shift towards monomers in the equilibrium involving ribosomal particles. Concomitant changes in the intracellular levels of polyamines were observed: putrescine and spermidine increased markedly, and cadaverine disappeared.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Goldemberg</LastName>
<ForeName>S H</ForeName>
<Initials>SH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Algranati</LastName>
<ForeName>I D</ForeName>
<Initials>ID</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>110-60-1</RegistryNumber>
<NameOfSubstance>Putrescine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Division</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Escherichia coli</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Protein Biosynthesis</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Putrescine</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribosomes</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Species Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887094</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Binding of estradiol receptor complexes to isolated human breast chromatin.</ArticleTitle>
<Pagination>
<MedlinePgn>79-86</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The interaction of estradiol-receptor complexes and isolated human breast tumor chromatin was studied under equilibrium conditions. The estradiol-receptor complexes bound specifically to the chromatin of hormone dependent tumors and showed a single class of binding sites with a Ka of 0.96 X 10(10) M-1 and a binding capacity of 1.5 pmoles/mg DNA. The binding was a temperature-dependent process and involved a &quot;transformation&quot; of the receptor protein. The heat-activated hormone-receptor complex was more active than the 8S form in the binding phenomenon. The specific interaction of estradiol-receptor complex with isolated chromatin was saturable and sensitive to conditions of temperature and ionic strength. Furthermore under optimal conditions no acceptor sites were detected in chromatin of hormone independent tumors.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Charreau</LastName>
<ForeName>E H</ForeName>
<Initials>EH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Baldi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Chromatin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Neoplasm</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Receptors, Estrogen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-28-2</RegistryNumber>
<NameOfSubstance>Estradiol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7647-14-5</RegistryNumber>
<NameOfSubstance>Sodium Chloride</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromatin</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA, Neoplasm</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Estradiol</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Osmolar Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Receptors, Estrogen</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sodium Chloride</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Temperature</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887095</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Rate of concentration and digestion of radioactive growth hormone preparations injected in rats, as measured by the amount and nature of radioactivity in the tissues.</ArticleTitle>
<Pagination>
<MedlinePgn>87-96</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Retegui-Sardou</LastName>
<ForeName>L A</ForeName>
<Initials>LA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Scaramal</LastName>
<ForeName>L O</ForeName>
<Initials>LO</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dellacha</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Paladini</LastName>
<ForeName>A C</ForeName>
<Initials>AC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Carbon Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Guanidines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Iodine Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9002-72-6</RegistryNumber>
<NameOfSubstance>Growth Hormone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carbon Radioisotopes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cattle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Growth Hormone</DescriptorName>
<QualifierName MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Guanidines</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Iodine Radioisotopes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Isotope Labeling</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kidney</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Liver</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Muscles</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Organ Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pancreas</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spleen</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18669</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0300-8177</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>16</Volume>
<Issue>2</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jul</Month>
<Day>5</Day>
</PubDate>
</JournalIssue>
<Title>Molecular and cellular biochemistry</Title>
<ISOAbbreviation>Mol. Cell. Biochem.</ISOAbbreviation>
</Journal>
<ArticleTitle>Porphyrin biosynthesis. Immobilized enzymes. IV. Studies on aminolaevulate dehydratase attached to Sepharose.</ArticleTitle>
<Pagination>
<MedlinePgn>97-104</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Bovine liver aminolaevulate dehydratase (ALA-D) has been chemically attached to Sepharose 4B and its properties have been studied. The optimal conditions for coupling have been determined. It was found that the immobilized enzyme retained a significant percentage of the activity of the free enzyme. The coupling yield was rather high. The insolubilized enzyme requires both anaerobiosis and a thiol activator for maximal activity. It can be stored at 4 degrees C for long periods with little loss of activity and it can be repeatedly used without alteration of its enzymic capacity. Attachment of ALA-D to the gel has led to an enhanced thermal stability. pH optima of free and bound enzyme was the same while a small decrease in the Km of the matrix bonded ALA-D as compared to that of the soluble enzyme was observed. The use of the fixed-ALA-D for the preparation of PBG is described.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stella</LastName>
<ForeName>A M</ForeName>
<Initials>AM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wider de Xifra</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>del C Batlle</LastName>
<ForeName>A M</ForeName>
<Initials>AM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Cell Biochem</MedlineTA>
<NlmUniqueID>0364456</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Enzymes, Immobilized</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>487-90-1</RegistryNumber>
<NameOfSubstance>Porphobilinogen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9012-36-6</RegistryNumber>
<NameOfSubstance>Sepharose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.2.1.-</RegistryNumber>
<NameOfSubstance>Hydro-Lyases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 4.2.1.24</RegistryNumber>
<NameOfSubstance>Porphobilinogen Synthase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cattle</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Stability</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Enzymes, Immobilized</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydro-Lyases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kinetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Liver</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Methods</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Porphobilinogen</DescriptorName>
<QualifierName MajorTopicYN="N">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Porphobilinogen Synthase</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sepharose</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Temperature</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887096</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0301-4851</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Molecular biology reports</Title>
<ISOAbbreviation>Mol. Biol. Rep.</ISOAbbreviation>
</Journal>
<ArticleTitle>Lectin activity of chromatin non-histone proteins.</ArticleTitle>
<Pagination>
<MedlinePgn>265-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Non-histone proteins from chromatin of sea urchin embryos were found to possess the ability to agglutinate erythrocytes.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sevaljević</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Konstantinović</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tomović</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pavlović</LastName>
<ForeName>Z</ForeName>
<Initials>Z</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Biol Rep</MedlineTA>
<NlmUniqueID>0403234</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Agglutinins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Chromatin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hemagglutinins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Agglutinins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Chromatin</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Hemagglutinins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Proteins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Sea Urchins</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887097</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0301-4851</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Molecular biology reports</Title>
<ISOAbbreviation>Mol. Biol. Rep.</ISOAbbreviation>
</Journal>
<ArticleTitle>Template active chromatin structures: degradation by deoxyribonuclease I.</ArticleTitle>
<Pagination>
<MedlinePgn>269-74</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Chicken embryos were pulse-labelled in vivo with [3H]uridine (10 min), the chromatin isolated and treated with DNAse I. The residual chromatin was separated from the degradation products by centrifugation. The nascent pulse-labelled RNA is completely recovered in the residual chromatin even after prolonged incubation with DNAase I, whereas the DNA is completely degraded to 80 base polynucleotide fragments and smaller fragments.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Knöchel</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Asahi</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Born</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tiedemann</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Biol Rep</MedlineTA>
<NlmUniqueID>0403234</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Chromatin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>63231-63-0</RegistryNumber>
<NameOfSubstance>RNA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-49-2</RegistryNumber>
<NameOfSubstance>DNA</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.1.-</RegistryNumber>
<NameOfSubstance>Deoxyribonucleases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chick Embryo</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Chromatin</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Deoxyribonucleases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">RNA</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Templates, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887098</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0301-4851</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Molecular biology reports</Title>
<ISOAbbreviation>Mol. Biol. Rep.</ISOAbbreviation>
</Journal>
<ArticleTitle>Detection of methyltransferase activities which modify Gppp G to m7GpppGm in embryonic chick lens.</ArticleTitle>
<Pagination>
<MedlinePgn>275-81</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>GpppG was modified to m7 GpppGm by a cytoplasmic extract, prepared from embryonic lens cells, in a reaction mixture which contained S-adenosyl-methionine as methyl group donor. The appearance of m7 GpppGm was a function of time and lens extract concentration. S-adenosyl-homocysteine inhibited both the m7G and Gm modification reactions. Analogues of GpppG, pG, ppG and pppG were relatively ineffective as substrates.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lavers</LastName>
<ForeName>G C</ForeName>
<Initials>GC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Biol Rep</MedlineTA>
<NlmUniqueID>0403234</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.1.1.-</RegistryNumber>
<NameOfSubstance>Methyltransferases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chick Embryo</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lens, Crystalline</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Methyltransferases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Protein Biosynthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">RNA, Messenger</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>69989</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0301-4851</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Molecular biology reports</Title>
<ISOAbbreviation>Mol. Biol. Rep.</ISOAbbreviation>
</Journal>
<ArticleTitle>Inhibition of oxidation by peroxidase of human serum proteins.</ArticleTitle>
<Pagination>
<MedlinePgn>283-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The oxidation of essential serum proteins, albumin and gamma globulin, by the enzyme peroxidase can be partially inhibited by compounds, such as EDTA and 2,4-pentanedione, that complex with the iron ion in peroxidase. The importance of such inhibition lies in the circumstance that the oxidations in question might be a possible causative factor in tissue aging.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gemant</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Biol Rep</MedlineTA>
<NlmUniqueID>0403234</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antioxidants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Blood Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Serum Albumin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>gamma-Globulins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>60-00-4</RegistryNumber>
<NameOfSubstance>Edetic Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>67-64-1</RegistryNumber>
<NameOfSubstance>Acetone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.11.1.-</RegistryNumber>
<NameOfSubstance>Peroxidases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acetone</DescriptorName>
<QualifierName MajorTopicYN="N">analogs &amp; derivatives</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Antioxidants</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Blood Proteins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Edetic Acid</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Peroxidases</DescriptorName>
<QualifierName MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Serum Albumin</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">gamma-Globulins</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887099</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0301-4851</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Molecular biology reports</Title>
<ISOAbbreviation>Mol. Biol. Rep.</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of the protein content of free and membrane-bound rat liver polysomes and of the derived subunits.</ArticleTitle>
<Pagination>
<MedlinePgn>289-96</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Ribosomal proteins from pure free and membrane-bound rat liver polysomes were analyzed with a highly resolutive two-dimensional gel electrophoresis technique, using sodium dodecyl sulfate in the second dimension. Three acidic proteins found in free polysomes were always absent from the membrane-bound polysomes. Their molecular weights were estimated to be 20 000, 19 500 and 18 500. When free ribosomes were dissociated into subunits, the three protein spots were still found in the 60S subunit pattern, but they were weaker than in polysomes. A possible involvement of these three proteins in the attachment of ribosomal structures to the membranes is proposed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Madjar</LastName>
<ForeName>J J</ForeName>
<Initials>JJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Arpin</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Marion</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reboud</LastName>
<ForeName>J P</ForeName>
<Initials>JP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Biol Rep</MedlineTA>
<NlmUniqueID>0403234</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Ribosomal Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Liver</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Polyribosomes</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribosomal Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887100</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0301-4851</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Molecular biology reports</Title>
<ISOAbbreviation>Mol. Biol. Rep.</ISOAbbreviation>
</Journal>
<ArticleTitle>Denaturation of mouse satellite and ribosomal DNA during hydroxyapatite thermal chromatography of chromatin.</ArticleTitle>
<Pagination>
<MedlinePgn>297-303</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Mouse DNA and chromatin were melted on hydroxyapatite and the denaturation profiles of ribosomal and satellite DNAs were followed by hybridization with their complementary RNAs. Neither ribosomal nor bulk DNA had significantly different melting profiles in chromatin as compared to DNA. However, most of satellite DNA eluted at higher temperature from chromatin than from purified DNA. One explaination for the higher melting temperature of mouse satellite DNA in chromatin suggests that the complex between this particular DNA component and at least some proteins in chromatin is more stable than the average DNA-protein interaction.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pashev</LastName>
<ForeName>I G</ForeName>
<Initials>IG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Biol Rep</MedlineTA>
<NlmUniqueID>0403234</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Chromatin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Satellite</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hydroxyapatites</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-49-2</RegistryNumber>
<NameOfSubstance>DNA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromatin</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chromatography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">DNA</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA, Satellite</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydroxyapatites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Nucleic Acid Denaturation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196186</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0301-4851</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Molecular biology reports</Title>
<ISOAbbreviation>Mol. Biol. Rep.</ISOAbbreviation>
</Journal>
<ArticleTitle>An investigation of the stability of messenger RNAs in cell-free, translational systems from uninfected and mengovirus-infected Ehrlich ascites tumor cells.</ArticleTitle>
<Pagination>
<MedlinePgn>305-13</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The stabilities and translation of Ehrlich ascites tumor cell poly(A)-containing mRNA and mengovirus RNA in fractionated cell-free protein synthesizing systems from uninfected and mengovirus-infected Ehrlich ascites tumor cells were studied. During incubation of the systems about 20% of the input RNA is reduced in size and associated with ribosomes engaged in polypeptide synthesis; the remainder is rapidly degraded by RNases. At the end of active translation, both mRNA and nascent proteins are bound to polysomes which are of the same size as those formed during active protein synthesis. The kinetics of protein synthesis closely follow those of RNA hydrolysis. The stabilities of mengovirus RNA and poly(A)-containing mRNA from Ehrlich ascites tumor cells are the same in both systems.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hackett</LastName>
<ForeName>P B</ForeName>
<Initials>PB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Egberts</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Traub</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Biol Rep</MedlineTA>
<NlmUniqueID>0403234</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Neoplasm</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>RNA, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Carcinoma, Ehrlich Tumor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell-Free System</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mengovirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Protein Biosynthesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">RNA, Messenger</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">RNA, Neoplasm</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">RNA, Viral</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>560626</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0301-4851</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<Issue>4</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Molecular biology reports</Title>
<ISOAbbreviation>Mol. Biol. Rep.</ISOAbbreviation>
</Journal>
<ArticleTitle>2'(3'),5'-ADP inhibits initiation-dependent protein synthesis in a cell-free system from Ehrlich ascites tumor cells.</ArticleTitle>
<Pagination>
<MedlinePgn>315-21</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>When tested in a poly(U)-dependent polyphenylalanine synthesizing system and in a postnuclear supernatant, both derived from Ehrlich ascites tumor cells, 2'(3'),5'-ADP did not affect chain elongation of polypeptide synthesis. In a cell-free system which was dependent on initiation and programmed by natural mRNA, however, the amino acid incorporating activity was suppressed to about 10% of the control in the presence of 1 mM 2'(3'),5'-ADP. The inhibitor was shown not to interfere with the attachment of poly(U) to the small ribosomal subunit and with the formation of mRNA-80S ribosome complexes in a complete protein synthesizing system. The subsequent attachment of a 40S ribosomal subunit to the mRNA-80S ribosome complex and the formation of polysomes, however, was depressed by the inhibitor. The experimental results suggest that 2',(3'),5'-ADP inhibits initiation-dependent protein synthesis between monosome formation and the formation of the first peptide bond(s).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Buchwald</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hackett</LastName>
<ForeName>P B</ForeName>
<Initials>PB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Egberts</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Traub</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Mol Biol Rep</MedlineTA>
<NlmUniqueID>0403234</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Neoplasm Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>58-64-0</RegistryNumber>
<NameOfSubstance>Adenosine Diphosphate</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenosine Diphosphate</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carcinoma, Ehrlich Tumor</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell-Free System</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neoplasm Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Peptide Chain Initiation, Translational</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329123</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-9298</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>125</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Monatsschrift für Kinderheilkunde</Title>
</Journal>
<ArticleTitle>[On certain embryopathies induced by teratogenic agents (author's transl]</ArticleTitle>
<Pagination>
<MedlinePgn>609-20</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In a survey of the literature the teratogenic effects of radiation and some drugs are discussed. Teratogenicity is proved for thalidomide, aminopterin, busulfan, cyclophosphamide, chlorambucil, mercaptopurin and diphenylhydantoin, trimethadione and warfarin. After the thalidomide-tragedy drug-induced malformations of the embryo are extremely rare, whereas malformations due to alcohol are rather frequent. Own experiences with more than 70 patients with alcoholembryopathy are reported. Nicotin seems not to be teratogenic, but due to nicotin the perinatal mortality is elevated. The questionable teratogenic effects of Heroin and LSD are discussed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Majewski</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Uber einige durch teratogene Noxen induzierte Fehlbildungen.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Monatsschr Kinderheilkd</MedlineTA>
<NlmUniqueID>0400751</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Teratogens</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>127-48-0</RegistryNumber>
<NameOfSubstance>Trimethadione</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>305-03-3</RegistryNumber>
<NameOfSubstance>Chlorambucil</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-18-0</RegistryNumber>
<NameOfSubstance>Cyclophosphamide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-35-1</RegistryNumber>
<NameOfSubstance>Thalidomide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-37-3</RegistryNumber>
<NameOfSubstance>Lysergic Acid Diethylamide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-44-2</RegistryNumber>
<NameOfSubstance>6-Mercaptopurine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>54-11-5</RegistryNumber>
<NameOfSubstance>Nicotine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>54-62-6</RegistryNumber>
<NameOfSubstance>Aminopterin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>55-98-1</RegistryNumber>
<NameOfSubstance>Busulfan</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>57-41-0</RegistryNumber>
<NameOfSubstance>Phenytoin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>64-17-5</RegistryNumber>
<NameOfSubstance>Ethanol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>81-81-2</RegistryNumber>
<NameOfSubstance>Warfarin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">6-Mercaptopurine</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Abnormalities, Drug-Induced</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aminopterin</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Busulfan</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chlorambucil</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cyclophosphamide</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ethanol</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germany, West</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heroin Dependence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant Mortality</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lysergic Acid Diethylamide</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nicotine</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenytoin</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radiation Injuries</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Teratogens</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Thalidomide</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Trimethadione</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Warfarin</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>135</NumberOfReferences>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329124</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-9298</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>125</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Monatsschrift für Kinderheilkunde</Title>
</Journal>
<ArticleTitle>[Diagnostic therapeutic problems of defibrination syndrome in shock, sepsis, and neonatal hypoxia (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>621-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The diagnosis of defibrination syndrome in shock, sepsis and neonatal hypoxia is based, in addition to the clinical picture, upon a few parameters of the hemostatic system, which, in part as global tests, provide information about the course of coagulation. The parameters measured are partial thromboplastin time, thromboplastin time, plasma thrombin time, fibrinogen, thrombin-coagulase and reptilase times as well as platelet count. Normal values of these laboratory parameters were established for healthy newborns 1--5 days of age, and for healthy adults. It is suggested that especially partial thromboplastin time, the thrombin-coagulase and reptilase times, the latter influenced by fibrinolysis cleavage products, are representative for the tentative diagnosis of disseminated intravascular coagulation with fibrinolysis syndrome (DICFS). The platelet fall often lags 1--2 days behind the event. Moreover normal values for newborns, are markedly higher than those for older children or adults. In the presence of DICFS, a low-dose heparin therapy is immediately initiated. If completed defibrination is manifest, therapy is supplemented with urokinase and streptokinase, For DICFS with congenital sepsis, an exchange transfusion with heparinized fresh blood is the treatment of choice.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kirsch</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Büttner</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wenzel</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Diagnostische und therapeutische Probleme der Verbrauchskoagulopathie bei Schock, Sepsis und neonataler Hypoxie.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Monatsschr Kinderheilkd</MedlineTA>
<NlmUniqueID>0400751</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>9005-49-6</RegistryNumber>
<NameOfSubstance>Heparin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.-</RegistryNumber>
<NameOfSubstance>Streptokinase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.21.73</RegistryNumber>
<NameOfSubstance>Urinary Plasminogen Activator</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Asphyxia Neonatorum</DescriptorName>
<QualifierName MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Cell Count</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Coagulation Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Platelets</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Disseminated Intravascular Coagulation</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Exchange Transfusion, Whole Blood</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fibrinolysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heparin</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Reference Values</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sepsis</DescriptorName>
<QualifierName MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Shock</DescriptorName>
<QualifierName MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Streptokinase</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Urinary Plasminogen Activator</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>32</NumberOfReferences>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>267804</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-9298</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>125</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Monatsschrift für Kinderheilkunde</Title>
</Journal>
<ArticleTitle>[Acute lymphoblastic leukemia and lymphoblastic lymphoma. Two names for one disease (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>628-33</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Of 14 non-T-cell malignant non-Hodgkin lymphomas (mNHL) 5/14 presented with leukemic transformation of the bone marrow; in three more cases bone marrow involvement developed during an observation period of 60--200weeks. In 2/14 cases mNHL terminated the first continuous and complete remission of acute lymphoblastic leukemia (ALL). CNS involvement has been observed without preceding bone marrow involvement. Only 4/14 mNHL remained local diseases. These clinical courses as well as hematological findings and further clinical observations suggests a very close relationship between mNHL and ALL if not basic identity. With the same systemic treatment additional to local treatment, prognosis of mNHL is by no means worse but rather better than the prognosis of ALL.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Winkler</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Landbeck</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Akute Lymphoblastische Leukämie und Lymphoblastisches Lymphosarkom. Zwei Namen, eine Krankheit (Fallbericht).</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Monatsschr Kinderheilkd</MedlineTA>
<NlmUniqueID>0400751</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bone Marrow Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Central Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Leukemia, Lymphoid</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lymphoma, Non-Hodgkin</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Remission, Spontaneous</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Terminology as Topic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882103</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-9298</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>125</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Monatsschrift für Kinderheilkunde</Title>
</Journal>
<ArticleTitle>[Clinical and radiological findings in 78 children during the 1974/75 mycoplasma-pneumonia-epidemic (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>634-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Between August 1974 and October 1975 78 patients with mycoplasma-pneumonia-infection were admitted to the 3 pediatric clinics of Hannover. Their clinical and radiological findings were studied. 20 patients with serological diagnosis of additional viral infection were not included in this study. The clinical diagnosis was confirmed by complement fixation test. The commonest symptoms were fever, coughing and abnormal auscultatory findings over the lungs. Chest roentgenograms showed three different patterns of infiltration: 1. Disseminated, non homogenous bronchial lines and mottled shadows often with swollen hilar lymphnodes in 46% of all patients.--2. Homogenous, extensive, opaque infiltrates in 29% of all patients.--3. Perivascular and peribronchial infiltrates at the hilus with or without swollen lymphnodes in 21% of all patients.--This means that in half of the patients abnormal signs in chestroentgenogram (type 2 and 3) were present, which formerly were described as &quot;atypical pneumonia.&quot;--4. There were no radiological symptoms in 4% of the patients.--Those who were treated with tetracyclin or erythromycin became afebrile within 1--3 days, in those who didn't get antibiotics at all or were treated with other antibiotics fever lasted longer.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Müller-Wening</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bernsau</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hamann</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>von der Hardt</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wenner</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Klinische und röntgenologische Beobachtungen an Kindern während einer Mykoplasma-pneumoniae-Epidemie 1974--1975.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Monatsschr Kinderheilkd</MedlineTA>
<NlmUniqueID>0400751</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>114-07-8</RegistryNumber>
<NameOfSubstance>Erythromycin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>60-54-8</RegistryNumber>
<NameOfSubstance>Tetracycline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Auscultation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Complement Fixation Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cough</DescriptorName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythromycin</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mycoplasma Infections</DescriptorName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pneumonia</DescriptorName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tetracycline</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196187</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-9298</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>125</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Monatsschrift für Kinderheilkunde</Title>
</Journal>
<ArticleTitle>[Myoclonic encephalopathy in childhood (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>640-5</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Two new cases of infantile myoclonic encephalopathy are reported and a survey of literature is given. The disease is characterized by generalised myoclonic jerks in all striated muscles, by cerebellar ataxia and by fast, jerking, mostly conjugated irregular eye movements (opsoclonus). The disease develops mostly during late infancy and early childhood. The pathogenesis is unknown, probably it is caused by immunological reactions to various agents. Treatment with ACTH or corticosteroids leads to rapid remission of the initial neurological symptoms, but it is suggested that therapy does not prevent frequent sequelae of psychomotor retardation and speech distubances. Remarkably, there is the high coincidence of infantile myoclonic encephalopathy and neuroblastoma. Therefore it is necessary to keep in mind the possibility of a causative neuroblastoma in all children with myoclonic encephalopathy and to control repeatly radiological findings and urin-excretion of catecholamines as well as their metabolic products.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Heyer</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hamann</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Offner</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Uebbing</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Die myoklonische Encephalopathie im Kindesalter.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Monatsschr Kinderheilkd</MedlineTA>
<NlmUniqueID>0400751</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Adrenal Cortex Hormones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Catecholamines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9002-60-2</RegistryNumber>
<NameOfSubstance>Adrenocorticotropic Hormone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adrenocorticotropic Hormone</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Catecholamines</DescriptorName>
<QualifierName MajorTopicYN="N">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cerebellar Ataxia</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Eye Movements</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Myoclonus</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neuroblastoma</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Psychomotor Disorders</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Speech Disorders</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Syndrome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882104</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-9298</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>125</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Monatsschrift für Kinderheilkunde</Title>
</Journal>
<ArticleTitle>[Subdural hygroma in infants with congenital toxoplasmosis (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>646-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Cytological examination of the fluid from subdural hygromas revealed congenital Toxoplasmosis in 14 of 43 infants (32,5%). Conversely, subdural hygroma was a significant clinical symptom in 42 cases of congenital Toxoplasmosis. In 9 cases trophozoites or cystes of Toxoplasma Gondii were found in the subdural fluid, and in 4 of these in the cerebrospinal fluid as well. Since serological investigations in young infants and particularly severe infections often remain inconclusive the cytological examination of cerebrospinal fluid is emphasized importance of.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ulbrych-Jablońska</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kalenik</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Herman</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rachwal-Kleinrok</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Die subduralen Hygrome bei den Säuglingen mit angeborener Toxoplasmose.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Monatsschr Kinderheilkd</MedlineTA>
<NlmUniqueID>0400751</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cysts</DescriptorName>
<QualifierName MajorTopicYN="N">cerebrospinal fluid</QualifierName>
<QualifierName MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hematoma, Subdural</DescriptorName>
<QualifierName MajorTopicYN="N">cerebrospinal fluid</QualifierName>
<QualifierName MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Toxoplasmosis, Congenital</DescriptorName>
<QualifierName MajorTopicYN="N">cerebrospinal fluid</QualifierName>
<QualifierName MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882105</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-9298</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>125</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Monatsschrift für Kinderheilkunde</Title>
</Journal>
<ArticleTitle>[Laryngeal complications in newborns following intratracheal intubation (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>649-54</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Histological and bacteriological findings in comparison to clinical data concerning intubation for 38 dead premature infants and newborns were studied to elucidate conditions complicating intratrachial intubation at the laryngeal level. The larynx was intact in 3 cases. Slight lesions of mucosa (epithelabrasion, hemorrhage) were found in 13, moderately severe lesions (necrosis of epithelium, ulcers, pseudomembranes) in 11, and severe lesions (deep necrosis, perichondritis with sceletisation) in 10 cases. 1 case showed a stage of regeneration. The narrow passage between the two processus vocales is a site of predilection for tubus-induced lesions, the epithelium bein immediately adjacent to the cartilage. Successful bacteriological demonstration of the infectious agent correlated with the rising degree of mucosal lesions, and increasing duration of intubation. 3 cases, however, already had severe lesions after short-time-intubation. Formal and causal pathogenesis are described. Essential causes are: trauma of intubation, irritation by the tubus in situ, duration of intubation, and infection. Regenerative power of the infantile laryngeal mucosa is strong. Permanent lesions may occur as scarred stenosis. Careful indication, accurate and careful technology of intubation, choice of the smallest possible diameter of tubus, good care for the tubus, and generous prophylaxis against infections are to be demanded.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Venzmer</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wiedersberg</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pawlowski</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Komplikationen am Kehlkopf nach Intubationsbehandlung im Neugeborenenalter.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Monatsschr Kinderheilkd</MedlineTA>
<NlmUniqueID>0400751</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hemorrhage</DescriptorName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant, Premature</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Intubation, Intratracheal</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Laryngeal Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Laryngostenosis</DescriptorName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Larynx</DescriptorName>
<QualifierName MajorTopicYN="Y">injuries</QualifierName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Necrosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ulcer</DescriptorName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196188</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-9298</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>125</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Monatsschrift für Kinderheilkunde</Title>
</Journal>
<ArticleTitle>[Prognosis of prenatal varicella-zoster-infections in relation to their onset during pregnancy (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>655-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>7 children were observed, whose mothers had Varicella-Zoster-Virus-infection. 3 of these children developed postnatal Herpes Zoster without Varicella in their history; 1 child had Varicella in the neonatal period. There are indications that primary infection with Varicella-Zoster-Virus during the first four months of pregnancy may cause deformities in the child; the same during the last five days of pregnancy increases the risk of varicella with a complicated course in the newborn. Independent of the time of infection during pregnancy the prognosis of a secondary Varicella-Zoster-Virus-infection in the mother seems always to be good for the child. Aspects of the child's immunological maturation, still incomplete at birth, are discussed and can help to understand the different prognoses during pregnancy. The importance of serological diagnosis has been emphasized.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Balg</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Zur prognostischen Bedeutung des Zeitpunktes einer pränatalen Infection mit dem Varizella-Zoster-Virus.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Monatsschr Kinderheilkd</MedlineTA>
<NlmUniqueID>0400751</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chickenpox</DescriptorName>
<QualifierName MajorTopicYN="Y">congenital</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Herpes Zoster</DescriptorName>
<QualifierName MajorTopicYN="Y">congenital</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Herpesvirus 3, Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant, Newborn, Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">congenital</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18670</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-9298</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>125</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Monatsschrift für Kinderheilkunde</Title>
</Journal>
<ArticleTitle>[Complications of pertussis immunization (author transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>660-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>16 cases of neurological disease and/or death shortly after pertussis immunization are reported. Eight patients had convulsions, six with ensuing permanent defects. Severe polymyositis was observed in one case. Five infants died 12 h to 4 days after vaccination: two after acute encephalopathy and three in the form of a sudden unexpected death (SID). In two fatal cases the morphological changes in the brain corresponded to those of pertussis encephalopathy: neuronal degeneration in various parts of the cortex, especially in the region of the ammons horn, and in the cerebellum. There were no signs of inflammation. Three cases underwent forensic autopsy and death was attributed to bronchopulmonary infection. Complete neuropathological work-up was only done in one case, in which the brain was normal. The critique of episodical reports and the demand for prospective studies is appreciated. Knowledge of all possible forms of complications, however, is indispensable for future investigations. Polymyositis and SID have so far not been listed as abnormal reactions to immunization. The majority of our cases became known accidentally from hospital sheets or from discussions with collegues. For a detection of all possible cases a greater awareness of doctors for the problem of pertussis immunization appears necessary. Only another 23 cases have been reported to the health authorities of the state of Lower Saxony during the last 6 to 7 years. Of those, nine were either harmless reactions or diseases probably unrelated to vaccination. Two were cases of SID, 12 and 72 h after vaccination. It is concluded that only a minor proportion of possible complications is presently reported to the health authorities.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lenard</LastName>
<ForeName>H G</ForeName>
<Initials>HG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fest</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Scholz</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Komplikationen nach Pertussisschutzimpfung.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Monatsschr Kinderheilkd</MedlineTA>
<NlmUniqueID>0400751</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Pertussis Vaccine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Brain</DescriptorName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cerebellum</DescriptorName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Encephalomyelitis, Acute Disseminated</DescriptorName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hippocampus</DescriptorName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pertussis Vaccine</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sudden Infant Death</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Whooping Cough</DescriptorName>
<QualifierName MajorTopicYN="Y">prevention &amp; control</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882106</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-9298</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>125</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Monatsschrift für Kinderheilkunde</Title>
</Journal>
<ArticleTitle>[Congenital tracheal stenosis due to pulmonary artery sling (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>668-70</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Congenital stridor was observed in a newborn due to left pulmonary artery sling. Clinical signs and the course of the disease were determined by an extreme tracheal stenosis. In newborns and infants with apneic episodes, inspiratory and expiratory wheezing and cyanosis a pulmonary sling should be considered. Unilateral hyperexpansion of the lung and an anterior indentation of the esophagus are helpful diagnostic signs. Surgical treatment for pulmonary sling is possible but remains unsatisfactory. Patients with associated tracheobronchial stenosis show a high over-all mortality rate.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Manz</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Conradi</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Neumann</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wolf</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Angeborene hochgradige Trachealstenose durch anomalen Verlauf der Arteria pulmonalis sinistra.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Monatsschr Kinderheilkd</MedlineTA>
<NlmUniqueID>0400751</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Autopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cyanosis</DescriptorName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dyspnea</DescriptorName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pulmonary Artery</DescriptorName>
<QualifierName MajorTopicYN="Y">abnormalities</QualifierName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tracheal Stenosis</DescriptorName>
<QualifierName MajorTopicYN="Y">congenital</QualifierName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882107</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-9298</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>125</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Monatsschrift für Kinderheilkunde</Title>
</Journal>
<ArticleTitle>[On an unusual case of hypoplastic anaemia (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>671-3</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The authors describe an unusual case of hypoplastic anaemia. The condition developed shortly after birth as a typical case of Josephs-Blackfan Diamond and was favourably influenced only by a combined treatment with Prednison and Dianabol. The improvement, however, did not last long and after shorter or longer periods of time anaemia recurred again. Applying the same therapy the authors succeeded, despite the sometimes grave condition of the child, not only to save his life but also to normalize the erythrocyte count. It must be noted that the child showed viability for a long period of time no matter how pronounced the anaemia was. Thus, therapy was not necessary to be repeated often. Of special interest for this case were bone marrow examinations. During the first year of the child's life only 1 to 4 erythroblasts were seen the examination was performed several times. After the sixth year the bone marrow contained many erythroblasts although the type of anaemia remained unchanged. According to the authors this peculiarity could be explained only as a transition from a hypoplastic into a pseudohypoplastic anaemia.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Panoff</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Milanoff</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Uber einen besonderen Fall von hypoplastischer Anämie.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Monatsschr Kinderheilkd</MedlineTA>
<NlmUniqueID>0400751</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>53-03-2</RegistryNumber>
<NameOfSubstance>Prednisone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>72-63-9</RegistryNumber>
<NameOfSubstance>Methandrostenolone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Anemia, Aplastic</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bone Marrow Examination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythrocytes, Abnormal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Methandrostenolone</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Prednisone</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Recurrence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Syndrome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882108</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0026-9298</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>125</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Monatsschrift für Kinderheilkunde</Title>
</Journal>
<ArticleTitle>[New definition of infant mortality]</ArticleTitle>
<Pagination>
<MedlinePgn>674</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ewerbeck</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Neue Definition bei der Säuglingssterblichkeit.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Monatsschr Kinderheilkd</MedlineTA>
<NlmUniqueID>0400751</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germany, West</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Infant Mortality</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Terminology as Topic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407448</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>21</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Current neurologic diagnosis]</ArticleTitle>
<Pagination>
<MedlinePgn>suppl 7-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Suchenwirth</LastName>
<ForeName>R M</ForeName>
<Initials>RM</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Editorial</PublicationType>
</PublicationTypeList>
<VernacularTitle>Neurologische Diagnostik heute.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196189</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>21</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Examination at the bedside (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>711-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The difficulties of neurological examination techniques are often over-estimated. It is feared that the large number of individual symptoms cannot be disentangled. But if the principles of classification are known, the individual findings can easily be interpreted and evaluated. If several functions are disordered the disturbance must be sought where the tracts or groups of cells serving these functions lie close together. The investigation of motoricity and sensitivity, the testing of reflexes, coordination, cerebral nerves, circulation in the head and the higher cerebral functions are presented in detail. The significance of the simple clinical examination is considerably increased if the individual symptoms can be seen as an integrated whole.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wolf</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Die Untersuchung am Krankenbett.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cerebrovascular Disorders</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Methods</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Movement Disorders</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neurologic Examination</DescriptorName>
<QualifierName MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Paralysis</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Peripheral Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Reflex</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sensation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407449</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>21</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Diagnostic value of the EEG. Neurologic diagnosis today]</ArticleTitle>
<Pagination>
<MedlinePgn>717-20</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The principal fields of application of the EEG are 1) the identification of transient functional disturbances - especially in cerebral seizures - which cannot always be reliably observed clinically, 2) the tracing of concomitant signs of substantial lesions which in the silent areas are not necessarily associated with isolated neurological defects and 3) the determination of the degree of severity of abnormalities when they do not agree with neurological or psychic disturbances. The discrepancies of the clinical findings themselves sometimes demand attention and benefit the patient when they lead to the identification of disturbances which could not at first be recognized. Selective indications, planned interrogation and thorough correlations with the clinical examinations and other findings are decisive for the value of the EEG in detail.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kugler</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schrader</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Spatz</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ross</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Der diagnostische Wert des EEG. Neurologische Diagnostik heute.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Brain Damage, Chronic</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Electroencephalography</DescriptorName>
<QualifierName MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Epilepsy</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Evaluation Studies as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ischemic Attack, Transient</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Narcolepsy</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neurologic Examination</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407450</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>21</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[The electronystagmography in neurology (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>721-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The electronystagmogram has its place in clinical neurological diagnosis as a recording method for the investigation of nystagmus with different conditions (spontaneous nystagmus, testing of eye-following movements, optokinetic nystagmus and rotational excitability). It must be used in all patients with complaints of dizziness, with clinically demonstrable nystagmus phenomena, in patients being examined for expert opinion after cranial traumata and in searching for vestibular involvement in certain diseases, e.g. vestibular disinhibition or dishabituation in multiple sclerosis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>von Albert</LastName>
<ForeName>H H</ForeName>
<Initials>HH</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Die Elektronystagmographie in der Neurologie.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CitationSubset>S</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Electronystagmography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Electrooculography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Eye Movements</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Multiple Sclerosis</DescriptorName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nervous System Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neurologic Examination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nystagmus, Pathologic</DescriptorName>
<QualifierName MajorTopicYN="N">congenital</QualifierName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407451</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>21</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Ultrasound-Doppler-sonography of carotid circulation]</ArticleTitle>
<Pagination>
<MedlinePgn>727-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Manz</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Ultraschall-Doppler-Sonographie des Karotis-Kreislaufs.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Flow Velocity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carotid Arteries</DescriptorName>
<QualifierName MajorTopicYN="N">physiology</QualifierName>
<QualifierName MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carotid Artery Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pulse</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Regional Blood Flow</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Ultrasonography</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407452</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>21</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Contrast-free radiological diagnosis of the skull (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>729-32</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>From the broad spectrum of contrast-free radiological diagnosis of the skull, diseases with asymmetrical appearance of the face were selected and the syndromes similar to them are presented from the differential diagnostic point of view. Asymmetry of the head very frequently indicates a disease of the skull area and should be subjected to appropriate diagnostic investigations.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Krokowski</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Röntgenologische Nativdiagnostik des Schädels.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bone Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bone Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Face</DescriptorName>
<QualifierName MajorTopicYN="N">abnormalities</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fibrous Dysplasia of Bone</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Maxillofacial Development</DescriptorName>
<QualifierName MajorTopicYN="N">radiation effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Meningioma</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neoplasm Metastasis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Osteoma</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radiotherapy</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Skull</DescriptorName>
<QualifierName MajorTopicYN="Y">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sturge-Weber Syndrome</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407453</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>21</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Axial computer tomography of the neurocranium (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>733-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Computer tomography (CT), a new radiographic examination technique, is very highly efficient, for it has high informative content with little stress for the patient. In contrast to the conventional X-ray technology, CT succeeds, by direct presentation of the structure of the soft parts, in obtaining information which comes close to that of macroscopic neuropathology. The capacity and limitations of the method at the present stage of development are reported. Computer tomography cannot displace conventional neuroradiological methods of investigation, although it is rightly presented as a screening method and helps towards selective use. Indications, technical integration and handling of CT are prerequisites for the exhaustive benefit of the excellent new technique.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stöppler</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Die axiale Computer-Tomographie des Gehirnschädels.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Brain Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
<QualifierName MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407454</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>21</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[The physicians duty to inform the patient before treatment with gentamicin]</ArticleTitle>
<Pagination>
<MedlinePgn>739</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Federspil</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
<VernacularTitle>Aufklärungspflicht vor Gentamicin-Behandlung.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Gentamicins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ear Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gentamicins</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germany, West</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Health Education</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Informed Consent</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407455</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>21</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[A new cancer-test?]</ArticleTitle>
<Pagination>
<MedlinePgn>739-40</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tautz Chr</LastName>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
<VernacularTitle>Ein neuer Krebs-Test?</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Methods</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407456</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>22</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Care of rheumatic patients]</ArticleTitle>
<Pagination>
<MedlinePgn>suppl 7</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mathies</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Editorial</PublicationType>
</PublicationTypeList>
<VernacularTitle>Probleme der Betreuung Rheumakranker.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germany, West</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Interprofessional Relations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Patient Care Planning</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rheumatic Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407457</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>22</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Programmed diagnosis of rheumatic diseases in general practice (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>747-60</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In the large number of rheumatic diseases and their often very different types - typical symptomatology is seldom complete - a reliable classification of a particular form of disease is often not easy. The &quot;programmed diagnosis&quot; presented here should be a signpost from the clinical picture, by way of the provisional diagnosis and the necessary diagnostic measures, to the final diagnosis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mathies</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Programmierte Diagnostik rheumatischer Erkrankungen für die Praxis.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Arthritis, Reactive</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carpal Tunnel Syndrome</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Family Practice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gout</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Osteoarthritis</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Osteoporosis</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Periarthritis</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Polymyalgia Rheumatica</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Programmed Instruction as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rheumatic Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rheumatic Fever</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spinal Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spondylitis, Ankylosing</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Streptococcal Infections</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407458</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>22</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Cardinal radiological signs of the most important rheumatic diseases of joints in adults (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>761-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The assessment of roentgenograms in rheumatology is frequently complicated because all forms of the disease have lesions of connective tissue structures in common. A reliable classification of a particular rheumatic disease is sometimes only possible on the basis of repeated examination during the course of the disease. Certain cardinal radiological signs are useful aids to diagnosis. Thus arthritis is characterized by concentric reductions in the height of the joint cavity and the bone lesion, arthrosis by excentric reduction of height and osteophytes. Special pointers to rheumatoid arthritis, psoriatic arthritis, the degenerative diseases, ankylosing spondylitis and related diseases are given.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Meythaler</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Röntgen-Leitsymptome der wichtigsten rheumatischen Gelenkerkrankungen beim Erwachsenen.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Arthritis</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Arthrography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bone and Bones</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Osteoarthritis</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rheumatic Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">radiography</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spondylitis, Ankylosing</DescriptorName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407459</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>22</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Guidelines for the laboratory diagnosis of rheumatic diseases (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>767-72</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The methods for laboratory diagnosis of rheumatic diseases are subdivided into 10 groups according to their informative value. The following aspects are taken into consideration: general diagnosis of inflammation, infective processes with hemolytic streptococci and staphylococci, streptococcal agglutinations, rheumatoid factor tests in the strictest sense, detection of autoantibodies, the HLA-system, investigations in metabolic diseases and generalized skeletal diseases, bacteriological and serological investigations in joint infections and tests in symptomatic diseases of joints and muscles. In the evaluation of the individual methods and the discussion of their application in various types of disease, the following provisional diagnoses are gone into: streptococcal rheumatism, rheumatoid arthritis, monarthritis, ankylosing spondylitis, Reiter's syndrome and psoriatic arthritis, myositis and polymyositis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Harter</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Richtlinien für die Labordiagnostik rheumatischer Erkrankungen.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Sedimentation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Methods</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rheumatic Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>14</NumberOfReferences>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196190</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>22</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Guidelines to the therapie of the most important rheumatic diseases (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>773-82</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Causal therapy of rheumatic diseases is only possible in the few cases of bacterial infection and some arthroses. In the usually etiologically obscure inflammatory forms, however, the considered use of operative, medicinal and physical measures may achieve improvement or long continued remission, even if healing occurs only rarely. Medicinal treatment and the, in principle, equally justified physiotherapy, especially kinesitherapy, are to be planned from the beginning as longterm therapy which demands close cooperation between the fully informed physician and the completely enlightened patient. The high incidence of side effects of the &quot;basis&quot; drugs and the often necessary combinations of palliatives with corticosteroids enforces a strict indication and constant critical appraisal of the current treatment.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Heimstädt</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Leitlinien der Therapie der wichtigsten rheumatischen Erkrankungen.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Anti-Inflammatory Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Steroids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Tissue Extracts</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>52-67-5</RegistryNumber>
<NameOfSubstance>Penicillamine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>54-05-7</RegistryNumber>
<NameOfSubstance>Chloroquine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-57-5</RegistryNumber>
<NameOfSubstance>Gold</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9002-60-2</RegistryNumber>
<NameOfSubstance>Adrenocorticotropic Hormone</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adrenocorticotropic Hormone</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gold</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Patient Care Planning</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Penicillamine</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Physical Therapy Modalities</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rheumatic Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N">surgery</QualifierName>
<QualifierName MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Steroids</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue Extracts</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407460</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>22</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>3</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Rheumatic diseases from the viewpoint of industrial medicine]</ArticleTitle>
<Pagination>
<MedlinePgn>783-4</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mathies</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Arbeitsmedizinische Aspekte der Erkrankungen des rheumatischen Formenkreises.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Economics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germany, West</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Occupational Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rheumatic Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Work Capacity Evaluation</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196191</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>23</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>10</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Psychiatric services]</ArticleTitle>
<Pagination>
<MedlinePgn>suppl 7-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Arnold</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Editorial</PublicationType>
</PublicationTypeList>
<VernacularTitle>Psychiatrischer Fürsorgedienst.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aftercare</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ambulatory Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Denmark</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germany, West</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mental Health Services</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Psychiatric Nursing</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407461</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>23</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>10</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Forty years of psychosomatic medicine. A historical retrospect (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>795-800</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The close interweaving of psychosocial and pathophysiological problems is emphasized with examples such as duodenal ulcer, the functional syndromes, psychogenic nanism, essential hypertension and even carcinoma. The increase in fatalities from coronary heart diseases, bronchial carcinoma, liver cirrhosis and road accidents confront us with the question of how far our industrial culture itself produces pathogenic factors. Medicine is therefore faced with the task of investigating the effects of human interreactions on health and disease. In so doing, medicine itself and the institutions it has created cannot be excluded. This is particularly true of internal medicine which, if it does not wish to withdraw from its traditional integrative duty, must cooperate still more closely with psychosomatic medicine.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Uexküll</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Historical Article</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>40 Jahre psychosomatische Medizin. Ein geschichtlicher Rückblick.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Placebos</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CitationSubset>Q</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Duodenal Ulcer</DescriptorName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germany</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Great Britain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">History, 20th Century</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Physician-Patient Relations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Placebos</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Psychophysiologic Disorders</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Psychosomatic Medicine</DescriptorName>
<QualifierName MajorTopicYN="Y">history</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Stress</DescriptorName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vascular Resistance</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407462</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>23</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>10</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Frequency of depressive diseases (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>801-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Depressive diseases are among the most frequent illnesses. They are only partly recognized and treated. The largest number of depressed patients are found in the offices of the general practitioner and internist. Only a small fraction of patients with severe, predominantly endogenous psychotic depressions are treated in hospital. The following consequences arise from this frequency distribution: by improvement of diagnostic methods to recognize, if at all possible, all depressed patients requiring therapy and to treat them suitably; by improvement of prevention, primary in risk groups and tertiary in prophylaxis of recurrence, to lower the morbidity of depression; and by improvement of ambulant therapy with regard to controlling suicidal tendencies and anxiety and prevention of chronicity and resistance to therapy to reduce the necessity for hospitalization.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Helmchen</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Häufigkeit depressiver Erkrankungen.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ambulatory Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Denmark</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Depression</DescriptorName>
<QualifierName MajorTopicYN="N">classification</QualifierName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnostic Errors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germany, West</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Iceland</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Suicide</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sweden</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407463</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>23</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>10</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[The informative value of diagnostic methods in chronic headache. A study of 112 cases (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>807-12</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>A thorough neurological diagnostic investigation was carried out in 112 patients with chronic headache existing for an average of 14 years, using a case history questionnaire we had designed for the purpose. Apart from the history and clinical examination, the program included X-ray negatives, angiography, computer tomography, sequence scanning, electroencephalogram and echoencephalogram. Migraine was the most common diagnosis (54.5%). Three cases in which admission to a ward was necessary for more detailed examination are described and demonstrated with reference to neuroradiological illustrative material.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rodiek</LastName>
<ForeName>S O</ForeName>
<Initials>SO</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Büll</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Scherer</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Steinhoff</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Die Aussagekraft diagnostischer Methoden beim chronischen Kopfschmerz. Eine Studie anhand von 112 Fällen.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>7440-26-8</RegistryNumber>
<NameOfSubstance>Technetium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Brain Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Headache</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hypertension</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Migraine Disorders</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Osteolysis</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radionuclide Imaging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spinal Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Technetium</DescriptorName>
<QualifierName MajorTopicYN="N">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407464</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>23</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>10</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Effect of air-electric fields on driving and reaction patterns. Test subjects in the car driving simulator (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>813-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In the relevant frequency range of about 10 Hertz cars can be considered very largely as Faraday cages and consequently as screens against air-electric fields. This may have a negative influence on driving and reaction patterns as a result. In an extensive investigation 48 subjects in a driving simulator were exposed to definite artificially produced air-electric fields. The self-rating of the performance and concentration of the subjects, reaction times and driving errors were determined. While the reaction times remained practically constant, the driving behavior of the subjects improved.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Anselm</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Danner</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kirmaier</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>König</LastName>
<ForeName>H L</ForeName>
<Initials>HL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Müller-Limmroth</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reis</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schauerte</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Einfluss von luftelektrischen Impulsfeldern auf das Fahr- und Reaktionsverhalten. Probanden im Kraftfahrzeug-Fahrsimulator.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Air</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Automobile Driving</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Behavior</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Electromagnetic Fields</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Electromagnetics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Equipment and Supplies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Personality</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Reaction Time</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196192</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>23</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>10</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Therapy of herpes zoster with sodium pentosan polysulfate]</ArticleTitle>
<Pagination>
<MedlinePgn>817-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Raff</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fanta</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>In Vitro</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Herpes-zoster-Therapie mit Natriumpentosan-polysulfat.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Interferon Inducers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Polysaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>37300-21-3</RegistryNumber>
<NameOfSubstance>Pentosan Sulfuric Polyester</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9008-11-1</RegistryNumber>
<NameOfSubstance>Interferons</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Biological Assay</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cytopathogenic Effect, Viral</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fibroblasts</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Herpes Zoster</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Herpesvirus 3, Human</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunity, Cellular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Interferon Inducers</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Interferons</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pentosan Sulfuric Polyester</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Plaque Assay</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Polysaccharides</DescriptorName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407465</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>23</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>10</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[In memorian Walter Brednow]</ArticleTitle>
<Pagination>
<MedlinePgn>819</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Scharf</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Biography</PublicationType>
<PublicationType>Historical Article</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>In memoriam Walter Brednow.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CitationSubset>Q</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germany, West</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">History, 20th Century</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Internal Medicine</DescriptorName>
<QualifierName MajorTopicYN="N">history</QualifierName>
</MeshHeading>
</MeshHeadingList>
<PersonalNameSubjectList>
<PersonalNameSubject>
<LastName>Brednow</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</PersonalNameSubject>
</PersonalNameSubjectList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407466</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>24</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Hepatits from A to Z?]</ArticleTitle>
<Pagination>
<MedlinePgn>suppl 7-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Deinhardt</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Editorial</PublicationType>
</PublicationTypeList>
<VernacularTitle>Hepatitis von A bis Z?</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Hepatitis, Viral, Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407467</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>24</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Live influenza vaccines (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>821-4</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Recent progress in live influenza A vaccine research is reviewed. As vaccine strains with new antigenic determinants have to be available in a short time, methods for rapid and reproducible attenuation of wild strains are needed. The possibilities for attenuation of influenza A wild strains and their relative merits are discussed. Particular problems arise from the fact that in interpandemic periods the population is composed of individuals with varying degrees of immunity. Vaccine strains of different virulence or different dosages for nonimmune and partially immune segments of the population may be necessary. Vaccine trials of the last few years are reviewed and the future uses of live influenza vaccines are discussed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gerth</LastName>
<ForeName>H J</ForeName>
<Initials>HJ</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Influenza-Lebendimpfungen.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antigens, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Influenza Vaccines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Vaccines, Attenuated</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antigens, Viral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Influenza A virus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
<QualifierName MajorTopicYN="N">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Vaccines, Attenuated</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>39</NumberOfReferences>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407468</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>24</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Identification of hepatitis A antigen and antibody for the diagnosis of hepatitis A infection (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>825-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The maximal shedding of hepatitis A antigen (HA Ag) was found about one week before the appearance of icterus. In the first week after the appearance of jaundice, it was demonstrable in 57%, and in 22% in the second week. Since no persistent shedders of antigen have been found so far, in some cases a recent hepatitis A can be detected by identification of HA Ag in a stool sample obtained as soon as possible after the onset of the disease. The reliability of the investigation for antibodies against HA Ag (Anti-HAV) was tested with respect to 892 samples sent for diagnostic evaluation. Anti-HAV could be demonstrated regularly at the onset of the disease. It increased rapidly in the first two weeks after the appearance of jaundice.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Frösner</LastName>
<ForeName>G G</ForeName>
<Initials>GG</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Nachweis von Hepatitis-A-Antigen und -Antikörpern zur Diagnose der Hepatitis-A-Infektion.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antigens, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Immunoglobulin M</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acute Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antigens, Viral</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Feces</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hepatitis A</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunoassay</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunoglobulin M</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Jaundice</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microscopy, Electron</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radioimmunoassay</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142209</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>24</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Occurrence of penicillin-resistant gonococci]</ArticleTitle>
<Pagination>
<MedlinePgn>829-30</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Neubert</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Zum Auftreten Penicillin-resistenter Gonokokken.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Penicillins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>15318-45-3</RegistryNumber>
<NameOfSubstance>Thiamphenicol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>1695-77-8</RegistryNumber>
<NameOfSubstance>Spectinomycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gonorrhea</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neisseria gonorrhoeae</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Penicillin Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Penicillins</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spectinomycin</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Thiamphenicol</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407469</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>24</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Botulism after eating country smoked ham (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>831-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>14 persons ate from a country smoked ham in which botulin was found. From this group, two had complaints which suggested a nonspecific food poisoning; two persons died. Of the dead, clinical symptoms of a botulinus intoxication could be ascertained from other people. In one case, botulinus toxin could be demonstrated in the blood, in the other the botulinus toxin was identified on forensic examination in suspensions of the preserved organ and body fluids, in spite of advanced putrefaction. Histological examination of the brain and of the cerebral and peripheral nerves provided no clear indication of the primary disease.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Korsukewitz</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lenk</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schneider</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Uber eine Botulismus-Gruppenerkrankung nach Genuss von geräuchertem Landschinken.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Botulinum Toxins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Autopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Botulinum Toxins</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Botulism</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Food Poisoning</DescriptorName>
<QualifierName MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germany, East</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germany, West</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Meat</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407470</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>24</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Urinary tract infections. Sensitivity and specificity of previous screening methods (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>837-40</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The frequency of symptomatic and unapparent bacteriuria in infants and children of preschool age is estimated to be 1 to 2%. Ca. 5% of all girls and less than 0.5% of all boys between the ages of 6 and 19 years undergo bacteriuria. Women suffer from it to 5 to 15% during pregnancy and diabetics of about 10 to 20%. The sensitivity and specificity of different screening processes are evaluated with reference to numerous publications. It appears that the agar slide, which is in use all over the world, is markedly superior to all other methods with respect to price, handling and sensitivity, The only weakness of this method is frequent failure in the presence of inhibitors in the urine sample.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Abdou</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Harnwegsinfektionen. Empfindlichkeit und Spezifität der bisherigen Screening-Verfahren.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>9002-18-0</RegistryNumber>
<NameOfSubstance>Agar</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Agar</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacteriuria</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Evaluation Studies as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mass Screening</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Serologic Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Urinary Tract Infections</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Urine</DescriptorName>
<QualifierName MajorTopicYN="Y">microbiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407471</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>24</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Spontaneous registration of unwanted effects of drugs in the Federal Republic--a summary]</ArticleTitle>
<Pagination>
<MedlinePgn>841-4</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ehlers</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kimbel</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Spontanerfassung unerwünschter Arzneimittel-wirkungen in der Bundesrepublik -- eine Bilanz.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Information Services</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Therapy</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Germany, West</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Registries</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407472</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0341-3098</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>119</Volume>
<Issue>24</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
<Day>17</Day>
</PubDate>
</JournalIssue>
<Title>MMW, Münchener medizinische Wochenschrift</Title>
</Journal>
<ArticleTitle>[Tetracycline levels in the sputum in chronic obstructive bronchitis (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>845-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>After 3 control days, the tetracycline concentration in the sputum of 34 patients was measured daily on 7 days during treatment with the antibiotic. 14 patients took tetracycline (Hostacyclin) in normal doses (2X500 mg or 2X1000 mg) by mouth. 20 patients received rolitetracycline (Reverin) 2X275 mg i.v. daily. With considerable individual fluctuations, sputum concentrations were attained in all series ranging from 1.5 to 2.0 microgram/ml after intravenous administration and from 1.1 to 1.6 microgram/ml after oral dosage. The higher dosage administered orally had no greater influence on the sputum concentration. In each case, sputum levels were attained which lie above the necessary minimum concentrations (0.5 microgram/ml).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zimmermann</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ulmer</LastName>
<ForeName>W T</ForeName>
<Initials>WT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ritzerfeld</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Tetracyclin-Spiegel im Sputum bei chronisch-obstruktiver Bronchitis.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>MMW Munch Med Wochenschr</MedlineTA>
<NlmUniqueID>7801805</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>60-54-8</RegistryNumber>
<NameOfSubstance>Tetracycline</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>751-97-3</RegistryNumber>
<NameOfSubstance>Rolitetracycline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Administration, Oral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bronchitis</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Injections, Intravenous</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rolitetracycline</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sputum</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tetracycline</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329125</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0027-5557</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>20</Volume>
<Issue>5</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Mykosen</Title>
</Journal>
<ArticleTitle>[Differentiation and diagnostic significance of immunoglobulin classes of antibodies against cell wall antigens of yeast and mycelial phase of Candida albicans (author's transl)]</ArticleTitle>
<Pagination>
<MedlinePgn>167-77</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ansorg</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gunesch</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bandelow</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Thomssen</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Differenzierung und diagnostische Bedeutung der Immunglobulinklassen humoraler Antikörper gegen Zellwandantigene der Sprosszellen- und Myzelphase von Candida albicans.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mykosen</MedlineTA>
<NlmUniqueID>0400765</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antibodies, Fungal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antigens, Fungal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Immunoglobulin A</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Immunoglobulin G</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Immunoglobulin M</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Immunoglobulins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>37341-29-0</RegistryNumber>
<NameOfSubstance>Immunoglobulin E</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antibodies, Fungal</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Antigens, Fungal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Candida albicans</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Candidiasis</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cell Wall</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunoglobulin A</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunoglobulin E</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunoglobulin G</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunoglobulin M</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunoglobulins</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Serologic Tests</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329126</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0027-5557</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>20</Volume>
<Issue>5</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Mykosen</Title>
</Journal>
<ArticleTitle>[Demonstration of precipitating antibodies in Candida infections using a polyethylene glycol agar as diffusion medium]</ArticleTitle>
<Pagination>
<MedlinePgn>178-82</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kaben</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Westphal</LastName>
<ForeName>H J</ForeName>
<Initials>HJ</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Der Nachweis präzipitierender Antikörper bei Candida-Infektionen unter Verwendung eines Polyäthylenglykol-haltigen Agars als Diffusionsmedium.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mykosen</MedlineTA>
<NlmUniqueID>0400765</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antibodies, Fungal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antigens, Fungal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Gels</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Polyethylene Glycols</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9002-18-0</RegistryNumber>
<NameOfSubstance>Agar</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Agar</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antibodies, Fungal</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antigens, Fungal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Candida albicans</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Candidiasis</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gels</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Polyethylene Glycols</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Precipitin Tests</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329127</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0027-5557</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>20</Volume>
<Issue>5</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Mykosen</Title>
</Journal>
<ArticleTitle>[The lymphocyte stimulation test (LST) for the detection of sensitization due to fungi. II. Findings with Candida antigen in patients with and without Candida infection]</ArticleTitle>
<Pagination>
<MedlinePgn>183-97</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hollmann</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Friedrich</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mykosen</MedlineTA>
<NlmUniqueID>0400765</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antigens, Fungal</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Antigens, Fungal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Candida albicans</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Candidiasis</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Lymphocyte Activation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887101</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0027-5557</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>20</Volume>
<Issue>5</Issue>
<PubDate>
<Year>1977</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Mykosen</Title>
</Journal>
<ArticleTitle>Studies on the physical, chemical and serological properties of haemagglutinins of dermatophytes.</ArticleTitle>
<Pagination>
<MedlinePgn>198-202</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Refai</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shalaf</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Saber</LastName>
<ForeName>M S</ForeName>
<Initials>MS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mykosen</MedlineTA>
<NlmUniqueID>0400765</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Agglutinins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hemagglutinins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Agglutinins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cross Reactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Epidermophyton</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythrocytes</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hemagglutination Inhibition Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Hemagglutinins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microsporum</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Species Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Trichophyton</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407473</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0027-5557</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>20</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Mykosen</Title>
</Journal>
<ArticleTitle>[Contribution to immunologic studies of dermatomycoses]</ArticleTitle>
<Pagination>
<MedlinePgn>209-23</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tomsíková</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pokorný</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Novácková</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Beitrag zu immunologischen Untersuchungen bei Dermatophytosen.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mykosen</MedlineTA>
<NlmUniqueID>0400765</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antibodies, Fungal</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antibodies, Fungal</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Complement Fixation Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dermatomycoses</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Epidermophyton</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Foot Dermatoses</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hand Dermatoses</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunodiffusion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microsporum</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Skin Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Trichophyton</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>142210</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0027-5557</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>20</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Mykosen</Title>
</Journal>
<ArticleTitle>[Small x-ray doses as an accidental infection-promoting factor in a tinea of the right index finger]</ArticleTitle>
<Pagination>
<MedlinePgn>224-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Götz</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Zabel</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Unterschwellige Röntgenstrahlendosen als akzidenteller infektionsfördernder Faktor für eine Tinea des rechten Zeigefingers.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mykosen</MedlineTA>
<NlmUniqueID>0400765</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Amplifiers</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dermatitis, Occupational</DescriptorName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hand Dermatoses</DescriptorName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radiodermatitis</DescriptorName>
<QualifierName MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radiology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tinea</DescriptorName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Trichophyton</DescriptorName>
<QualifierName MajorTopicYN="N">isolation &amp; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">X-Rays</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887102</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2003</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0027-5557</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>20</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Mykosen</Title>
</Journal>
<ArticleTitle>Mouse inoculation with various saprophytic fungi.</ArticleTitle>
<Pagination>
<MedlinePgn>229-34</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hubálek</LastName>
<ForeName>Z</ForeName>
<Initials>Z</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mykosen</MedlineTA>
<NlmUniqueID>0400765</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ascomycota</DescriptorName>
<QualifierName MajorTopicYN="N">growth &amp; development</QualifierName>
<QualifierName MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mitosporic Fungi</DescriptorName>
<QualifierName MajorTopicYN="N">growth &amp; development</QualifierName>
<QualifierName MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mycoses</DescriptorName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Species Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Temperature</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329128</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0027-5557</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>20</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1977</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Mykosen</Title>
</Journal>
<ArticleTitle>[Reactivity of human serums to Candida antigens in passive hemagglutination test and in counterimmunoelectrophoresis]</ArticleTitle>
<Pagination>
<MedlinePgn>235-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kövary</LastName>
<ForeName>P M</ForeName>
<Initials>PM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fegeler</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fegeler</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nolting</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>English Abstract</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Reaktivität menschlicher Seren mit Candida-Antigenen im passiven Hämagglutinationstest und in der Gegenstromelektrophorese.</VernacularTitle>
</Article>
<MedlineJournalInfo>
<Country>GERMANY, WEST</Country>
<MedlineTA>Mykosen</MedlineTA>
<NlmUniqueID>0400765</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antibodies, Fungal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antigens, Fungal</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antibodies, Fungal</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Antigens, Fungal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Candida albicans</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Counterimmunoelectrophoresis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Hemagglutination Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Immunoelectrophoresis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>560627</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Red-cell and platelet fragmentation in idiopathic autoimmune thrombocytopenic purpura.</ArticleTitle>
<Pagination>
<MedlinePgn>517-23</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We investigated the abnormal small-particle spike discerned in the platelet-rich plasma of patients with severe idiopathic autoimmune thrombocytopenic purpura. By electron microscopy, erythrocyte as well as platelet fragments were found in the 27,000 X g plasma sediment of 15 patients with severe disease. These fragments were not observed in the plasma sediment of 12 normal subjects, two healthy asplenic subjects, three patients with thrombocytopenia of nonimmunologic origin, and two with autoimmune thrombocytopenic purpura in remission. Weak complement sensitization of red blood cells was noted in seven out of 12 patients with the disease. Coating of red blood cells with IgG or IgM was not detected in these patients. Whereas erythrophagocytosis was conspicuously absent, phagocytosis of intact platelets as well as platelet fragments and other cellular debris was frequently observed. Autoimmune mechanisms may be directed against erythrocytes as well as platelets in most cases of severe idiopathic autoimmune thrombocytopenia.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zucker-Franklin</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Karpatkin</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Autoantibodies</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Immunoglobulin G</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Immunoglobulin M</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-36-7</RegistryNumber>
<NameOfSubstance>Complement System Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Autoantibodies</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Autoimmune Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Platelets</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Complement System Proteins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythrocytes</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
<QualifierName MajorTopicYN="Y">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunoglobulin G</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunoglobulin M</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Monocytes</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phagocytosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Purpura, Thrombocytopenic</DescriptorName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Splenectomy</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887103</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Oral choline administration to patients with tardive dyskinesia.</ArticleTitle>
<Pagination>
<MedlinePgn>524-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We gave pharmacologic doses of choline to patients with tardive dyskinesia in an attempt to suppress involuntary facial movements. Choline is the physiologic precursor of acetylcholine, and its administration elevates brain acetylcholine levels in laboratory animals and, possibly, in human beings. Hence, we thought that its use could benefit patients with diseases like tardive dyskinesia, which is believed to result from deficient central cholinergic tone. Twenty patients with stable baccal-lingual-masticatory movements took oral doses of choline for two weeks according to a double-blind crossover protocol. Plasma choline levels rose from 12.4 +/- 1.0 to 33.5 +/- 2.5 nmol per milliliter (mean +/- S.E.M.; P less than 0.001) during this period. Choreic movements decreased in nine patients, worsened in one and were unchanged in 10. Thus, oral doses of choline can be useful in neurologic diseases in which an increase in acetylcholine release is desired.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Growdon</LastName>
<ForeName>J H</ForeName>
<Initials>JH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hirsch</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wurtman</LastName>
<ForeName>R J</ForeName>
<Initials>RJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wiener</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Clinical Trial</PublicationType>
<PublicationType>Controlled Clinical Trial</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>62-49-7</RegistryNumber>
<NameOfSubstance>Choline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Administration, Oral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Choline</DescriptorName>
<QualifierName MajorTopicYN="Y">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N">cerebrospinal fluid</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Tolerance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Dyskinesia, Drug-Induced</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887104</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Adverse effects on offspring of maternal alcohol abuse during pregnancy.</ArticleTitle>
<Pagination>
<MedlinePgn>528-30</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>To evaluate the risk of offspring of heavy drinking during pregnancy, we administered a questionnaire to 633 women at the first prenatal visit. Nutritional status, smoking, drug and alcohol use were determined. Women were classified into three groups: abstinent and rare drinkers; moderate drinkers; and heavy drinkers. After delivery, detailed pediatric, neurologic and developmental examinations were administered by a physician without prior knowledge of any history. Infants born to heavy drinkers had twice the risk of abnormality of those born to abstinent or moderate drinkers (P less than 0.001). Thirty-two per cent of infants born to heavy drinkers demonstrated congenital anomalies, as compared to 9 per cent in the abstinent and 14 per cent in the moderate group (P less than 0.001). Microcephaly and multiple congenital anomalies were much more frequent in this group (P less than 0.001). Heavy drinking during pregnancy increases the risk to offspring.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ouellette</LastName>
<ForeName>E M</ForeName>
<Initials>EM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rosett</LastName>
<ForeName>H L</ForeName>
<Initials>HL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rosman</LastName>
<ForeName>N P</ForeName>
<Initials>NP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weiner</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Abnormalities, Drug-Induced</DescriptorName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Abnormalities, Multiple</DescriptorName>
<QualifierName MajorTopicYN="N">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Alcohol Drinking</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fetal Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Maternal-Fetal Exchange</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Microcephaly</DescriptorName>
<QualifierName MajorTopicYN="N">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Risk</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Smoking</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887105</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Violent death in a metropolitan county. Changing patterns in homicide (1958-74).</ArticleTitle>
<Pagination>
<MedlinePgn>531-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Analysis of homicide patterns in Cuyahoga County, Ohio (metropolitan Cleveland), for 1958-1974 discloses the following major trends: a dramatic rise in overall homicide rates in the city (320 per cent) and suburbs (200 per cent); an increase in justifiable homicide; a doubling of the percentage of homicides incident to other felonies; a markedly increased incidence of homicide among younger persons; a conspicuous rise in firearm killings (now 81 per cent of all homicides); and a continued preponderance of intraracial homicide, with the highest rates among nonwhite males in the city. The trends in Cuyahoga County are consistent with those in other United States metropolitan counties. Homicide is responsible for a major part of the decreased life expectancy among young, urban, non-white men. The factor most consistently associated with these trends is the increased use of handguns.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rushforth</LastName>
<ForeName>N B</ForeName>
<Initials>NB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ford</LastName>
<ForeName>A B</ForeName>
<Initials>AB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hirsch</LastName>
<ForeName>C S</ForeName>
<Initials>CS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rushforth</LastName>
<ForeName>N M</ForeName>
<Initials>NM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Adelson</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">African Americans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Crime</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">European Continental Ancestry Group</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Forecasting</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Homicide</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ohio</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sex Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Statistics as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Urban Population</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Violence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Wounds, Gunshot</DescriptorName>
<QualifierName MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Wounds, Stab</DescriptorName>
<QualifierName MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>69990</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Biologic activity of cold-reacting autoantibodies (first of two parts).</ArticleTitle>
<Pagination>
<MedlinePgn>538-42</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pruzanski</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shumak</LastName>
<ForeName>K H</ForeName>
<Initials>KH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Agglutinins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Autoantibodies</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Epitopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hemagglutinins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hemolysin Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Immunoglobulin M</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Agglutinins</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Anemia, Hemolytic, Autoimmune</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antibody Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Autoantibodies</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Cold</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Epitopes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythrocyte Membrane</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythrocytes</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hemagglutinins</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hemolysin Proteins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunoglobulin M</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Paraproteinemias</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>69</NumberOfReferences>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887106</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Who needs iron?</ArticleTitle>
<Pagination>
<MedlinePgn>543-5</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Crosby</LastName>
<ForeName>W H</ForeName>
<Initials>WH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>7439-89-6</RegistryNumber>
<NameOfSubstance>Iron</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-73-2</RegistryNumber>
<NameOfSubstance>Ferritins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Anemia, Hypochromic</DescriptorName>
<QualifierName MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ferritins</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Intestinal Absorption</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Iron</DescriptorName>
<QualifierName MajorTopicYN="Y">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">physiology</QualifierName>
<QualifierName MajorTopicYN="N">toxicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nutritional Requirements</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>267805</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36--1977.</ArticleTitle>
<Pagination>
<MedlinePgn>546-51</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aspergillosis</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacterial Infections</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood</DescriptorName>
<QualifierName MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ecthyma</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Leukemia, Myeloid, Acute</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nasal Cavity</DescriptorName>
<QualifierName MajorTopicYN="N">microbiology</QualifierName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nose Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Periapical Abscess</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sepsis</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887107</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>More than sutures and transfusions.</ArticleTitle>
<Pagination>
<MedlinePgn>552-3</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Relman</LastName>
<ForeName>A S</ForeName>
<Initials>AS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Homicide</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Legislation as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Massachusetts</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Violence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Wounds, Gunshot</DescriptorName>
<QualifierName MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329129</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Sound advice for conducting clinical trials.</ArticleTitle>
<Pagination>
<MedlinePgn>553-4</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Byar</LastName>
<ForeName>D P</ForeName>
<Initials>DP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Clinical Trial</PublicationType>
<PublicationType>Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Great Britain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Research Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Statistics as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Therapeutics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887108</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>The case for minority admissions.</ArticleTitle>
<Pagination>
<MedlinePgn>554-6</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Schatzkin</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yergan</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Civil Rights</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Educational Measurement</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Minority Groups</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Prejudice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">School Admission Criteria</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Schools, Medical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407474</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Firearms and gun control: a public-health concern.</ArticleTitle>
<Pagination>
<MedlinePgn>556-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mahler</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fielding</LastName>
<ForeName>J E</ForeName>
<Initials>JE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Health Expenditures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Homicide</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Legislation as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Massachusetts</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Wounds, Gunshot</DescriptorName>
<QualifierName MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y">mortality</QualifierName>
<QualifierName MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>301985</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Von Willebrand's disease.</ArticleTitle>
<Pagination>
<MedlinePgn>558</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Head</LastName>
<ForeName>D R</ForeName>
<Initials>DR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bowman</LastName>
<ForeName>R P</ForeName>
<Initials>RP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Marmer</LastName>
<ForeName>D J</ForeName>
<Initials>DJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brossoit</LastName>
<ForeName>A D</ForeName>
<Initials>AD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antigens</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>von Willebrand Factor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9001-27-8</RegistryNumber>
<NameOfSubstance>Factor VIII</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antigens</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Factor VIII</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Molecular Weight</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">von Willebrand Disease</DescriptorName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">von Willebrand Factor</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18671</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Hypoxemia during dialysis.</ArticleTitle>
<Pagination>
<MedlinePgn>558-9</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sherlock</LastName>
<ForeName>J E</ForeName>
<Initials>JE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ledwith</LastName>
<ForeName>J W</ForeName>
<Initials>JW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Letteri</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Anoxia</DescriptorName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pulmonary Diffusing Capacity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Renal Dialysis</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887109</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Glucagon, pancreatectomy and ketoacidosis.</ArticleTitle>
<Pagination>
<MedlinePgn>559</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Unger</LastName>
<ForeName>R H</ForeName>
<Initials>RH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>11061-68-0</RegistryNumber>
<NameOfSubstance>Insulin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-92-5</RegistryNumber>
<NameOfSubstance>Glucagon</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acidosis</DescriptorName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glucagon</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Insulin</DescriptorName>
<QualifierName MajorTopicYN="Y">deficiency</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Pancreatectomy</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887110</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Why is diabetic bile lithogenic?</ArticleTitle>
<Pagination>
<MedlinePgn>559-60</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rennard</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>57-88-5</RegistryNumber>
<NameOfSubstance>Cholesterol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bile</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cholelithiasis</DescriptorName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cholesterol</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diabetes Mellitus</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Solubility</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196193</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Chlamydia and CMV in pneumonitis.</ArticleTitle>
<Pagination>
<MedlinePgn>560</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shanley</LastName>
<ForeName>J D</ForeName>
<Initials>JD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jordan</LastName>
<ForeName>M C</ForeName>
<Initials>MC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Chlamydia Infections</DescriptorName>
<QualifierName MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chlamydia trachomatis</DescriptorName>
<QualifierName MajorTopicYN="N">isolation &amp; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cytomegalovirus</DescriptorName>
<QualifierName MajorTopicYN="N">isolation &amp; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Cytomegalovirus Infections</DescriptorName>
<QualifierName MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lung</DescriptorName>
<QualifierName MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pulmonary Fibrosis</DescriptorName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887111</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Rotor's and Dubin-Johnson syndromes.</ArticleTitle>
<Pagination>
<MedlinePgn>560</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Namihisa</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nambu</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hyperbilirubinemia, Hereditary</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Jaundice, Chronic Idiopathic</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887112</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Saccharin and cancer.</ArticleTitle>
<Pagination>
<MedlinePgn>560-1</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>81-07-2</RegistryNumber>
<NameOfSubstance>Saccharin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Legislation, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Risk</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Saccharin</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States Food and Drug Administration</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887113</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Peer review by residents.</ArticleTitle>
<Pagination>
<MedlinePgn>562</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Katzel</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Internship and Residency</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Peer Review</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887114</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>10</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>8</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Zones of excess mortality.</ArticleTitle>
<Pagination>
<MedlinePgn>562</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Greenberg</LastName>
<ForeName>M S</ForeName>
<Initials>MS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">African Continental Ancestry Group</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Boston</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">European Continental Ancestry Group</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mortality</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sex Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196194</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Ectopic production of chorionic gonadotropin and its subunits by islet-cell tumors. A specific marker for malignancy.</ArticleTitle>
<Pagination>
<MedlinePgn>565-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We measured human chorionic gonadotropin (hCG) and its subunits in 76 patients with islet-cell tumors. Seventeen of 27 patients with functioning islet-cell carcinomas had elevated plasma levels of hCG or one of its subunits (hCG-alpha and hCG-beta). Secretion was often discordant; the most frequent finding was an elevated level of hCG-alpha alone. In one patient responding to streptozocin, changes in hCG-alpha correlated with the clinical course. Studies of tumor extracts suggested that the markers observed in the circulation were being produced in the tumor itself. In contrast, none of the 43 patients with benign disease or the six patients with nonfunctioning malignant tumors had elevated levels of hCG, hCG-alpha or hCG-beta. These data show that hCG and its subunits are prevalent and specific markers for islet-cell carcinoma, and suggest that ectopic secretion results from malignant derepression of the genome rather than overproduction by an aberrant &quot;cell rest.&quot;</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kahn</LastName>
<ForeName>C R</ForeName>
<Initials>CR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rosen</LastName>
<ForeName>S W</ForeName>
<Initials>SW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Weintraub</LastName>
<ForeName>B D</ForeName>
<Initials>BD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fajans</LastName>
<ForeName>S S</ForeName>
<Initials>SS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gorden</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Chorionic Gonadotropin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hormones, Ectopic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>18883-66-4</RegistryNumber>
<NameOfSubstance>Streptozocin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9035-54-5</RegistryNumber>
<NameOfSubstance>Placental Lactogen</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenoma, Islet Cell</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chorionic Gonadotropin</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="Y">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hormones, Ectopic</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="Y">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Placental Lactogen</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="N">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radioimmunoassay</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Streptozocin</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196195</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Estrogen and endometrial carcinoma. An independent pathology review supporting original risk estimate.</ArticleTitle>
<Pagination>
<MedlinePgn>570-1</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Initial evidence suggested that estrogen therapy increases the risk of endometrial carcinoma. It was then suggested that some studies may have exaggerated the hazard of estrogen therapy by including patients with atypical endometrial hyperplasia among those having endometrial carcinoma. Three internationally recognized pathologists reviewed the histology slides available from the Ziel and Finkle study, which originally reported a risk ratio of 7.6 for estrogen users. At least one of the pathologists concurred with the original diagnosis in all but one case. Furthermore, all pathologists aggreed that 74 per cent (66/89) were correctly diagnosed. In the 66 patients with unanimous diagnosis, 61 per cent (40/66) had used conjugated estrogens, versus 57 per cent (54/94) in the original study. On the basis of 66 patients and 132 matched controls, the revised risk-ratio estimate is 8.1 (with a one-sided 95 per cent lower confidence limit of 4.5), validating the original estimate.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Gordon</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reagan</LastName>
<ForeName>J W</ForeName>
<Initials>JW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Finkle</LastName>
<ForeName>W D</ForeName>
<Initials>WD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ziel</LastName>
<ForeName>H K</ForeName>
<Initials>HK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Estrogens, Conjugated (USP)</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Endometrial Hyperplasia</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Endometrium</DescriptorName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Estrogens, Conjugated (USP)</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Risk</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Uterine Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887115</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Mortality among patients with ankylosing spondylitis not given X-ray therapy.</ArticleTitle>
<Pagination>
<MedlinePgn>572-6</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We investigated age-specific mortality rates of 836 patients with ankylosing spondylitis diagnosed during 1935-57. These patients were not given deep x-ray therapy, and thus their mortality was not confounded by possible late effects of radiation. Follow-up observation was to January 1, 1968--on the average, over 13 years from enrollment. Men had higher mortality than women; excess mortality was observed in men for diseases known to be associated with spondylitis, such as ulcerative colitis, nephritis and tuberculosis or other respiratory disease. In addition, their mortality risk relative to the general male population was fourfold for all gastrointestinal disease, nearly twofold for accidents, suicide and cerebrovascular disease and 40 per cent in excess for other circulatory diseases. These results indicate that, at least in men, ankylosing spondylitis has life-threatening consequences related to many organ systems, consistent with systemic vascular degeneration as one long-term consequence of the disease.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Radford</LastName>
<ForeName>E P</ForeName>
<Initials>EP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Doll</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Smith</LastName>
<ForeName>P G</ForeName>
<Initials>PG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>HLA Antigens</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Gastrointestinal Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">HLA Antigens</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kidney Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Respiratory Tract Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Risk</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sex Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spondylitis, Ankylosing</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
<QualifierName MajorTopicYN="Y">mortality</QualifierName>
<QualifierName MajorTopicYN="Y">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vascular Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">X-Ray Therapy</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18672</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism.</ArticleTitle>
<Pagination>
<MedlinePgn>576-83</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>In four patients with renal hyperchloremic acidosis and hyperkalemia, hyporeninemic hypoaldosteronism and chronic renal insufficiency (glomerular filtration rates of 13, 31, 35 and 44 ml per minute per 1.73 m2), prolonged administration of fludrocortisone increased urinary potassium and net acid excretion, corrected hyperkalemia and substantially ameliorated acidosis. Except in the patient with the lowest glomerular filtration rate, the increased net acid excretion was due mostly to increased ammonium excretion. Urine pH decreased initially in each patient, but in the three patients with the highest filtration rates, it increased subsequently as ammonium excretion increased, indicating that renal ammonia production increased. Urinary ammonium excretion correlated inversely with serum potassium concentration and did not decrease on discontinuation of therapy if hyperkalemia was prevented from recurring. In patients with renal acidosis and hyporeninemic hypoaldosteronism, administration of mineralocorticoid hormone can augment both renal hydrogen-ion secretion and, by correction of hyperkalemia, renal ammonia production, and thereby ameliorate metabolic acidosis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sebastian</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schambelan</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lindenfeld</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Morris</LastName>
<ForeName>R C</ForeName>
<Initials>RC</Initials>
<Suffix>Jr</Suffix>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>127-31-1</RegistryNumber>
<NameOfSubstance>Fludrocortisone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>52-39-1</RegistryNumber>
<NameOfSubstance>Aldosterone</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-09-7</RegistryNumber>
<NameOfSubstance>Potassium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7647-14-5</RegistryNumber>
<NameOfSubstance>Sodium Chloride</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7664-41-7</RegistryNumber>
<NameOfSubstance>Ammonia</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.23.15</RegistryNumber>
<NameOfSubstance>Renin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acidosis, Renal Tubular</DescriptorName>
<QualifierName MajorTopicYN="N">classification</QualifierName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aldosterone</DescriptorName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ammonia</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fludrocortisone</DescriptorName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glomerular Filtration Rate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nephritis, Interstitial</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Potassium</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="N">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Renin</DescriptorName>
<QualifierName MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sodium Chloride</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Syndrome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329130</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Biologic activity of cold-reacting autoantibodies (second of two parts).</ArticleTitle>
<Pagination>
<MedlinePgn>583-9</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Pruzanski</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Shumak</LastName>
<ForeName>K H</ForeName>
<Initials>KH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Agglutinins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Autoantibodies</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Agglutinins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Autoantibodies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Transfusion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Body Temperature</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Cold</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Erythrocytes</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Leukemia</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Leukocytes</DescriptorName>
<QualifierName MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lymphocytes</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Macrophages</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neutrophils</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Paraproteinemias</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
<QualifierName MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phagocytosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Plasmapheresis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>67</NumberOfReferences>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887116</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Potential hazards of rapid smoking as a technic for the modification of smoking behavior.</ArticleTitle>
<Pagination>
<MedlinePgn>590-2</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Miller</LastName>
<ForeName>L C</ForeName>
<Initials>LC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schilling</LastName>
<ForeName>A F</ForeName>
<Initials>AF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Logan</LastName>
<ForeName>D L</ForeName>
<Initials>DL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Johnson</LastName>
<ForeName>R L</ForeName>
<Initials>RL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hemoglobins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>124-38-9</RegistryNumber>
<NameOfSubstance>Carbon Dioxide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9061-29-4</RegistryNumber>
<NameOfSubstance>Carboxyhemoglobin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aversive Therapy</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carbon Dioxide</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carboxyhemoglobin</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heart Rate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hemoglobins</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oximetry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Partial Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Respiration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Satiation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Smoking</DescriptorName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Spirometry</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887117</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Mechanical forces producing pulmonary edema in acute asthma.</ArticleTitle>
<Pagination>
<MedlinePgn>592-6</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stalcup</LastName>
<ForeName>S A</ForeName>
<Initials>SA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mellins</LastName>
<ForeName>R B</ForeName>
<Initials>RB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acute Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Airway Obstruction</DescriptorName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Airway Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Asthma</DescriptorName>
<QualifierName MajorTopicYN="Y">complications</QualifierName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Forced Expiratory Flow Rates</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lung</DescriptorName>
<QualifierName MajorTopicYN="N">physiology</QualifierName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lung Volume Measurements</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Osmotic Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pleura</DescriptorName>
<QualifierName MajorTopicYN="N">physiology</QualifierName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pulmonary Edema</DescriptorName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vital Capacity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887118</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Localization and mechanisms of airway responses.</ArticleTitle>
<Pagination>
<MedlinePgn>596-600</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ingram</LastName>
<ForeName>R H</ForeName>
<Initials>RH</Initials>
<Suffix>Jr</Suffix>
</Author>
<Author ValidYN="Y">
<LastName>McFadden</LastName>
<ForeName>E R</ForeName>
<Initials>ER</Initials>
<Suffix>Jr</Suffix>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Bronchodilator Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Airway Obstruction</DescriptorName>
<QualifierName MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Airway Resistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Asthma</DescriptorName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bronchi</DescriptorName>
<QualifierName MajorTopicYN="N">physiology</QualifierName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bronchial Spasm</DescriptorName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bronchodilator Agents</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Exertion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Forced Expiratory Flow Rates</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Lung Volume Measurements</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Maximal Expiratory Flow Rate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Muscle Contraction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Muscle, Smooth</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Smoking</DescriptorName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Total Lung Capacity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vital Capacity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887119</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 37-1977.</ArticleTitle>
<Pagination>
<MedlinePgn>601-8</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Abscess</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
<QualifierName MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aortic Valve</DescriptorName>
<QualifierName MajorTopicYN="N">microbiology</QualifierName>
<QualifierName MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Endocarditis, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Haemophilus</DescriptorName>
<QualifierName MajorTopicYN="N">isolation &amp; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pericardial Effusion</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pericarditis</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
<QualifierName MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196196</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Glycopeptide hormones and neoplasms.</ArticleTitle>
<Pagination>
<MedlinePgn>609-10</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Odell</LastName>
<ForeName>W D</ForeName>
<Initials>WD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Chorionic Gonadotropin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Hormones, Ectopic</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adenoma, Islet Cell</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chorionic Gonadotropin</DescriptorName>
<QualifierName MajorTopicYN="Y">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hormones, Ectopic</DescriptorName>
<QualifierName MajorTopicYN="Y">secretion</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y">secretion</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887120</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>The changing scene in tuberculosis.</ArticleTitle>
<Pagination>
<MedlinePgn>610-11</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bates</LastName>
<ForeName>J H</ForeName>
<Initials>JH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Disease Outbreaks</DescriptorName>
<QualifierName MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Periodicity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tuberculosis</DescriptorName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887121</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Sounding board. The pill: a perspective for assessing risks and benefits.</ArticleTitle>
<Pagination>
<MedlinePgn>612-4</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jaffe</LastName>
<ForeName>F S</ForeName>
<Initials>FS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Contraceptives, Oral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CitationSubset>J</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Contraceptive Devices</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Contraceptives, Oral</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Family Planning Services</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Research</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Risk</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Social Class</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="PIP">772280</OtherID>
<OtherID Source="POP">00040302</OtherID>
<OtherAbstract Type="PIP">
<AbstractText>Over the past 17 years, a &quot;contraceptive revolution&quot; has occurred, based on highly effective methods which can be applied at a time unrelated to sexual intercourse.  In the 1950s, birth control was thought to be a settled issue for the middle and upper class.  Although motivated to limit family size, low-income women found the diaphragm and condom inappropriate for their life style.  Between 1960-1965, Planned Parenthood's caseloads of low-income women tripled.  By 1975, nearly 4 million women of low and marginal income were clinic patients, with 72% choosing oral contraceptives.  Those who advocate replacing the pill because of medical risk with coitally related methods are ignoring the needs of many low-income women in the U.S.  Tietze et al. have shown that except for older women who smoke, the risk of mortality from using any method of fertility control is lower than the risk from automobile accidents or from childbirth.  A more comprehensive framework is needed for weighing the total benefits expected by contraceptors against the total risks of any particular method.  We also need an enlarged research program for safer contraceptives;  a higher priority in the National Institutes of Health budget.</AbstractText>
</OtherAbstract>
<KeywordList Owner="PIP">
<Keyword MajorTopicYN="Y">Abortion, Induced</Keyword>
<Keyword MajorTopicYN="N">Acceptor Characteristics</Keyword>
<Keyword MajorTopicYN="N">Americas</Keyword>
<Keyword MajorTopicYN="N">Blood Coagulation Effects</Keyword>
<Keyword MajorTopicYN="Y">Contraception</Keyword>
<Keyword MajorTopicYN="N">Contraceptive Methods</Keyword>
<Keyword MajorTopicYN="N">Contraceptive Methods Chosen</Keyword>
<Keyword MajorTopicYN="Y">Contraceptive Usage</Keyword>
<Keyword MajorTopicYN="N">Developed Countries</Keyword>
<Keyword MajorTopicYN="N">Diseases</Keyword>
<Keyword MajorTopicYN="N">Economic Factors</Keyword>
<Keyword MajorTopicYN="N">Embolism</Keyword>
<Keyword MajorTopicYN="Y">Evaluation</Keyword>
<Keyword MajorTopicYN="Y">Evaluation Report</Keyword>
<Keyword MajorTopicYN="N">Family Planning</Keyword>
<Keyword MajorTopicYN="N">Family Planning Policy</Keyword>
<Keyword MajorTopicYN="N">Fertility Control, Postconception</Keyword>
<Keyword MajorTopicYN="N">Fertility Rate</Keyword>
<Keyword MajorTopicYN="Y">Iud</Keyword>
<Keyword MajorTopicYN="Y">Low Income Population</Keyword>
<Keyword MajorTopicYN="N">North America</Keyword>
<Keyword MajorTopicYN="N">Northern America</Keyword>
<Keyword MajorTopicYN="Y">Oral Contraceptives</Keyword>
<Keyword MajorTopicYN="N">Social Class</Keyword>
<Keyword MajorTopicYN="Y">Social Welfare</Keyword>
<Keyword MajorTopicYN="N">Socioeconomic Factors</Keyword>
<Keyword MajorTopicYN="Y">Socioeconomic Status</Keyword>
<Keyword MajorTopicYN="Y">Thromboembolism</Keyword>
<Keyword MajorTopicYN="N">United States</Keyword>
<Keyword MajorTopicYN="N">Vascular Diseases</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887122</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>B12-binding proteins after injection of cyanocobalamin.</ArticleTitle>
<Pagination>
<MedlinePgn>614-5</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Blood Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Transcobalamins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>68-19-9</RegistryNumber>
<NameOfSubstance>Vitamin B 12</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Proteins</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Radioimmunoassay</DescriptorName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transcobalamins</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vitamin B 12</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887123</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Potency of pancreatic enzyme preparations.</ArticleTitle>
<Pagination>
<MedlinePgn>615-6</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Pancreatic Extracts</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pancreatic Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pancreatic Extracts</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pancreatic Juice</DescriptorName>
<QualifierName MajorTopicYN="N">secretion</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887124</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Oncotic pressure and wedge pressure.</ArticleTitle>
<Pagination>
<MedlinePgn>616</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tremper</LastName>
<ForeName>K K</ForeName>
<Initials>KK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Blood Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Capillaries</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hydrostatic Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Myocardial Infarction</DescriptorName>
<QualifierName MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Osmotic Pressure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Pulmonary Circulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pulmonary Edema</DescriptorName>
<QualifierName MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>407475</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Tuberculosis treatment in Massachusetts in 1977.</ArticleTitle>
<Pagination>
<MedlinePgn>616-7</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kaplan</LastName>
<ForeName>A I</ForeName>
<Initials>AI</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ambulatory Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Health Expenditures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Length of Stay</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Massachusetts</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tuberculosis</DescriptorName>
<QualifierName MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887125</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Identification of catheter-related infections.</ArticleTitle>
<Pagination>
<MedlinePgn>617</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Galgiani</LastName>
<ForeName>J N</ForeName>
<Initials>JN</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kamm</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood</DescriptorName>
<QualifierName MajorTopicYN="Y">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Catheterization</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sepsis</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329131</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Proteinuria and antibody-coated bacteria in the urine.</ArticleTitle>
<Pagination>
<MedlinePgn>617-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Braude</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Block</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antibodies, Bacterial</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antibodies, Fungal</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Immunoglobulins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antibodies, Bacterial</DescriptorName>
<QualifierName MajorTopicYN="Y">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antibodies, Fungal</DescriptorName>
<QualifierName MajorTopicYN="N">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bacteria</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">False Positive Reactions</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Fungi</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunoglobulins</DescriptorName>
<QualifierName MajorTopicYN="N">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Immunologic Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Proteinuria</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Urinary Tract Infections</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Urine</DescriptorName>
<QualifierName MajorTopicYN="Y">microbiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887126</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>An early plan for the sharing of cost risk by physicians.</ArticleTitle>
<Pagination>
<MedlinePgn>619</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Butler</LastName>
<ForeName>A M</ForeName>
<Initials>AM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Insurance, Major Medical</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Methods</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Physicians</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>887127</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>11</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Click in the neck--unusual presentation of mitral-valve prolapse.</ArticleTitle>
<Pagination>
<MedlinePgn>619</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Desser</LastName>
<ForeName>K B</ForeName>
<Initials>KB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Benchimol</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Auscultation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heart Valve Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Mitral Valve</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Neck</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Posture</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Prolapse</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882109</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii.</ArticleTitle>
<Pagination>
<MedlinePgn>405-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We examined the relation of coffee and alcohol consumption to the risk of coronary heart disease during a six-year period in a cohort of 7705 Japanese men living in Hawaii. The analysis was based on 294 new cases of coronary heart disease. There was a positive association between coffee intake and risk, but it became statistically insignificant when cigarette smoking was taken into account. There was a strong negative association between moderate alcohol consumption (up to 60 ml per day), mainly from beer, and the risk of nonfatal myocardial infarction and death from coronary heart disease. This association remained significant in multivariate analysis, taking into account smoking and other risk factors. The correlation of alcohol consumption with the level of alpha cholesterol (positive) and beta cholesterol (negative) may partly account for the observed negative association between alcohol and coronary heart disease.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yano</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rhoads</LastName>
<ForeName>G G</ForeName>
<Initials>GG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kagan</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Coffee</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>57-88-5</RegistryNumber>
<NameOfSubstance>Cholesterol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Alcohol Drinking</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Alcoholic Beverages</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Angina Pectoris</DescriptorName>
<QualifierName MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cholesterol</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Coffee</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Coronary Disease</DescriptorName>
<QualifierName MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hawaii</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Japan</DescriptorName>
<QualifierName MajorTopicYN="N">ethnology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Myocardial Infarction</DescriptorName>
<QualifierName MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Risk</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sex Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Smoking</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882110</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>A pharmacologic evaluation of penicillin in children with purulent meningitis.</ArticleTitle>
<Pagination>
<MedlinePgn>410-3</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We undertook a prospective study of the pharmacokinetics of penicillin G (administered intravenously every four hours for a total of b50,000 U per kilogram per day) in the cerebrospinal fluid of children with purulent meningitis. Both the absolute mean cerebrospinal-fluid penicillin concentration (0.8, 0.7 and 0.3 microgram per milliliter) and the percentage of the simultaneous serum penicillin concentration measurable in the cerebrospinal fluid (18.4, 9.9, 4.9 per cent) declined on the first, fifth and 10th days of therapy, respectively. A mean peak cerebrospinal-fluid penicillin concentration of 0.96 micrograms per milliliter was measured at least transiently on all three study days. This pharmacokinetic pattern correlated with the return of cerebrospinal-fluid protein concentration toward normal (P less than 0.01). Penicillin G in the dosage studied is adequate therapy for most streptococcal and meningococcal meningitis in children; an increased dosage may be necessary when the minimal inhibitory concentration of penicillin to the etiologic agent is unusually high.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hieber</LastName>
<ForeName>J P</ForeName>
<Initials>JP</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nelson</LastName>
<ForeName>J D</ForeName>
<Initials>JD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Clinical Trial</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>61-33-6</RegistryNumber>
<NameOfSubstance>Penicillin G</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood-Brain Barrier</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Drug Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Injections, Intravenous</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Meninges</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Meningitis</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Penicillin G</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="Y">cerebrospinal fluid</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329132</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Risks of vesicoureteric reflux in the transplanted kidney.</ArticleTitle>
<Pagination>
<MedlinePgn>414-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The risk to the transplanted kidney of vesicoureteric reflux was evaluated in 150 consecutive first cadaveric renal allografts surviving for over three months. Of the 119 (79 per cent) allografts studied by micturating cystography 29 (24 per cent) were shown to reflux. The presence of reflux was associated with urine leakage and reoperation, and with ureteric insertion involving a short intramural tunnel. Graft failure (graft nephrectomy or death from renal failure) occurred in 14 of 29 refluxing grafts as compared to 14 failures in 90 nonrefluxing grafts (P less than 0.01). Graft failure in the refluxing group was typically slow, and commonly associated with proteinuria, microscopic hematuria, hypertension and a biopsy appearance of mesangiocapillary glomerular change. Urinary infection, though frequent (69 per cent), was not more common in the group with than in that without reflux. Vesicoureteric reflux is an important cause of late renal-graft failure.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Mathew</LastName>
<ForeName>T H</ForeName>
<Initials>TH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kincaid-Smith</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vikraman</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cadaver</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Glomerulonephritis</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Graft Rejection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hematuria</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Kidney Transplantation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Postoperative Complications</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Proteinuria</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tissue Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Transplantation, Homologous</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Urinary Tract Infections</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Vesico-Ureteral Reflux</DescriptorName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882111</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Continuous subcutaenous administration of deferoxamine in patients with iron overload.</ArticleTitle>
<Pagination>
<MedlinePgn>418-23</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Since deferoxamine B, when administered as a single daily intramuscular injection of 0.75 g, is unable to promote sufficient urinary iron excretion to achieve net negative iron balance in siderosis, we evaluated its administration as a constant infusion over 24 hours. We compared intravenous and subcutaneous routes in 24 siderotic patients who had excreted 420 to 630 mg (mean, 480 mg) of iron per month on intramuscular therapy. With the intravenous route urinary iron excretions increased to 570 to 3690 mg (mean, 1595 mg) per month. Constant subcutaneous delivery was 90 per cent as effective as intravenous administration on a dose-for-dose basis. Noteworthy net cumulative urinary iron excretions (urinary iron excretions minus transfused iron), often in excess of 1 g per month, have been maintained in all patients. Constant subcutaneous deferoxamine administration may prove to be an effective and practical means of eliminating large quantities of iron in siderosis.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Propper</LastName>
<ForeName>R D</ForeName>
<Initials>RD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cooper</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rufo</LastName>
<ForeName>R R</ForeName>
<Initials>RR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nienhuis</LastName>
<ForeName>A W</ForeName>
<Initials>AW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Anderson</LastName>
<ForeName>W F</ForeName>
<Initials>WF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bunn</LastName>
<ForeName>H F</ForeName>
<Initials>HF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rosenthal</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nathan</LastName>
<ForeName>D G</ForeName>
<Initials>DG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>50-81-7</RegistryNumber>
<NameOfSubstance>Ascorbic Acid</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>70-51-9</RegistryNumber>
<NameOfSubstance>Deferoxamine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7439-89-6</RegistryNumber>
<NameOfSubstance>Iron</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Administration, Oral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ascorbic Acid</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Deferoxamine</DescriptorName>
<QualifierName MajorTopicYN="Y">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Injections, Intramuscular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Injections, Subcutaneous</DescriptorName>
<QualifierName MajorTopicYN="N">instrumentation</QualifierName>
<QualifierName MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Iron</DescriptorName>
<QualifierName MajorTopicYN="N">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Siderosis</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Thalassemia</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882112</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Health-services research and innovations in health-care delivery. Does research make a difference?</ArticleTitle>
<Pagination>
<MedlinePgn>423-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Members of the Institute of Medicine were asked to list the most important innovations in the health-care system for the past quarter century, and to identify health-services researchers who might be recognized by some prize or award. There was considerable difficulty in identifying such innovations. A large number of investigators were named as health-services researchers deserving commendation, but only a few received more than two or three votes. There was little evidence of linkage between the innovations described and the work for which investigators were nominated for recognition. There is little reason to expect such research to produce major alterations in the system, since these alterations are linked to changes in the values and expectations of society. However, the research may of some value in documenting the effects (or lack thereof) of proposed changes and also promote if not create change.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lewis</LastName>
<ForeName>C E</ForeName>
<Initials>CE</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Academies and Institutes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Delivery of Health Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Health Services</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Research</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329133</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Food additives.</ArticleTitle>
<Pagination>
<MedlinePgn>427-30</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jukes</LastName>
<ForeName>T H</ForeName>
<Initials>TH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antioxidants</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Carcinogens</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Food Additives</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Nitrates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Nitrites</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Nitrosamines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CitationSubset>S</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antioxidants</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carcinogens</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Food Additives</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N">chemical synthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Food Microbiology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hyperkinesis</DescriptorName>
<QualifierName MajorTopicYN="N">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Legislation, Drug</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nitrates</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nitrites</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nitrosamines</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>5</NumberOfReferences>
<OtherID Source="NASA">77232620</OtherID>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882113</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Lithium carbonate attenuation of chemotherapy-induced neutropenia.</ArticleTitle>
<Pagination>
<MedlinePgn>430-1</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stein</LastName>
<ForeName>R S</ForeName>
<Initials>RS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Beaman</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ali</LastName>
<ForeName>M Y</ForeName>
<Initials>MY</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hansen</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jenkins</LastName>
<ForeName>D D</ForeName>
<Initials>DD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jume'an</LastName>
<ForeName>H G</ForeName>
<Initials>HG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antineoplastic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Carbonates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7439-93-2</RegistryNumber>
<NameOfSubstance>Lithium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Agranulocytosis</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Carbonates</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Leukocytes</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Leukocytosis</DescriptorName>
<QualifierName MajorTopicYN="N">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lithium</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Neutropenia</DescriptorName>
<QualifierName MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882114</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Hypercalcemia in disseminated coccidioidomycosis.</ArticleTitle>
<Pagination>
<MedlinePgn>431-3</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Catanzaro</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Parthemore</LastName>
<ForeName>J G</ForeName>
<Initials>JG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Roach</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Deftos</LastName>
<ForeName>L J</ForeName>
<Initials>LJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>1397-89-3</RegistryNumber>
<NameOfSubstance>Amphotericin B</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>22916-47-8</RegistryNumber>
<NameOfSubstance>Miconazole</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7440-70-2</RegistryNumber>
<NameOfSubstance>Calcium</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-12-9</RegistryNumber>
<NameOfSubstance>Calcitonin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Amphotericin B</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bone Marrow</DescriptorName>
<QualifierName MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Calcitonin</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Calcium</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Coccidioides</DescriptorName>
<QualifierName MajorTopicYN="N">isolation &amp; purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Coccidioidomycosis</DescriptorName>
<QualifierName MajorTopicYN="Y">complications</QualifierName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hypercalcemia</DescriptorName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Miconazole</DescriptorName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ribs</DescriptorName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329134</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>The care of the elderly--the Royal Commission and the role of the doctor--a jubilee postscript.</ArticleTitle>
<Pagination>
<MedlinePgn>434-6</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lister</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Biography</PublicationType>
<PublicationType>Historical Article</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CitationSubset>Q</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Boston</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Curriculum</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Education, Medical</DescriptorName>
<QualifierName MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Great Britain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">History, 20th Century</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Old Age Assistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Periodicals as Topic</DescriptorName>
<QualifierName MajorTopicYN="N">history</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Physicians</DescriptorName>
<QualifierName MajorTopicYN="Y">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Public Assistance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Social Medicine</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<PersonalNameSubjectList>
<PersonalNameSubject>
<LastName>Lister</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</PersonalNameSubject>
</PersonalNameSubjectList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882115</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 34--1977.</ArticleTitle>
<Pagination>
<MedlinePgn>436-42</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cartilage</DescriptorName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Cysts</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lymphangioma</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Mediastinal Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Thymus Gland</DescriptorName>
<QualifierName MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Trachea</DescriptorName>
<QualifierName MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Tracheal Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">etiology</QualifierName>
<QualifierName MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882116</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Coffee, cocktails and coronary candidates.</ArticleTitle>
<Pagination>
<MedlinePgn>443-4</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Kannel</LastName>
<ForeName>W B</ForeName>
<Initials>WB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Coffee</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>64-17-5</RegistryNumber>
<NameOfSubstance>Ethanol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Alcohol Drinking</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Alcoholism</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Coffee</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Coronary Disease</DescriptorName>
<QualifierName MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ethanol</DescriptorName>
<QualifierName MajorTopicYN="N">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heart</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Risk</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Smoking</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>560628</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Iron loading and thalassemia--experimental successes and practical realities.</ArticleTitle>
<Pagination>
<MedlinePgn>445-6</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Weatherall</LastName>
<ForeName>D J</ForeName>
<Initials>DJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pippard</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Callender</LastName>
<ForeName>S T</ForeName>
<Initials>ST</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Comparative Study</PublicationType>
<PublicationType>Editorial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>70-51-9</RegistryNumber>
<NameOfSubstance>Deferoxamine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7439-89-6</RegistryNumber>
<NameOfSubstance>Iron</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Deferoxamine</DescriptorName>
<QualifierName MajorTopicYN="Y">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Injections, Intramuscular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Injections, Subcutaneous</DescriptorName>
<QualifierName MajorTopicYN="N">instrumentation</QualifierName>
<QualifierName MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Iron</DescriptorName>
<QualifierName MajorTopicYN="N">urine</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Thalassemia</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329135</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Silver jubilee of the &quot;London Post&quot;.</ArticleTitle>
<Pagination>
<MedlinePgn>446-7</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ingelfinger</LastName>
<ForeName>F J</ForeName>
<Initials>FJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Biography</PublicationType>
<PublicationType>Editorial</PublicationType>
<PublicationType>Historical Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CitationSubset>Q</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Boston</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Great Britain</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">History, 20th Century</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Periodicals as Topic</DescriptorName>
<QualifierName MajorTopicYN="Y">history</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Writing</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<PersonalNameSubjectList>
<PersonalNameSubject>
<LastName>Lister</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</PersonalNameSubject>
</PersonalNameSubjectList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882117</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Myocardial ischemia.</ArticleTitle>
<Pagination>
<MedlinePgn>447-9</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Acute Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName>
<QualifierName MajorTopicYN="N">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Clinical Enzyme Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Death, Sudden</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Heart Failure</DescriptorName>
<QualifierName MajorTopicYN="N">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Myocardial Infarction</DescriptorName>
<QualifierName MajorTopicYN="N">complications</QualifierName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Necrosis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882118</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Amniocentesis and educational attainment.</ArticleTitle>
<Pagination>
<MedlinePgn>449</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bannerman</LastName>
<ForeName>R M</ForeName>
<Initials>RM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gillick</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Van Coevering</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Knobloch</LastName>
<ForeName>N L</ForeName>
<Initials>NL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ingall</LastName>
<ForeName>G B</ForeName>
<Initials>GB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Amniocentesis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Educational Status</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Social Class</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882119</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Oral contraceptives and myocardial infarction.</ArticleTitle>
<Pagination>
<MedlinePgn>449</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bader</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Contraceptives, Oral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CitationSubset>J</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Contraceptives, Oral</DescriptorName>
<QualifierName MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Myocardial Infarction</DescriptorName>
<QualifierName MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName MajorTopicYN="Y">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Risk</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="PIP">771817</OtherID>
<OtherID Source="POP">00039215</OtherID>
<OtherAbstract Type="PIP">
<AbstractText>In a previous article, an increased risk for myocardial infarction has been described for women over the age of 40 who smoke cigarettes and also take oral contraceptives.  The mortality rate from coronary heart disease for women under age 40 has been unchanged since 1935.  It is very minimal.  That among women 40-49 years old has declined slightly since 1940.  These findings suggest that oral contraceptives have had little impact upon coronary-heart-disease mortality.</AbstractText>
</OtherAbstract>
<KeywordList Owner="PIP">
<Keyword MajorTopicYN="Y">Age Factors</Keyword>
<Keyword MajorTopicYN="N">Contraception</Keyword>
<Keyword MajorTopicYN="N">Contraceptive Methods--side effects</Keyword>
<Keyword MajorTopicYN="N">Demographic Factors</Keyword>
<Keyword MajorTopicYN="N">Diseases</Keyword>
<Keyword MajorTopicYN="N">Family Planning</Keyword>
<Keyword MajorTopicYN="Y">Heart Diseases</Keyword>
<Keyword MajorTopicYN="N">Mortality</Keyword>
<Keyword MajorTopicYN="Y">Oral Contraceptives--side effects</Keyword>
<Keyword MajorTopicYN="N">Population</Keyword>
<Keyword MajorTopicYN="N">Population Characteristics</Keyword>
<Keyword MajorTopicYN="N">Washington</Keyword>
</KeywordList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882120</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Alcohol and blood pressure.</ArticleTitle>
<Pagination>
<MedlinePgn>450-1</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>64-17-5</RegistryNumber>
<NameOfSubstance>Ethanol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Alcohol Drinking</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Pressure</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Pressure Determination</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ethanol</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882121</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Lymphangiography in Hodgkin's disease.</ArticleTitle>
<Pagination>
<MedlinePgn>451-2</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Decision Making</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hodgkin Disease</DescriptorName>
<QualifierName MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Laparotomy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lymphography</DescriptorName>
<QualifierName MajorTopicYN="Y">mortality</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Risk</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882122</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Attenuation of myelosuppression with lithium.</ArticleTitle>
<Pagination>
<MedlinePgn>452-3</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Catane</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kaufman</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mittelman</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Murphy</LastName>
<ForeName>G P</ForeName>
<Initials>GP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Nitrogen Mustard Compounds</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>2998-57-4</RegistryNumber>
<NameOfSubstance>Estramustine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7439-93-2</RegistryNumber>
<NameOfSubstance>Lithium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bone Marrow</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Estramustine</DescriptorName>
<QualifierName MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
<QualifierName MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Leukocytes</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lithium</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Nitrogen Mustard Compounds</DescriptorName>
<QualifierName MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Prostatic Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>577999</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Bromocriptine in encephalopathy.</ArticleTitle>
<Pagination>
<MedlinePgn>453</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lipper</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Ergolines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>25614-03-3</RegistryNumber>
<NameOfSubstance>Bromocriptine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Bromocriptine</DescriptorName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Ergolines</DescriptorName>
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Hepatic Encephalopathy</DescriptorName>
<QualifierName MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>329136</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>More on Creutzfeldt-Jakob disease and sheep brain.</ArticleTitle>
<Pagination>
<MedlinePgn>453</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Alter</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Brain</DescriptorName>
<QualifierName MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Creutzfeldt-Jakob Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y">transmission</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Rabies</DescriptorName>
<QualifierName MajorTopicYN="N">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sheep</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882123</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Serotonin in essential myoclonus.</ArticleTitle>
<Pagination>
<MedlinePgn>454</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Omenn</LastName>
<ForeName>G S</ForeName>
<Initials>GS</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bird</LastName>
<ForeName>T D</ForeName>
<Initials>TD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Johnsen</LastName>
<ForeName>S D</ForeName>
<Initials>SD</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>50-49-7</RegistryNumber>
<NameOfSubstance>Imipramine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-67-9</RegistryNumber>
<NameOfSubstance>Serotonin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Blood Platelets</DescriptorName>
<QualifierName MajorTopicYN="N">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Imipramine</DescriptorName>
<QualifierName MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Myoclonus</DescriptorName>
<QualifierName MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N">genetics</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Serotonin</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>301986</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Value of antitrypsin screening.</ArticleTitle>
<Pagination>
<MedlinePgn>454-5</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lieberman</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pulmonary Emphysema</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y">etiology</QualifierName>
<QualifierName MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">alpha 1-Antitrypsin Deficiency</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>18673</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>CPC--ivory-tower medicine?</ArticleTitle>
<Pagination>
<MedlinePgn>455</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Morgan</LastName>
<ForeName>W K</ForeName>
<Initials>WK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Congresses</PublicationType>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Boston</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Congresses as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Diagnostic Services</DescriptorName>
<QualifierName MajorTopicYN="Y">utilization</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Health Expenditures</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lung Diseases</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lung Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Sarcoidosis</DescriptorName>
<QualifierName MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882124</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Medical aspects of trauma.</ArticleTitle>
<Pagination>
<MedlinePgn>455</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Davis</LastName>
<ForeName>J H</ForeName>
<Initials>JH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Boston</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Medical History Taking</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Periodicals as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Wounds and Injuries</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882125</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Education of public about health.</ArticleTitle>
<Pagination>
<MedlinePgn>455-6</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Communication</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Health Education</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Physician-Patient Relations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882126</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>The case for profit-making hospitals.</ArticleTitle>
<Pagination>
<MedlinePgn>456</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Frist</LastName>
<ForeName>W H</ForeName>
<Initials>WH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Hospitals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Hospitals, Proprietary</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Income</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>882127</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>8</Issue>
<PubDate>
<Year>1977</Year>
<Month>Aug</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Medicine and Public Affairs. Grant Swinger's innovations.</ArticleTitle>
<Pagination>
<MedlinePgn>459-60</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Greenberg</LastName>
<ForeName>D S</ForeName>
<Initials>DS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">District of Columbia</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Government Agencies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Politics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Science</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">United States</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Wit and Humor as Topic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>301987</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2004</Year>
<Month>11</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>9</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Terminal deoxynucleotidyl transferase activity in malignant lymphomas.</ArticleTitle>
<Pagination>
<MedlinePgn>461-4</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>To determine the usefulness of terminal deoxynucleotidyl transferase enzyme activity as a biochemical marker in the study of lymphoma, we assayed 50 various malignant lymphomas as well as normal lymphoid tissue for this activity. Neoplastic cells from patients with Hodgkin's disease, Burkitt's tumor, Sézary's syndrome, chronic lymphocytic leukemia, leukemic reticuloendotheliosis and lymphocytic lymphomas (poorly differentiated and intermediate) were all without notable enzyme activity. Large-cell tumors of B-cell type were also negative. One of three large-cell tumors without B-cell or T-cell-surface specificity was positive (1.40 nmol per hour per milligram of DNA). Enzyme activity was consistently present only in lymphoblastic lymphomas (all six cases studied), with a mean activity of 7.80 nmol per hour per milligram of DNA. These six cases had heterogeneous surface immunomarkers. We conclude that terminal deoxynucleotidyl transferase is a biochemical marker that will be useful in the study of lymphoma.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Donlon</LastName>
<ForeName>J A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jaffe</LastName>
<ForeName>E S</ForeName>
<Initials>ES</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Braylan</LastName>
<ForeName>R C</ForeName>
<Initials>RC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Oligonucleotides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.7.-</RegistryNumber>
<NameOfSubstance>DNA Nucleotidyltransferases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">B-Lymphocytes</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Burkitt Lymphoma</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA Nucleotidyltransferases</DescriptorName>
<QualifierName MajorTopicYN="Y">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Leukemia</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lymphoid Tissue</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Lymphoma</DescriptorName>
<QualifierName MajorTopicYN="N">classification</QualifierName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Oligonucleotides</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Reticuloendotheliosis</DescriptorName>
<QualifierName MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">T-Lymphocytes</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID>196197</PMID>
<DateCreated>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>1977</Year>
<Month>09</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0028-4793</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>297</Volume>
<Issue>9</Issue>
<PubDate>
<Year>1977</Year>
<Month>Sep</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>A cluster of Epstein-Barr-virus-associated American Burkitt's lymphoma.</ArticleTitle>
<Pagination>
<MedlinePgn>464-8</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We investigated four patients in whom histologically confirmed Burkitt's lymphomas developed during a one-year period. They were young adults living within 50 km of each other in a rural area of Pennsylvania. Two patients were related by marriage, but there was no contact with or between the other two. Although the majority of American Burkitt's lymphomas are not associated with the Epstein-Barr virus, all four patients showed spectra and titers of antibodies to antigens related to that virus that were characteristic of virus-associated Burkitt's lymphoma in Africa. Viral DNA and numerous cells with virus-determined nuclear antigen were found in tumor specimens available from three patients. These cases are unusual, since time-space clustering of Burkitt's lymphoma associated with Epstein-Barr virus has been observed thus far only in Africa.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Judson</LastName>
<ForeName>S C</ForeName>
<Initials>SC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Henle</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Henle</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Case Reports</PublicationType>
<PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antigens, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>DNA, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Antigens, Viral</DescriptorName>
<QualifierName MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Burkitt Lymphoma</DescriptorName>
<QualifierName MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName MajorTopicYN="N">genetics</QualifierName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">DNA, Viral</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Herpesvirus 4, Human</DescriptorName>
<QualifierName MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N">Pennsylvania</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
</MedlineCitationSet>